Compound Name,SMILES,Synonyms,SPARK Terms of Use,SPARK Data Downloads,Plant family,Extraction type,Country,Tissue (extraction source),Family (extraction source),Extraction source (full name),Extraction source (tissue),Extraction source (family),Plant name,Tissue,DOS_LIBRARY,Plant species/author epithet,Plant genus,Plant name (full),Previously listed as,SOURCE,STEREOCHEMISTRY,idStereoParent,FULL_CONFIG,Batch Name,Batch Compound-Batch ID,Batch Salt,Batch Formula weight,Initial Amount,Current Amount,Location,Alternate Names,Additional Names,Additional Names 2,Code/Source,Chembl #,Chembl link,Pubchem #,Pubchem Link,PubMed ID,DOI,Alternate Src Info,Alternate Source ID,Compound ID - Source,External ID,Common Name,Brand,Synonyms,CAS,Compound Class,Compound SubClass,Compound Type,Target,Effect,ModeOfAction,Administration,Development Status,Approval Date,Licensee,Indication,ModelSplit,Scaffold,Charge,clogD7.4,CO-ADD Project ID,CO-ADD Library Name,?SPARK Terms of Use and Data Downloads: Subset Date,?SPARK Terms of Use and Data Downloads: Subset Person,?SPARK Terms of Use and Data Downloads: Subset Lab,?SPARK Terms of Use and Data Downloads: Subset Conditions,?SPARK Terms of Use and Data Downloads: Subset ELN Entry,?SPARK Terms of Use and Data Downloads: Project Name,?SPARK Terms of Use and Data Downloads: SPARK Terms of Use,?SPARK Terms of Use and Data Downloads: SPARK Data Downloads,Curated & Transformed MIC Data: Subset Date,Curated & Transformed MIC Data: Subset Person,Curated & Transformed MIC Data: Subset Lab,Curated & Transformed MIC Data: Subset Conditions,Curated & Transformed MIC Data: Subset ELN Entry,Curated & Transformed MIC Data: Project Name,Curated & Transformed MIC Data: MIC (µg/mL),Curated & Transformed MIC Data: MIC/GIC reported as,Curated & Transformed MIC Data: MIC value (µg/mL),Curated & Transformed MIC Data: Test Article Type,Curated & Transformed MIC Data: MIC (in microM) (microM),Curated & Transformed MIC Data: Threshold of growth inhibition,Curated & Transformed MIC Data: pMIC,Curated & Transformed MIC Data: GIC (µg/mL),Curated & Transformed MIC Data: GIC % inhibition,Curated & Transformed MIC Data: Species,Curated & Transformed MIC Data: Strain,Curated & Transformed MIC Data: Strain - Other IDs,Curated & Transformed MIC Data: Clinical isolate?,Curated & Transformed MIC Data: Accumulation phenotype,Curated & Transformed MIC Data: Strain Genotype,Curated & Transformed MIC Data: Strain notes,Curated & Transformed MIC Data: Phenotype,Curated & Transformed MIC Data: Additives,Curated & Transformed MIC Data: Solvent,Curated & Transformed MIC Data: Solvent Amt. (%),Curated & Transformed MIC Data: Condition,Curated & Transformed MIC Data: Media,Curated & Transformed MIC Data: Buffered?,Curated & Transformed MIC Data: Method used,Curated & Transformed MIC Data: Source,Curated & Transformed MIC Data: Source - Link to original data,Curated & Transformed MIC Data: DOI,Curated & Transformed MIC Data: Curator notes,Curated & Transformed MIC Data: Curation Date,Extracted & Uploaded MIC Data: Subset Date,Extracted & Uploaded MIC Data: Subset Person,Extracted & Uploaded MIC Data: Subset Lab,Extracted & Uploaded MIC Data: Subset Conditions,Extracted & Uploaded MIC Data: Subset ELN Entry,Extracted & Uploaded MIC Data: Project Name,Extracted & Uploaded MIC Data: MIC (µg/mL),Extracted & Uploaded MIC Data: MIC/GIC reported as,Extracted & Uploaded MIC Data: MIC (in µM) (µM),Extracted & Uploaded MIC Data: Test Article Type,Extracted & Uploaded MIC Data: Threshold of growth inhibition,Extracted & Uploaded MIC Data: pMIC,Extracted & Uploaded MIC Data: GIC (Growth Inhibition Concentration) (µg/mL),Extracted & Uploaded MIC Data: GIC % Inhibition (%),Extracted & Uploaded MIC Data: Species,Extracted & Uploaded MIC Data: Strain,Extracted & Uploaded MIC Data: Strain - Other IDs,Extracted & Uploaded MIC Data: Clinical Isolate?,Extracted & Uploaded MIC Data: Accumulation phenotype,Extracted & Uploaded MIC Data: Strain Genotype,Extracted & Uploaded MIC Data: Strain notes,Extracted & Uploaded MIC Data: Phenotype,Extracted & Uploaded MIC Data: Additives,Extracted & Uploaded MIC Data: Solvent,Extracted & Uploaded MIC Data: Solvent Amt (%),Extracted & Uploaded MIC Data: Condition,Extracted & Uploaded MIC Data: Media,Extracted & Uploaded MIC Data: Methods used,Extracted & Uploaded MIC Data: Buffered?,Extracted & Uploaded MIC Data: Source,Extracted & Uploaded MIC Data: Year,Extracted & Uploaded MIC Data: Data Source Type,Extracted & Uploaded MIC Data: DOI,Extracted & Uploaded MIC Data: Chembl Activity ID,Extracted & Uploaded MIC Data: Extractor,Extracted & Uploaded MIC Data: Extractor notes,Extracted & Uploaded MIC Data: Upload Date,Extracted & Uploaded MIC Data: Upload Automation,Extracted & Uploaded MIC Data: Values converted by Extractor?
SPK-0258452,OB1OCC2=CC=CC(OCCC[N+]3=CC=CC=C3)=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258452-001,"No Salt, free base or acid",270.110,"","","",PMID: - Cmpd : 46,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",46,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258452,OB1OCC2=CC=CC(OCCC[N+]3=CC=CC=C3)=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258452-002,"No Salt, free base or acid",270.110,"","","",PMID:33228356 - Cmpd : 46,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",46,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 32.0,Modal,> 32.0,Test article,> 118,Visual,< 3.9,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 32.0,Modal,> 118,Test article,Visual,< 3.93,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258452,OB1OCC2=CC=CC(OCCC[N+]3=CC=CC=C3)=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258452-002,"No Salt, free base or acid",270.110,"","","",PMID:33228356 - Cmpd : 46,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",46,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,16.0,Modal,16.0,Test article,59.2,Visual,4.2,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,16.0,Modal,59.2,Test article,Visual,4.23,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258452,OB1OCC2=CC=CC(OCCC[N+]3=CC=CC=C3)=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258452-002,"No Salt, free base or acid",270.110,"","","",PMID:33228356 - Cmpd : 46,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",46,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 32.0,Modal,> 32.0,Test article,> 118,Visual,< 3.9,"","",Escherichia coli,CGSC 7636,BW25113; ARPX; NB27176,No,Wild type,"?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, rph-1, ?(rhaD-rhaB)568, hsdR514",Commonly used lab strain; parent strain for Keio collection of single gene knockout mutants,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 32.0,Modal,> 118,Test article,Visual,< 3.93,"","",Escherichia coli,BW25113,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258451,NC(=[NH2+])NCCCOC1=C2B(O)OCC2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258451-001,"No Salt, free base or acid",249.080,"","","",PMID: - Cmpd : 45,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",45,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258451,NC(=[NH2+])NCCCOC1=C2B(O)OCC2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258451-002,"No Salt, free base or acid",249.080,"","","",PMID:33228356 - Cmpd : 45,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",45,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 257,Visual,< 3.6,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 257,Test article,Visual,< 3.59,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258451,NC(=[NH2+])NCCCOC1=C2B(O)OCC2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258451-002,"No Salt, free base or acid",249.080,"","","",PMID:33228356 - Cmpd : 45,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",45,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,32.0,Modal,32.0,Test article,128,Visual,3.9,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,32.0,Modal,128,Test article,Visual,3.89,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258451,NC(=[NH2+])NCCCOC1=C2B(O)OCC2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258451-002,"No Salt, free base or acid",249.080,"","","",PMID:33228356 - Cmpd : 45,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",45,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,64.0,Modal,64.0,Test article,257,Visual,3.6,"","",Escherichia coli,CGSC 7636,BW25113; ARPX; NB27176,No,Wild type,"?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, rph-1, ?(rhaD-rhaB)568, hsdR514",Commonly used lab strain; parent strain for Keio collection of single gene knockout mutants,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,64.0,Modal,257,Test article,Visual,3.59,"","",Escherichia coli,BW25113,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258450,[NH3+]CCCOC1=C2B(O)OCC2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258450-001,"No Salt, free base or acid",207.040,"","","",PMID: - Cmpd : 44,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",44,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258450,[NH3+]CCCOC1=C2B(O)OCC2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258450-002,"No Salt, free base or acid",207.040,"","","",PMID:33228356 - Cmpd : 44,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",44,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,16.0,Modal,16.0,Test article,77.3,Visual,4.1,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,16.0,Modal,77.3,Test article,Visual,4.11,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258450,[NH3+]CCCOC1=C2B(O)OCC2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258450-002,"No Salt, free base or acid",207.040,"","","",PMID:33228356 - Cmpd : 44,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",44,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,2.00,Modal,2.00,Test article,9.66,Visual,5.0,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,2.00,Modal,9.66,Test article,Visual,5.02,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258450,[NH3+]CCCOC1=C2B(O)OCC2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258450-002,"No Salt, free base or acid",207.040,"","","",PMID:33228356 - Cmpd : 44,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",44,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,2.00,Modal,2.00,Test article,9.66,Visual,5.0,"","",Escherichia coli,CGSC 7636,BW25113; ARPX; NB27176,No,Wild type,"?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, rph-1, ?(rhaD-rhaB)568, hsdR514",Commonly used lab strain; parent strain for Keio collection of single gene knockout mutants,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,2.00,Modal,9.66,Test article,Visual,5.02,"","",Escherichia coli,BW25113,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258449,OCCCOC1=C2B(O)OCC2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258449-001,"No Salt, free base or acid",208.020,"","","",PMID: - Cmpd : 43,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",43,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258449,OCCCOC1=C2B(O)OCC2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258449-002,"No Salt, free base or acid",208.020,"","","",PMID:33228356 - Cmpd : 43,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",43,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,16.0,Modal,16.0,Test article,76.9,Visual,4.1,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Data previouly reported in Motika 2020; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,16.0,Modal,76.9,Test article,Visual,4.11,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258449,OCCCOC1=C2B(O)OCC2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258449-002,"No Salt, free base or acid",208.020,"","","",PMID:33228356 - Cmpd : 43,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",43,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,1.00,Modal,1.00,Test article,4.81,Visual,5.3,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,1.00,Modal,4.81,Test article,Visual,5.32,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258449,OCCCOC1=C2B(O)OCC2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258449-002,"No Salt, free base or acid",208.020,"","","",PMID:33228356 - Cmpd : 43,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",43,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,8.00,Modal,8.00,Test article,38.5,Visual,4.4,"","",Escherichia coli,CGSC 7636,BW25113; ARPX; NB27176,No,Wild type,"?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, rph-1, ?(rhaD-rhaB)568, hsdR514",Commonly used lab strain; parent strain for Keio collection of single gene knockout mutants,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,8.00,Modal,38.5,Test article,Visual,4.42,"","",Escherichia coli,BW25113,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258448,CC(=O)NCCCOC1=C2B(O)OCC2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258448-001,"No Salt, free base or acid",249.070,"","","",PMID: - Cmpd : S13,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S13,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258448,CC(=O)NCCCOC1=C2B(O)OCC2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258448-002,"No Salt, free base or acid",249.070,"","","",PMID:33228356 - Cmpd : S13,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S13,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,32.0,Modal,32.0,Test article,128,Visual,3.9,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,32.0,Modal,128,Test article,Visual,3.89,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258448,CC(=O)NCCCOC1=C2B(O)OCC2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258448-002,"No Salt, free base or acid",249.070,"","","",PMID:33228356 - Cmpd : S13,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S13,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,1.00,Modal,1.00,Test article,4.01,Visual,5.4,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,1.00,Modal,4.01,Test article,Visual,5.40,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258448,CC(=O)NCCCOC1=C2B(O)OCC2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258448-002,"No Salt, free base or acid",249.070,"","","",PMID:33228356 - Cmpd : S13,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S13,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,8.00,Modal,8.00,Test article,32.1,Visual,4.5,"","",Escherichia coli,CGSC 7636,BW25113; ARPX; NB27176,No,Wild type,"?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, rph-1, ?(rhaD-rhaB)568, hsdR514",Commonly used lab strain; parent strain for Keio collection of single gene knockout mutants,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,8.00,Modal,32.1,Test article,Visual,4.49,"","",Escherichia coli,BW25113,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258447,OCCCOC1=C2B(O)OC(C[N+]3=CC=CC=C3)C2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258447-001,"No Salt, free base or acid",300.140,"","","",PMID: - Cmpd : S12,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S12,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258447,OCCCOC1=C2B(O)OC(C[N+]3=CC=CC=C3)C2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258447-002,"No Salt, free base or acid",300.140,"","","",PMID:33228356 - Cmpd : S12,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S12,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 213,Visual,< 3.7,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 213,Test article,Visual,< 3.67,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258447,OCCCOC1=C2B(O)OC(C[N+]3=CC=CC=C3)C2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258447-002,"No Salt, free base or acid",300.140,"","","",PMID:33228356 - Cmpd : S12,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S12,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 213,Visual,< 3.7,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 213,Test article,Visual,< 3.67,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258447,OCCCOC1=C2B(O)OC(C[N+]3=CC=CC=C3)C2=CC=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258447-002,"No Salt, free base or acid",300.140,"","","",PMID:33228356 - Cmpd : S12,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S12,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 213,Visual,< 3.7,"","",Escherichia coli,CGSC 7636,BW25113; ARPX; NB27176,No,Wild type,"?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, rph-1, ?(rhaD-rhaB)568, hsdR514",Commonly used lab strain; parent strain for Keio collection of single gene knockout mutants,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 213,Test article,Visual,< 3.67,"","",Escherichia coli,BW25113,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258446,NC(=[NH2+])NCC1OB(O)C2=C(OCCCO)C=CC=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258446-001,"No Salt, free base or acid",279.100,"","","",PMID: - Cmpd : S11,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S11,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258446,NC(=[NH2+])NCC1OB(O)C2=C(OCCCO)C=CC=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258446-002,"No Salt, free base or acid",279.100,"","","",PMID:33228356 - Cmpd : S11,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S11,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 229,Visual,< 3.6,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 229,Test article,Visual,< 3.64,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258446,NC(=[NH2+])NCC1OB(O)C2=C(OCCCO)C=CC=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258446-002,"No Salt, free base or acid",279.100,"","","",PMID:33228356 - Cmpd : S11,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S11,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 229,Visual,< 3.6,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 229,Test article,Visual,< 3.64,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258446,NC(=[NH2+])NCC1OB(O)C2=C(OCCCO)C=CC=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258446-002,"No Salt, free base or acid",279.100,"","","",PMID:33228356 - Cmpd : S11,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S11,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 229,Visual,< 3.6,"","",Escherichia coli,CGSC 7636,BW25113; ARPX; NB27176,No,Wild type,"?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, rph-1, ?(rhaD-rhaB)568, hsdR514",Commonly used lab strain; parent strain for Keio collection of single gene knockout mutants,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 229,Test article,Visual,< 3.64,"","",Escherichia coli,BW25113,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258445,[NH3+]CC1OB(O)C2=C(OCCCO)C=CC=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258445-001,"No Salt, free base or acid",237.060,"","","",PMID: - Cmpd : (±)42,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",(±)42,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258445,[NH3+]CC1OB(O)C2=C(OCCCO)C=CC=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258445-002,"No Salt, free base or acid",237.060,"","","",PMID:33228356 - Cmpd : (±)42,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",(±)42,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,4.00,Modal,4.00,Test article,16.9,Visual,4.8,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,4.00,Modal,16.9,Test article,Visual,4.77,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258445,[NH3+]CC1OB(O)C2=C(OCCCO)C=CC=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258445-002,"No Salt, free base or acid",237.060,"","","",PMID:33228356 - Cmpd : (±)42,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",(±)42,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,4.00,Modal,4.00,Test article,16.9,Visual,4.8,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,4.00,Modal,16.9,Test article,Visual,4.77,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258445,[NH3+]CC1OB(O)C2=C(OCCCO)C=CC=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258445-002,"No Salt, free base or acid",237.060,"","","",PMID:33228356 - Cmpd : (±)42,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",(±)42,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,4.00,Modal,4.00,Test article,16.9,Visual,4.8,"","",Escherichia coli,CGSC 7636,BW25113; ARPX; NB27176,No,Wild type,"?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, rph-1, ?(rhaD-rhaB)568, hsdR514",Commonly used lab strain; parent strain for Keio collection of single gene knockout mutants,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,4.00,Modal,16.9,Test article,Visual,4.77,"","",Escherichia coli,BW25113,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258444,OC1=NC(=NC(=C1)C1=CC=CS1)C1CCCN(CC2=CN(C=N2)C2=NC=C(C[N+]3=CC=CC=C3)C=N2)C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258444-001,"No Salt, free base or acid",511.630,"","","",PMID: - Cmpd : (±)S10,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",(±)S10,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258444,OC1=NC(=NC(=C1)C1=CC=CS1)C1CCCN(CC2=CN(C=N2)C2=NC=C(C[N+]3=CC=CC=C3)C=N2)C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258444-002,"No Salt, free base or acid",511.630,"","","",PMID:33228356 - Cmpd : (±)S10,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",(±)S10,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 128,Modal,> 128,Test article,> 250,Visual,< 3.6,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",M9-MOPS,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 128,Modal,> 250,Test article,Visual,< 3.60,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",M9-MOPS,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258444,OC1=NC(=NC(=C1)C1=CC=CS1)C1CCCN(CC2=CN(C=N2)C2=NC=C(C[N+]3=CC=CC=C3)C=N2)C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258444-002,"No Salt, free base or acid",511.630,"","","",PMID:33228356 - Cmpd : (±)S10,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",(±)S10,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 128,Modal,> 128,Test article,> 250,Visual,< 3.6,"","",Escherichia coli,CGSC 7636,BW25113; ARPX; NB27176,No,Wild type,"?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, rph-1, ?(rhaD-rhaB)568, hsdR514",Commonly used lab strain; parent strain for Keio collection of single gene knockout mutants,"","",DMSO,2.0,"37C, 18-20 hours",M9-MOPS,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 128,Modal,> 250,Test article,Visual,< 3.60,"","",Escherichia coli,BW25113,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",M9-MOPS,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258443,NC(=[NH2+])NCC1=CN=C(N=C1)N1C=NC(CN2CCCC(C2)C2=NC(=CC(O)=N2)C2=CC=CS2)=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258443-001,"No Salt, free base or acid",490.590,"","","",PMID: - Cmpd : (±)S9,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",(±)S9,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258443,NC(=[NH2+])NCC1=CN=C(N=C1)N1C=NC(CN2CCCC(C2)C2=NC(=CC(O)=N2)C2=CC=CS2)=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258443-002,"No Salt, free base or acid",490.590,"","","",PMID:33228356 - Cmpd : (±)S9,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",(±)S9,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,64.0,Modal,64.0,Test article,130,Visual,3.9,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",M9-MOPS,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,64.0,Modal,130,Test article,Visual,3.88,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",M9-MOPS,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258443,NC(=[NH2+])NCC1=CN=C(N=C1)N1C=NC(CN2CCCC(C2)C2=NC(=CC(O)=N2)C2=CC=CS2)=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258443-002,"No Salt, free base or acid",490.590,"","","",PMID:33228356 - Cmpd : (±)S9,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",(±)S9,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,64.0,Modal,64.0,Test article,130,Visual,3.9,"","",Escherichia coli,CGSC 7636,BW25113; ARPX; NB27176,No,Wild type,"?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, rph-1, ?(rhaD-rhaB)568, hsdR514",Commonly used lab strain; parent strain for Keio collection of single gene knockout mutants,"","",DMSO,2.0,"37C, 18-20 hours",M9-MOPS,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,64.0,Modal,130,Test article,Visual,3.88,"","",Escherichia coli,BW25113,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",M9-MOPS,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258442,NC(=[NH2+])NCC#CC1=CN=C(N=C1)N1C=NC(CN2CCCC(C2)C2=NC(=CC(O)=N2)C2=CC=CS2)=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258442-001,"No Salt, free base or acid",514.610,"","","",PMID: - Cmpd : (±)40,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",(±)40,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258442,NC(=[NH2+])NCC#CC1=CN=C(N=C1)N1C=NC(CN2CCCC(C2)C2=NC(=CC(O)=N2)C2=CC=CS2)=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258442-002,"No Salt, free base or acid",514.610,"","","",PMID:33228356 - Cmpd : (±)40,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",(±)40,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,8.00,Modal,8.00,Test article,15.5,Visual,4.8,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",M9-MOPS,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Data previouly reported in Motika 2020; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,8.00,Modal,15.5,Test article,Visual,4.81,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",M9-MOPS,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258442,NC(=[NH2+])NCC#CC1=CN=C(N=C1)N1C=NC(CN2CCCC(C2)C2=NC(=CC(O)=N2)C2=CC=CS2)=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258442-002,"No Salt, free base or acid",514.610,"","","",PMID:33228356 - Cmpd : (±)40,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",(±)40,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,64.0,Modal,64.0,Test article,124,Visual,3.9,"","",Escherichia coli,CGSC 7636,BW25113; ARPX; NB27176,No,Wild type,"?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, rph-1, ?(rhaD-rhaB)568, hsdR514",Commonly used lab strain; parent strain for Keio collection of single gene knockout mutants,"","",DMSO,2.0,"37C, 18-20 hours",M9-MOPS,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Data previouly reported in Motika 2020; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,64.0,Modal,124,Test article,Visual,3.91,"","",Escherichia coli,BW25113,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",M9-MOPS,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258441,[NH3+]CC#CC1=CN=C(N=C1)N1C=NC(CN2CCCC(C2)C2=NC(=CC(O)=N2)C2=CC=CS2)=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258441-001,"No Salt, free base or acid",472.570,"","","",PMID: - Cmpd : (±)39,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",(±)39,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258441,[NH3+]CC#CC1=CN=C(N=C1)N1C=NC(CN2CCCC(C2)C2=NC(=CC(O)=N2)C2=CC=CS2)=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258441-002,"No Salt, free base or acid",472.570,"","","",PMID:33228356 - Cmpd : (±)39,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",(±)39,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,0.500,Modal,0.500,Test article,1.06,Visual,6.0,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",M9-MOPS,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,0.500,Modal,1.06,Test article,Visual,5.98,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",M9-MOPS,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Data previouly reported in Motika 2020; Table S2,"","",""
SPK-0258441,[NH3+]CC#CC1=CN=C(N=C1)N1C=NC(CN2CCCC(C2)C2=NC(=CC(O)=N2)C2=CC=CS2)=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258441-002,"No Salt, free base or acid",472.570,"","","",PMID:33228356 - Cmpd : (±)39,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",(±)39,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,8.00,Modal,8.00,Test article,16.9,Visual,4.8,"","",Escherichia coli,CGSC 7636,BW25113; ARPX; NB27176,No,Wild type,"?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, rph-1, ?(rhaD-rhaB)568, hsdR514",Commonly used lab strain; parent strain for Keio collection of single gene knockout mutants,"","",DMSO,2.0,"37C, 18-20 hours",M9-MOPS,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Data previouly reported in Motika 2020; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,8.00,Modal,16.9,Test article,Visual,4.77,"","",Escherichia coli,BW25113,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",M9-MOPS,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Data previouly reported in Motika 2020; Table S2,"","",""
SPK-0258440,FC(F)(F)C1=NC(=NC(NCCC[N+]2=CC=CC=C2)=C1)C1=NNC2=CN=CC=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258440-001,"No Salt, free base or acid",400.389,"","","",PMID: - Cmpd : S6,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S6,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258440,FC(F)(F)C1=NC(=NC(NCCC[N+]2=CC=CC=C2)=C1)C1=NNC2=CN=CC=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258440-002,"No Salt, free base or acid",400.389,"","","",PMID:33228356 - Cmpd : S6,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S6,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 128,Modal,> 128,Test article,> 320,Visual,< 3.5,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 128,Modal,> 320,Test article,Visual,< 3.50,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258440,FC(F)(F)C1=NC(=NC(NCCC[N+]2=CC=CC=C2)=C1)C1=NNC2=CN=CC=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258440-002,"No Salt, free base or acid",400.389,"","","",PMID:33228356 - Cmpd : S6,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S6,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 128,Modal,> 128,Test article,> 320,Visual,< 3.5,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 128,Modal,> 320,Test article,Visual,< 3.50,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258440,FC(F)(F)C1=NC(=NC(NCCC[N+]2=CC=CC=C2)=C1)C1=NNC2=CN=CC=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258440-002,"No Salt, free base or acid",400.389,"","","",PMID:33228356 - Cmpd : S6,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S6,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 128,Modal,> 128,Test article,> 320,Visual,< 3.5,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 128,Modal,> 320,Test article,Visual,< 3.50,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258439,NC(=[NH2+])NCCCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258439-001,"No Salt, free base or acid",379.351,"","","",PMID: - Cmpd : S5,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S5,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258439,NC(=[NH2+])NCCCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258439-002,"No Salt, free base or acid",379.351,"","","",PMID:33228356 - Cmpd : S5,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S5,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,32.0,Modal,32.0,Test article,84.4,Visual,4.1,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,32.0,Modal,84.4,Test article,Visual,4.07,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258439,NC(=[NH2+])NCCCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258439-002,"No Salt, free base or acid",379.351,"","","",PMID:33228356 - Cmpd : S5,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,32.0,Modal,32.0,Test article,84.4,Visual,4.1,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,32.0,Modal,84.4,Test article,Visual,4.07,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258439,NC(=[NH2+])NCCCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258439-002,"No Salt, free base or acid",379.351,"","","",PMID:33228356 - Cmpd : S5,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 169,Visual,< 3.8,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 169,Test article,Visual,< 3.77,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258438,[NH3+]CCCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258438-001,"No Salt, free base or acid",337.310,"","","",PMID: - Cmpd : S4,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S4,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258438,[NH3+]CCCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258438-002,"No Salt, free base or acid",337.310,"","","",PMID:33228356 - Cmpd : S4,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S4,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 128,Modal,> 128,Test article,> 379,Visual,< 3.4,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 128,Modal,> 379,Test article,Visual,< 3.42,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258438,[NH3+]CCCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258438-002,"No Salt, free base or acid",337.310,"","","",PMID:33228356 - Cmpd : S4,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S4,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,128,Modal,128,Test article,379,Visual,3.4,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,128,Modal,379,Test article,Visual,3.42,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258438,[NH3+]CCCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258438-002,"No Salt, free base or acid",337.310,"","","",PMID:33228356 - Cmpd : S4,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S4,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 128,Modal,> 128,Test article,> 379,Visual,< 3.4,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 128,Modal,> 379,Test article,Visual,< 3.42,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258437,FC(F)(F)C1=NC(=NC(NCC[N+]2=CC=CC=C2)=C1)C1=NNC2=CN=CC=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258437-001,"No Salt, free base or acid",386.362,"","","",PMID: - Cmpd : 37,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",37,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258437,FC(F)(F)C1=NC(=NC(NCC[N+]2=CC=CC=C2)=C1)C1=NNC2=CN=CC=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258437-002,"No Salt, free base or acid",386.362,"","","",PMID:33228356 - Cmpd : 37,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",37,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 128,Modal,> 128,Test article,> 331,Visual,< 3.5,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 128,Modal,> 331,Test article,Visual,< 3.48,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258437,FC(F)(F)C1=NC(=NC(NCC[N+]2=CC=CC=C2)=C1)C1=NNC2=CN=CC=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258437-002,"No Salt, free base or acid",386.362,"","","",PMID:33228356 - Cmpd : 37,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",37,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 128,Modal,> 128,Test article,> 331,Visual,< 3.5,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 128,Modal,> 331,Test article,Visual,< 3.48,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258437,FC(F)(F)C1=NC(=NC(NCC[N+]2=CC=CC=C2)=C1)C1=NNC2=CN=CC=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258437-002,"No Salt, free base or acid",386.362,"","","",PMID:33228356 - Cmpd : 37,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",37,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 128,Modal,> 128,Test article,> 331,Visual,< 3.5,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 128,Modal,> 331,Test article,Visual,< 3.48,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258436,NC(=[NH2+])NCCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258436-001,"No Salt, free base or acid",365.324,"","","",PMID: - Cmpd : 36,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",36,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258436,NC(=[NH2+])NCCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258436-002,"No Salt, free base or acid",365.324,"","","",PMID:33228356 - Cmpd : 36,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",36,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,32.0,Modal,32.0,Test article,87.6,Visual,4.1,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,32.0,Modal,87.6,Test article,Visual,4.06,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258436,NC(=[NH2+])NCCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258436-002,"No Salt, free base or acid",365.324,"","","",PMID:33228356 - Cmpd : 36,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",36,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,32.0,Modal,32.0,Test article,87.6,Visual,4.1,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,32.0,Modal,87.6,Test article,Visual,4.06,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258436,NC(=[NH2+])NCCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258436-002,"No Salt, free base or acid",365.324,"","","",PMID:33228356 - Cmpd : 36,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",36,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 175,Visual,< 3.8,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 175,Test article,Visual,< 3.76,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258435,[NH3+]CCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258435-001,"No Salt, free base or acid",323.283,"","","",PMID: - Cmpd : 35,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",35,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258435,[NH3+]CCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258435-002,"No Salt, free base or acid",323.283,"","","",PMID:33228356 - Cmpd : 35,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",35,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 198,Visual,< 3.7,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 198,Test article,Visual,< 3.70,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258435,[NH3+]CCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258435-002,"No Salt, free base or acid",323.283,"","","",PMID:33228356 - Cmpd : 35,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",35,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 198,Visual,< 3.7,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 198,Test article,Visual,< 3.70,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258435,[NH3+]CCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258435-002,"No Salt, free base or acid",323.283,"","","",PMID:33228356 - Cmpd : 35,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",35,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 198,Visual,< 3.7,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 198,Test article,Visual,< 3.70,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258434,OCCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258434-001,"No Salt, free base or acid",324.267,"","","",PMID: - Cmpd : 34,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",34,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258434,OCCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258434-002,"No Salt, free base or acid",324.267,"","","",PMID:33228356 - Cmpd : 34,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",34,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,4.00,Modal,4.00,Test article,12.3,Visual,4.9,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,4.00,Modal,12.3,Test article,Visual,4.91,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258434,OCCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258434-002,"No Salt, free base or acid",324.267,"","","",PMID:33228356 - Cmpd : 34,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",34,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,8.00,Modal,8.00,Test article,24.7,Visual,4.6,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,8.00,Modal,24.7,Test article,Visual,4.61,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258434,OCCNC1=CC(=NC(=N1)C1=NNC2=CN=CC=C12)C(F)(F)F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258434-002,"No Salt, free base or acid",324.267,"","","",PMID:33228356 - Cmpd : 34,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",34,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 197,Visual,< 3.7,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 197,Test article,Visual,< 3.70,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258433,CC1=CC=C2N=C(\C=C\C3=CC=C(Cl)C=C3)N=C(NCC[N+]3=CC=CC=C3)C2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258433-001,"No Salt, free base or acid",401.920,"","","",PMID: - Cmpd : 33,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",33,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258433,CC1=CC=C2N=C(\C=C\C3=CC=C(Cl)C=C3)N=C(NCC[N+]3=CC=CC=C3)C2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258433-002,"No Salt, free base or acid",401.920,"","","",PMID:33228356 - Cmpd : 33,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",33,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,16.0,Modal,16.0,Test article,39.8,Visual,4.4,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,16.0,Modal,39.8,Test article,Visual,4.40,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258433,CC1=CC=C2N=C(\C=C\C3=CC=C(Cl)C=C3)N=C(NCC[N+]3=CC=CC=C3)C2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258433-002,"No Salt, free base or acid",401.920,"","","",PMID:33228356 - Cmpd : 33,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",33,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,16.0,Modal,16.0,Test article,39.8,Visual,4.4,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,16.0,Modal,39.8,Test article,Visual,4.40,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258433,CC1=CC=C2N=C(\C=C\C3=CC=C(Cl)C=C3)N=C(NCC[N+]3=CC=CC=C3)C2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258433-002,"No Salt, free base or acid",401.920,"","","",PMID:33228356 - Cmpd : 33,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",33,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 159,Visual,< 3.8,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 159,Test article,Visual,< 3.80,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258432,CC1=CC=C2N=C(\C=C\C3=CC=C(Cl)C=C3)N=C(NCCNC(N)=[NH2+])C2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258432-001,"No Salt, free base or acid",380.880,"","","",PMID: - Cmpd : 32,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",32,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258432,CC1=CC=C2N=C(\C=C\C3=CC=C(Cl)C=C3)N=C(NCCNC(N)=[NH2+])C2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258432-002,"No Salt, free base or acid",380.880,"","","",PMID:33228356 - Cmpd : 32,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",32,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,2.00,Modal,2.00,Test article,5.25,Visual,5.3,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,2.00,Modal,5.25,Test article,Visual,5.28,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258432,CC1=CC=C2N=C(\C=C\C3=CC=C(Cl)C=C3)N=C(NCCNC(N)=[NH2+])C2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258432-002,"No Salt, free base or acid",380.880,"","","",PMID:33228356 - Cmpd : 32,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",32,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,2.00,Modal,2.00,Test article,5.25,Visual,5.3,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,2.00,Modal,5.25,Test article,Visual,5.28,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258432,CC1=CC=C2N=C(\C=C\C3=CC=C(Cl)C=C3)N=C(NCCNC(N)=[NH2+])C2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258432-002,"No Salt, free base or acid",380.880,"","","",PMID:33228356 - Cmpd : 32,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",32,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,16.0,Modal,16.0,Test article,42.0,Visual,4.4,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,16.0,Modal,42.0,Test article,Visual,4.38,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258431,CC1=CC=C2N=C(\C=C\C3=CC=C(Cl)C=C3)N=C(NCC[NH3+])C2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258431-001,"No Salt, free base or acid",338.840,"","","",PMID: - Cmpd : 31,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",31,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258431,CC1=CC=C2N=C(\C=C\C3=CC=C(Cl)C=C3)N=C(NCC[NH3+])C2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258431-002,"No Salt, free base or acid",338.840,"","","",PMID:33228356 - Cmpd : 31,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",31,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,4.00,Modal,4.00,Test article,11.8,Visual,4.9,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,4.00,Modal,11.8,Test article,Visual,4.93,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258431,CC1=CC=C2N=C(\C=C\C3=CC=C(Cl)C=C3)N=C(NCC[NH3+])C2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258431-002,"No Salt, free base or acid",338.840,"","","",PMID:33228356 - Cmpd : 31,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",31,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,8.00,Modal,8.00,Test article,23.6,Visual,4.6,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,8.00,Modal,23.6,Test article,Visual,4.63,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258431,CC1=CC=C2N=C(\C=C\C3=CC=C(Cl)C=C3)N=C(NCC[NH3+])C2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258431-002,"No Salt, free base or acid",338.840,"","","",PMID:33228356 - Cmpd : 31,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",31,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,8.00,Modal,8.00,Test article,23.6,Visual,4.6,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,8.00,Modal,23.6,Test article,Visual,4.63,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258430,CC(=O)NCCNC1=NC(\C=C\C2=CC=C(Cl)C=C2)=NC2=CC=C(C)C=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258430-001,"No Salt, free base or acid",380.880,"","","",PMID: - Cmpd : 30,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",30,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258430,CC(=O)NCCNC1=NC(\C=C\C2=CC=C(Cl)C=C2)=NC2=CC=C(C)C=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258430-002,"No Salt, free base or acid",380.880,"","","",PMID:33228356 - Cmpd : 30,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",30,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,32.0,Modal,32.0,Test article,84.0,Visual,4.1,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,32.0,Modal,84.0,Test article,Visual,4.08,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258430,CC(=O)NCCNC1=NC(\C=C\C2=CC=C(Cl)C=C2)=NC2=CC=C(C)C=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258430-002,"No Salt, free base or acid",380.880,"","","",PMID:33228356 - Cmpd : 30,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",30,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,16.0,Modal,16.0,Test article,42.0,Visual,4.4,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,16.0,Modal,42.0,Test article,Visual,4.38,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258430,CC(=O)NCCNC1=NC(\C=C\C2=CC=C(Cl)C=C2)=NC2=CC=C(C)C=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258430-002,"No Salt, free base or acid",380.880,"","","",PMID:33228356 - Cmpd : 30,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",30,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 168,Visual,< 3.8,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 168,Test article,Visual,< 3.77,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258429,CC[NH+](CC)CCNC1=NC(\C=C\C2=CC=C(Cl)C=C2)=NC2=CC=C(C)C=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258429-001,"No Salt, free base or acid",394.950,"","","",PMID: - Cmpd : 29,"","","","","","","","",https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",29,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
SPK-0258429,CC[NH+](CC)CCNC1=NC(\C=C\C2=CC=C(Cl)C=C2)=NC2=CC=C(C)C=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258429-002,"No Salt, free base or acid",394.950,"","","",PMID:33228356 - Cmpd : 29,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",29,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,16.0,Modal,16.0,Test article,40.5,Visual,4.4,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,16.0,Modal,40.5,Test article,Visual,4.39,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258429,CC[NH+](CC)CCNC1=NC(\C=C\C2=CC=C(Cl)C=C2)=NC2=CC=C(C)C=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258429-002,"No Salt, free base or acid",394.950,"","","",PMID:33228356 - Cmpd : 29,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",29,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,8.00,Modal,8.00,Test article,20.3,Visual,4.7,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,8.00,Modal,20.3,Test article,Visual,4.69,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258429,CC[NH+](CC)CCNC1=NC(\C=C\C2=CC=C(Cl)C=C2)=NC2=CC=C(C)C=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258429-002,"No Salt, free base or acid",394.950,"","","",PMID:33228356 - Cmpd : 29,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",29,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 162,Visual,< 3.8,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 162,Test article,Visual,< 3.79,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258428,[NH3+]CCNC1=NC(\C=C\C2=CC=C(Cl)C=C2)=NC2=CC3=C(C=CC=C3)C=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258428-001,"No Salt, free base or acid",374.870,"","","",PMID:33228356 - Cmpd : S3,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S3,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,2.00,Modal,2.00,Test article,5.34,Visual,5.3,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,2.00,Modal,5.34,Test article,Visual,5.27,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258428,[NH3+]CCNC1=NC(\C=C\C2=CC=C(Cl)C=C2)=NC2=CC3=C(C=CC=C3)C=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258428-001,"No Salt, free base or acid",374.870,"","","",PMID:33228356 - Cmpd : S3,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S3,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,4.00,Modal,4.00,Test article,10.7,Visual,5.0,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,4.00,Modal,10.7,Test article,Visual,4.97,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258427,CC[NH+](CC)CCNC1=NC(\C=C\C2=CC=C(Cl)C=C2)=NC2=CC3=C(C=CC=C3)C=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258427-001,"No Salt, free base or acid",430.980,"","","",PMID:33228356 - Cmpd : S2,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S2,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,4.00,Modal,4.00,Test article,9.28,Visual,5.0,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,4.00,Modal,9.28,Test article,Visual,5.03,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258427,CC[NH+](CC)CCNC1=NC(\C=C\C2=CC=C(Cl)C=C2)=NC2=CC3=C(C=CC=C3)C=C12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258427-001,"No Salt, free base or acid",430.980,"","","",PMID:33228356 - Cmpd : S2,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",S2,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 148,Visual,< 3.8,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 148,Test article,Visual,< 3.83,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258426,CN1C(=O)C=C(C)C2=C1C1=C3N(C(C[N+]4=CC=CC=C4)CO1)C(=O)C=C(C)C3=C2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258426-001,"No Salt, free base or acid",388.446,"","","",PMID:33228356 - Cmpd : 28,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",28,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 165,Visual,< 3.8,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 165,Test article,Visual,< 3.78,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258426,CN1C(=O)C=C(C)C2=C1C1=C3N(C(C[N+]4=CC=CC=C4)CO1)C(=O)C=C(C)C3=C2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258426-001,"No Salt, free base or acid",388.446,"","","",PMID:33228356 - Cmpd : 28,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",28,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,16.0,Modal,16.0,Test article,41.2,Visual,4.4,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,16.0,Modal,41.2,Test article,Visual,4.39,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258426,CN1C(=O)C=C(C)C2=C1C1=C3N(C(C[N+]4=CC=CC=C4)CO1)C(=O)C=C(C)C3=C2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258426-001,"No Salt, free base or acid",388.446,"","","",PMID:33228356 - Cmpd : 28,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",28,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 165,Visual,< 3.8,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 165,Test article,Visual,< 3.78,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258425,CN1C(=O)C=C(C)C2=C1C1=C3N(C(CNC(N)=[NH2+])CO1)C(=O)C=C(C)C3=C2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258425-001,"No Salt, free base or acid",367.409,"","","",PMID:33228356 - Cmpd : 27,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",27,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,16.0,Modal,16.0,Test article,43.5,Visual,4.4,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,16.0,Modal,43.5,Test article,Visual,4.36,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258425,CN1C(=O)C=C(C)C2=C1C1=C3N(C(CNC(N)=[NH2+])CO1)C(=O)C=C(C)C3=C2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258425-001,"No Salt, free base or acid",367.409,"","","",PMID:33228356 - Cmpd : 27,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",27,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,2.00,Modal,2.00,Test article,5.44,Visual,5.3,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,2.00,Modal,5.44,Test article,Visual,5.26,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258425,CN1C(=O)C=C(C)C2=C1C1=C3N(C(CNC(N)=[NH2+])CO1)C(=O)C=C(C)C3=C2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258425-001,"No Salt, free base or acid",367.409,"","","",PMID:33228356 - Cmpd : 27,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",27,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 174,Visual,< 3.8,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,> 64.0,Modal,> 174,Test article,Visual,< 3.76,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258424,CN(CC1=C(C)C2=CC=CC=C2O1)C(=O)\C=C\C1=CN=C2NC(=O)C(CC[N+]3=CC=CC=C3)CC2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258424-001,"No Salt, free base or acid",481.575,"","","",PMID:33228356 - Cmpd : 24,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",24,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,0.250,Modal,0.250,Test article,0.519,Visual,6.3,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,0.250,Modal,0.519,Test article,Visual,6.28,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258424,CN(CC1=C(C)C2=CC=CC=C2O1)C(=O)\C=C\C1=CN=C2NC(=O)C(CC[N+]3=CC=CC=C3)CC2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258424-001,"No Salt, free base or acid",481.575,"","","",PMID:33228356 - Cmpd : 24,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",24,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,0.250,Modal,0.250,Test article,0.519,Visual,6.3,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,0.250,Modal,0.519,Test article,Visual,6.28,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258424,CN(CC1=C(C)C2=CC=CC=C2O1)C(=O)\C=C\C1=CN=C2NC(=O)C(CC[N+]3=CC=CC=C3)CC2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258424-001,"No Salt, free base or acid",481.575,"","","",PMID:33228356 - Cmpd : 24,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",24,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,64.0,Modal,64.0,Test article,133,Visual,3.9,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,64.0,Modal,133,Test article,Visual,3.88,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258423,CN(CC1=C(C)C2=CC=CC=C2O1)C(=O)\C=C\C1=CN=C2NC(=O)C(CCNC(N)=[NH2+])CC2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258423-001,"No Salt, free base or acid",460.538,"","","",PMID:33228356 - Cmpd : 23,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",23,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,0.125,Modal,0.125,Test article,0.271,Visual,6.6,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,0.125,Modal,0.271,Test article,Visual,6.57,"","",Staphylococcus aureus,ATCC 29213,"",No,NA / Gram Positive,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258423,CN(CC1=C(C)C2=CC=CC=C2O1)C(=O)\C=C\C1=CN=C2NC(=O)C(CCNC(N)=[NH2+])CC2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258423-001,"No Salt, free base or acid",460.538,"","","",PMID:33228356 - Cmpd : 23,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",23,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,0.500,Modal,0.500,Test article,1.09,Visual,6.0,"","",Escherichia coli,CGSC 11430,JW5503; JW5503-1; JW5503 1; NB27177,No,Efflux deficient,"CGSC 7636 F-, ?(araD-araB)567, ?lacZ4787(::rrnB-3), ?-, ?tolC732::kan, rph-1, ?(rhaD-rhaB)568, hsdR514",Efflux deficient (tolC) mutant derived from BW25113 (CGSC 7636),"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,0.500,Modal,1.09,Test article,Visual,5.96,"","",Escherichia coli,CGSC 11430,JW5503 ?tolC; JW5503-1; JW5503 1,No,Efflux deficient,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258423,CN(CC1=C(C)C2=CC=CC=C2O1)C(=O)\C=C\C1=CN=C2NC(=O)C(CCNC(N)=[NH2+])CC2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258423-001,"No Salt, free base or acid",460.538,"","","",PMID:33228356 - Cmpd : 23,"","","","","","","",33228356,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"","",23,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Curated Data,64.0,Modal,64.0,Test article,139,Visual,3.9,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,2.0,"37C, 18-20 hours",CAMHB,"",CLSI,Perlmutter 2020 ACS Infect. Dis. 7:162,https://app.collaborativedrug.com/vaults/4724/runs/455002,https://dx.doi.org/10.1021/acsinfecdis.0c00715,KRP; Table S2,2021-01-06,2021-01-20,Perlmutter 2020 ACS Infect. Dis. 7:162,"","Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

DOI: https://dx.doi.org/10.1021/acsinfecdis.0c00715","",Uploaded Data,64.0,Modal,139,Test article,Visual,3.86,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"","","","",DMSO,2.00,"37C, 18-20 hours",CAMHB,CLSI,"",Perlmutter 2020 ACS Infect. Dis. 7:162,2020,Other,https://dx.doi.org/10.1021/acsinfecdis.0c00715,"",KRP,Table S2,"","",""
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.0310,Modal,0.0310,Test article,0.0574,Visual,7.2,"","",Staphylococcus aureus,ATCC 19636,Smith; ATCC 13709,No,NA / Gram Positive,"",Parent strain of Staphylococcus aureus L-Phase variant strain Smith L (ATCC 19640); isolates from human with osteomyelitis,Methicillin susceptible (MSSA),"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.0310,"",0.0574,"","",7.24,"","",Staphylococcus aureus,Smith,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.250,Modal,0.250,Test article,0.463,Visual,6.3,"","",Streptococcus pneumoniae,IID554,"",No,NA / Gram Positive,"",From the Japanese Society for Bacteriology,Wild type,"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.250,"",0.463,"","",6.33,"","",Streptococcus pneumoniae,IID554,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,2.00,Modal,2.00,Test article,3.70,Visual,5.4,"","",Enterococcus faecalis,ATCC 29212,NCTC 12697; Portland; KCTC 2011,No,NA / Gram Positive,"",CLSI reference strain,"","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,2.00,"",3.70,"","",5.43,"","",Enterococcus faecalis,ATCC 29212,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,2.00,Modal,2.00,Test article,3.70,Visual,5.4,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,2.00,"",3.70,"","",5.43,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,8.00,Modal,8.00,Test article,14.8,Visual,4.8,"","",Pseudomonas aeruginosa,PAO1,ATCC BAA-47; ARC545; Pae545; PAM1020; APAE002; K767; K2732; NB52019,No,Wild type,aph(3')-IIb,Well characterized lab isolate,"","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,8.00,"",14.8,"","",4.83,"","",Pseudomonas aeruginosa,PAO1,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.250,Modal,0.250,Test article,0.463,Visual,6.3,"","",Acinetobacter baumannii,IID876,"",No,Wild type,"",From the Japanese Society for Bacteriology,Wild type,"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.250,"",0.463,"","",6.33,"","",Acinetobacter baumannii,IID876,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.0310,Modal,0.0310,Test article,0.0574,Visual,7.2,"","",Moraxella catarrhalis,ATCC 25238,"",No,Wild type,"",Strain designation Ne 11; quality control strain,Wild type,"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.0310,"",0.0574,"","",7.24,"","",Moraxella catarrhalis,ATCC 25238,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,1.00,Modal,1.00,Test article,1.85,Visual,5.7,"","",Haemophilus influenzae,ATCC 49247,TD-4,No,Not characterized,"",CLSI reference strain; quality Control strain,"","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,1.00,"",1.85,"","",5.73,"","",Haemophilus influenzae,ATCC 49247,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.0310,Modal,0.0310,Test article,0.0574,Visual,7.2,"","",Staphylococcus aureus,OITI 1-971,"",Yes,NA / Gram Positive,"","",Methicillin resistant,"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.0310,"",0.0574,"","",7.24,"","",Staphylococcus aureus,OITI 1-971,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,2.00,Modal,2.00,Test article,3.70,Visual,5.4,"","",Enterococcus faecium,A2373,"",No,NA / Gram Positive,vanA,"",Vancomycin resistant,"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,2.00,"",3.70,"","",5.43,"","",Enterococcus faecium,A2373,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,1.00,Modal,1.00,Test article,1.85,Visual,5.7,"","",Escherichia coli,TG1,"",No,Wild type,supE hsdD5 thi (?lac-proAB)/F? [traD36 proAB+ lacIq lac ?ZM15],"","","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,1.00,"",1.85,"","",5.73,"","",Escherichia coli,TG1,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,4.00E-03,Modal,4.00E-03,Test article,7.41E-03,Visual,8.1,"","",Escherichia coli,KAM3,"",No,Efflux deficient,TG1 ?acrAB supE hsdD5 thi (?lac-proAB)/F? [traD36 proAB+ lacIq lac ?ZM15],Efflux deficient (acrAB) mutant derived from TG1,"","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,4.00E-03,"",7.41E-03,"","",8.13,"","",Escherichia coli,KAM3,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,8.00,Modal,8.00,Test article,14.8,Visual,4.8,"","",Pseudomonas aeruginosa,PAO4009,"",No,Wild type,"","","","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,8.00,"",14.8,"","",4.83,"","",Pseudomonas aeruginosa,PAO4009,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,> 16.0,Modal,> 16.0,Test article,> 29.6,Visual,< 4.5,"","",Pseudomonas aeruginosa,KH4013e,"",No,Efflux overexpressor,nfxB,Reference: Tan et al. Antimicrob Agents Chemother. 2016 Aug; 60(8): 48304839.,MecCD OprJ overexpressor (derived from PAO4009),"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,> 16.0,"",> 29.6,"","",< 4.53,"","",Pseudomonas aeruginosa,KH4013E (nfxB),"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,16.0,Modal,16.0,Test article,29.6,Visual,4.5,"","",Pseudomonas aeruginosa,KH4014a,"",No,Efflux overexpressor,nfxC,Reference: Tan et al. Antimicrob Agents Chemother. 2016 Aug; 60(8): 48304839.,MexEF OprN overexpressor (derived from PAO4009),"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,16.0,"",29.6,"","",4.53,"","",Pseudomonas aeruginosa,KH4014a (nfxc),"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,8.00,Modal,8.00,Test article,14.8,Visual,4.8,"","",Pseudomonas aeruginosa,PAO969,"",No,Wild type,proC130,"Authors cite the strain is a gift from Dieter Haas (Mikrobiologisches Institut in Zurich Switzerland) and reference indicates it's from the ""Leisinger collection""","","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,8.00,"",14.8,"","",4.83,"","",Pseudomonas aeruginosa,PAO969,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,16.0,Modal,16.0,Test article,29.6,Visual,4.5,"","",Pseudomonas aeruginosa,PAO6006,"",No,Efflux overexpressor,proC130 nalB,"From Dieter Haas lab Mikrobiologisches Institut in Switzerland (Reference: Rella M, Haas D. Antimicrob Agents Chemother. 1982 Aug; 22(2):242-9.)",MexAB OprM overexpressor (derived from PAO969 proC130),"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,16.0,"",29.6,"","",4.53,"","",Pseudomonas aeruginosa,PAO6006 (nalB),"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.125,Modal,0.125,Test article,0.231,Visual,6.6,"","",Staphylococcus aureus,RN4220,NR-45946 (BEI Resources); NRS144,No,NA / Gram Positive,"Negative for mec, rsbU and agr; MLST sequence type (ST) 8; eGenomic spa type 59, eGenomic spa repeats YHGGFMBQBLO; Ridom spa type t211.",Derived from NCTC8325; whole genome sequenced; used as a cloning host due to mutation that makes it restriction deficient,Methicillin susceptible (MSSA),"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.125,"",0.231,"","",6.64,"","",Staphylococcus aureus,RN4220,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,2.00,Modal,2.00,Test article,3.70,Visual,5.4,"","",Staphylococcus aureus,APNBTI-1R,"",No,NA / Gram Positive,gyrA (D83N),Derived from RN4220; generated by sequential selection by plating bacterial suspension on Mueller-Hinton agar with 4-aminopiperidine-linked NBTI,"APNBTI resistant; APNBTI, 6-({1-(	)-2-(3-chloro-6-methoxy-[1,5]naphthyridin-4-yl)-2-hydroxy-ethyl-piperidin-4-ylamino}-methyl)-4H-pyrido[3,2-b][1,4]oxazin-3-one-dichloride)","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,2.00,"",3.70,"","",5.43,"","",Staphylococcus aureus,"APNBTI-1R gyrA (D83N)
APNBTI-2R gyrA (D83N) parC (D79N)","","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,> 16.0,Modal,> 16.0,Test article,> 29.6,Visual,< 4.5,"","",Staphylococcus aureus,APNBTI-2R,"",No,NA / Gram Positive,gyrA (D83N) parC (D79N),Derived from RN4220; generated by sequential selection by plating bacterial suspension on Mueller-Hinton agar with 4-aminopiperidine-linked NBTI,"APNBTI resistant; APNBTI, 6-({1-(	)-2-(3-chloro-6-methoxy-[1,5]naphthyridin-4-yl)-2-hydroxy-ethyl-piperidin-4-ylamino}-methyl)-4H-pyrido[3,2-b][1,4]oxazin-3-one-dichloride)","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,> 16.0,"",> 29.6,"","",< 4.53,"","",Staphylococcus aureus,APNBTI-2R gyrA (D83N) parC (D79N),"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.0630,Modal,0.0630,Test article,0.117,Visual,6.9,"","",Staphylococcus aureus,MS5935,"",No,NA / Gram Positive,"","",Methicillin susceptible,"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.0630,"",0.117,"","",6.93,"","",Staphylococcus aureus,MS5935,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.250,Modal,0.250,Test article,0.463,Visual,6.3,"","",Staphylococcus aureus,MS5935 grlA (S80F) gyrA (S84L) grlA (E84K) gyrA (E88V),"",No,NA / Gram Positive,grlA (S80F) gyrA (S84L) grlA (E84K) gyrA (E88V),Derived from MS5935,Fluoroquinolone resistant,"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.250,"",0.463,"","",6.33,"","",Staphylococcus aureus,MS5935 grlA (S80F) gyrA (S84L) grlA (E84K) gyrA (E88V),"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.500,Modal,0.500,Test article,0.926,Visual,6.0,"","",Streptococcus pneumoniae,IID553,"",No,NA / Gram Positive,"",From the Japanese Society for Bacteriology,Wild type,"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.500,"",0.926,"","",6.03,"","",Streptococcus pneumoniae,IID553,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.500,Modal,0.500,Test article,0.926,Visual,6.0,"","",Streptococcus pneumoniae,NC9971,"",No,NA / Gram Positive,parC (79Y) gyrA (S81F),Derived from IID553,Fluoroquinolone resistant,"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.500,"",0.926,"","",6.03,"","",Streptococcus pneumoniae,NC9971 parC (79Y) gyrA (S81F),"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.125,Modal,0.125,Test article,0.231,Visual,6.6,"","",Staphylococcus aureus,RN4220,NR-45946 (BEI Resources); NRS144,No,NA / Gram Positive,"Negative for mec, rsbU and agr; MLST sequence type (ST) 8; eGenomic spa type 59, eGenomic spa repeats YHGGFMBQBLO; Ridom spa type t211.",Derived from NCTC8325; whole genome sequenced; used as a cloning host due to mutation that makes it restriction deficient,Methicillin susceptible (MSSA),"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.125,"",0.231,"","",6.64,"","",Staphylococcus aureus,RN4220,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.125,Modal,0.125,Test article,0.231,Visual,6.6,"","",Staphylococcus aureus,RN4220,NR-45946 (BEI Resources); NRS144,No,NA / Gram Positive,"Negative for mec, rsbU and agr; MLST sequence type (ST) 8; eGenomic spa type 59, eGenomic spa repeats YHGGFMBQBLO; Ridom spa type t211.",Derived from NCTC8325; whole genome sequenced; used as a cloning host due to mutation that makes it restriction deficient,Methicillin susceptible (MSSA),"Salmon sperm DNA, 500 µg/mL","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.125,"",0.231,"","",6.64,"","",Staphylococcus aureus,RN4220,"","","","","","","Salmon sperm DNA, 500 U/ml","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258365-001,"No Salt, free base or acid",540.020,"","","",PMID:27246784 - Cmpd : AM-8722,Compound 4,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.125,Modal,0.125,Test article,0.231,Visual,6.6,"","",Staphylococcus aureus,RN4220,NR-45946 (BEI Resources); NRS144,No,NA / Gram Positive,"Negative for mec, rsbU and agr; MLST sequence type (ST) 8; eGenomic spa type 59, eGenomic spa repeats YHGGFMBQBLO; Ridom spa type t211.",Derived from NCTC8325; whole genome sequenced; used as a cloning host due to mutation that makes it restriction deficient,Methicillin susceptible (MSSA),"Human serum, 50%","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.125,"",0.231,"","",6.64,"","",Staphylococcus aureus,RN4220,"","","","","","","Human serum, 50%","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258365,OCCN1C(=O)C=CC2=C1C(CCC13CCC(CC1)(CO3)NCC1=NC3=C(OCC(=O)N3)C=C1)=C(Cl)C=N2,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",002,SPK-0258365-002,1.0 Hydrochloride,576.480,"","","",PMID:27246784 - Cmpd : AM-8722.HCl,4.HCl,"","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,AM-8722.HCl,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.125,Modal,0.125,Test article,0.217,Visual,6.7,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.125,"",0.217,"","",6.66,"","",Staphylococcus aureus,ATCC 29213,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.125,Modal,0.125,Test article,0.267,Visual,6.6,"","",Staphylococcus aureus,ATCC 19636,Smith; ATCC 13709,No,NA / Gram Positive,"",Parent strain of Staphylococcus aureus L-Phase variant strain Smith L (ATCC 19640); isolates from human with osteomyelitis,Methicillin susceptible (MSSA),"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.125,"",0.267,"","",6.57,"","",Staphylococcus aureus,Smith,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.500,Modal,0.500,Test article,1.07,Visual,6.0,"","",Streptococcus pneumoniae,IID554,"",No,NA / Gram Positive,"",From the Japanese Society for Bacteriology,Wild type,"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.500,"",1.07,"","",5.97,"","",Streptococcus pneumoniae,IID554,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,8.00,Modal,8.00,Test article,17.1,Visual,4.8,"","",Enterococcus faecalis,ATCC 29212,NCTC 12697; Portland; KCTC 2011,No,NA / Gram Positive,"",CLSI reference strain,"","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,8.00,"",17.1,"","",4.77,"","",Enterococcus faecalis,ATCC 29212,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,4.00,Modal,4.00,Test article,8.56,Visual,5.1,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,4.00,"",8.56,"","",5.07,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,8.00,Modal,8.00,Test article,17.1,Visual,4.8,"","",Pseudomonas aeruginosa,PAO1,ATCC BAA-47; ARC545; Pae545; PAM1020; APAE002; K767; K2732; NB52019,No,Wild type,aph(3')-IIb,Well characterized lab isolate,"","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,8.00,"",17.1,"","",4.77,"","",Pseudomonas aeruginosa,PAO1,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,4.00,Modal,4.00,Test article,8.56,Visual,5.1,"","",Acinetobacter baumannii,IID876,"",No,Wild type,"",From the Japanese Society for Bacteriology,Wild type,"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,4.00,"",8.56,"","",5.07,"","",Acinetobacter baumannii,IID876,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.500,Modal,0.500,Test article,1.07,Visual,6.0,"","",Haemophilus influenzae,ATCC 49247,TD-4,No,Not characterized,"",CLSI reference strain; quality Control strain,"","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.500,"",1.07,"","",5.97,"","",Haemophilus influenzae,ATCC 49247,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.500,Modal,0.500,Test article,1.07,Visual,6.0,"","",Staphylococcus aureus,OITI 1-971,"",Yes,NA / Gram Positive,"","",Methicillin resistant,"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.500,"",1.07,"","",5.97,"","",Staphylococcus aureus,OITI 1-971,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,8.00,Modal,8.00,Test article,17.1,Visual,4.8,"","",Enterococcus faecium,A2373,"",No,NA / Gram Positive,vanA,"",Vancomycin resistant,"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,8.00,"",17.1,"","",4.77,"","",Enterococcus faecium,A2373,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,2.00,Modal,2.00,Test article,4.28,Visual,5.4,"","",Escherichia coli,TG1,"",No,Wild type,supE hsdD5 thi (?lac-proAB)/F? [traD36 proAB+ lacIq lac ?ZM15],"","","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,2.00,"",4.28,"","",5.37,"","",Escherichia coli,TG1,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.0630,Modal,0.0630,Test article,0.135,Visual,6.9,"","",Escherichia coli,KAM3,"",No,Efflux deficient,TG1 ?acrAB supE hsdD5 thi (?lac-proAB)/F? [traD36 proAB+ lacIq lac ?ZM15],Efflux deficient (acrAB) mutant derived from TG1,"","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.0630,"",0.135,"","",6.87,"","",Escherichia coli,KAM3,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,8.00,Modal,8.00,Test article,17.1,Visual,4.8,"","",Pseudomonas aeruginosa,PAO4009,"",No,Wild type,"","","","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,8.00,"",17.1,"","",4.77,"","",Pseudomonas aeruginosa,PAO4009,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 137,Visual,< 3.9,"","",Pseudomonas aeruginosa,KH4013e,"",No,Efflux overexpressor,nfxB,Reference: Tan et al. Antimicrob Agents Chemother. 2016 Aug; 60(8): 48304839.,MecCD OprJ overexpressor (derived from PAO4009),"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,> 64.0,"",> 137,"","",< 3.86,"","",Pseudomonas aeruginosa,KH4013E (nfxB),"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,64.0,Modal,64.0,Test article,137,Visual,3.9,"","",Pseudomonas aeruginosa,KH4014a,"",No,Efflux overexpressor,nfxC,Reference: Tan et al. Antimicrob Agents Chemother. 2016 Aug; 60(8): 48304839.,MexEF OprN overexpressor (derived from PAO4009),"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,64.0,"",137,"","",3.86,"","",Pseudomonas aeruginosa,KH4014a (nfxc),"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,8.00,Modal,8.00,Test article,17.1,Visual,4.8,"","",Pseudomonas aeruginosa,PAO969,"",No,Wild type,proC130,"Authors cite the strain is a gift from Dieter Haas (Mikrobiologisches Institut in Zurich Switzerland) and reference indicates it's from the ""Leisinger collection""","","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,8.00,"",17.1,"","",4.77,"","",Pseudomonas aeruginosa,PAO969,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,32.0,Modal,32.0,Test article,68.4,Visual,4.2,"","",Pseudomonas aeruginosa,PAO6006,"",No,Efflux overexpressor,proC130 nalB,"From Dieter Haas lab Mikrobiologisches Institut in Switzerland (Reference: Rella M, Haas D. Antimicrob Agents Chemother. 1982 Aug; 22(2):242-9.)",MexAB OprM overexpressor (derived from PAO969 proC130),"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,32.0,"",68.4,"","",4.16,"","",Pseudomonas aeruginosa,PAO6006 (nalB),"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.500,Modal,0.500,Test article,1.07,Visual,6.0,"","",Staphylococcus aureus,RN4220,NR-45946 (BEI Resources); NRS144,No,NA / Gram Positive,"Negative for mec, rsbU and agr; MLST sequence type (ST) 8; eGenomic spa type 59, eGenomic spa repeats YHGGFMBQBLO; Ridom spa type t211.",Derived from NCTC8325; whole genome sequenced; used as a cloning host due to mutation that makes it restriction deficient,Methicillin susceptible (MSSA),"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.500,"",1.07,"","",5.97,"","",Staphylococcus aureus,RN4220,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,> 64.0,Modal,> 64.0,Test article,> 137,Visual,< 3.9,"","",Staphylococcus aureus,APNBTI-2R,"",No,NA / Gram Positive,gyrA (D83N) parC (D79N),Derived from RN4220; generated by sequential selection by plating bacterial suspension on Mueller-Hinton agar with 4-aminopiperidine-linked NBTI,"APNBTI resistant; APNBTI, 6-({1-(	)-2-(3-chloro-6-methoxy-[1,5]naphthyridin-4-yl)-2-hydroxy-ethyl-piperidin-4-ylamino}-methyl)-4H-pyrido[3,2-b][1,4]oxazin-3-one-dichloride)","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,> 64.0,"",> 137,"","",< 3.86,"","",Staphylococcus aureus,APNBTI-2R gyrA (D83N) parC (D79N),"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,8.00,Modal,8.00,Test article,17.1,Visual,4.8,"","",Staphylococcus aureus,APNBTI-1R,"",No,NA / Gram Positive,gyrA (D83N),Derived from RN4220; generated by sequential selection by plating bacterial suspension on Mueller-Hinton agar with 4-aminopiperidine-linked NBTI,"APNBTI resistant; APNBTI, 6-({1-(	)-2-(3-chloro-6-methoxy-[1,5]naphthyridin-4-yl)-2-hydroxy-ethyl-piperidin-4-ylamino}-methyl)-4H-pyrido[3,2-b][1,4]oxazin-3-one-dichloride)","","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,8.00,"",17.1,"","",4.77,"","",Staphylococcus aureus,"APNBTI-1R gyrA (D83N)
APNBTI-2R gyrA (D83N) parC (D79N)","","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.250,Modal,0.250,Test article,0.535,Visual,6.3,"","",Staphylococcus aureus,MS5935,"",No,NA / Gram Positive,"","",Methicillin susceptible,"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.250,"",0.535,"","",6.27,"","",Staphylococcus aureus,MS5935,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,1.00,Modal,1.00,Test article,2.14,Visual,5.7,"","",Staphylococcus aureus,MS5935 grlA (S80F) gyrA (S84L) grlA (E84K) gyrA (E88V),"",No,NA / Gram Positive,grlA (S80F) gyrA (S84L) grlA (E84K) gyrA (E88V),Derived from MS5935,Fluoroquinolone resistant,"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,1.00,"",2.14,"","",5.67,"","",Staphylococcus aureus,MS5935 grlA (S80F) gyrA (S84L) grlA (E84K) gyrA (E88V),"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.500,Modal,0.500,Test article,1.07,Visual,6.0,"","",Streptococcus pneumoniae,IID553,"",No,NA / Gram Positive,"",From the Japanese Society for Bacteriology,Wild type,"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.500,"",1.07,"","",5.97,"","",Streptococcus pneumoniae,IID553,"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258364,O[C@@]1(CN2CCC(CC2)NCC2=CC3=C(OCCO3)C=N2)CN2C3=C(C=CC2=O)N=CC(F)=C13,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258364-001,"No Salt, free base or acid",467.501,"","","",PMID:27246784 - Cmpd : 5,"","","","","","","",27246784,https://doi.org/10.1128/AAC.00619-16,"",Tan 2016 Antimicrob. Agents Chemother. 60:4830,5,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-23,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Curated Data,0.500,Modal,0.500,Test article,1.07,Visual,6.0,"","",Streptococcus pneumoniae,NC9971,"",No,NA / Gram Positive,parC (79Y) gyrA (S81F),Derived from IID553,Fluoroquinolone resistant,"","","","37C, 18-24 hours",Not specified,"",CLSI methods for agar and broth dilution,Tan 2016 Antimicrob. Agents Chemother. 60:4830,https://app.collaborativedrug.com/vaults/4724/runs/444597,https://doi.org/10.1128/AAC.00619-16,"TKW; Assume appropriate media types for each species were used since CLSI methods were followed but the methods don't specifically say (CAMHB, HTM, CAMHB+LHB, MHA).",2020-12-18,2020-12-28,Tan 2016 Antimicrob. Agents Chemother. 60:4830,"","In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

DOI: https://doi.org/10.1128/AAC.00619-16","",Uploaded Data,0.500,"",1.07,"","",5.97,"","",Streptococcus pneumoniae,NC9971 parC (79Y) gyrA (S81F),"","","","","","","","","","","","","",Tan 2016 Antimicrob. Agents Chemother. 60:4830,2016,ChEMBL 26,https://doi.org/10.1128/AAC.00619-16,"",SJ,"",2020-12-15,Full,No
SPK-0258361,[H][C@](NC(=O)[C@H](CCN)NC(=O)CCCCC(C)CC)([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@]([H])(NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258361-001,1.0 Sulfuric acid,"1,267.552","","","",PMID:20855724 - Cmpd : colistin sulfate,"","","","","","","",20855724,https://dx.doi.org/10.1128/aac.00834-10,"",Moffatt 2010 Antimicrob. Agents Chemother. 54:4971,colistin sulfate,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-15,Moffatt 2010 Antimicrob. Agents Chemother. 54:4971,"","Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.

DOI: https://dx.doi.org/10.1128/aac.00834-10","",Uploaded Data,1.00,"",0.789,"","",6.10,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34,No,Wild type,"","","","","","","","","","",Moffatt 2010 Antimicrob. Agents Chemother. 54:4971,"",ChEMBL 26,https://dx.doi.org/10.1128/aac.00834-10,5315546,JL,"","","",""
SPK-0258361,[H][C@](NC(=O)[C@H](CCN)NC(=O)CCCCC(C)CC)([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@]([H])(NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258361-001,1.0 Sulfuric acid,"1,267.552","","","",PMID:20855724 - Cmpd : colistin sulfate,"","","","","","","",20855724,https://dx.doi.org/10.1128/aac.00834-10,"",Moffatt 2010 Antimicrob. Agents Chemother. 54:4971,colistin sulfate,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-15,Moffatt 2010 Antimicrob. Agents Chemother. 54:4971,"","Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.

DOI: https://dx.doi.org/10.1128/aac.00834-10","",Uploaded Data,> 128,"",> 101,"","",< 4.00,"","",Acinetobacter baumannii,ATCC 19606R,"","","","","","","","","","","","","",Moffatt 2010 Antimicrob. Agents Chemother. 54:4971,"",ChEMBL 26,https://dx.doi.org/10.1128/aac.00834-10,5315547,JL,"","","",""
SPK-0258361,[H][C@](NC(=O)[C@H](CCN)NC(=O)CCCCC(C)CC)([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@]([H])(NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258361-001,1.0 Sulfuric acid,"1,267.552","","","",PMID:20855724 - Cmpd : colistin sulfate,"","","","","","","",20855724,https://dx.doi.org/10.1128/aac.00834-10,"",Moffatt 2010 Antimicrob. Agents Chemother. 54:4971,colistin sulfate,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-15,Moffatt 2010 Antimicrob. Agents Chemother. 54:4971,"","Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.

DOI: https://dx.doi.org/10.1128/aac.00834-10","",Uploaded Data,1.00,"",0.789,"","",6.10,"","",Acinetobacter baumannii,ATCC 19606R-pAL840,"","","","","","","","","","","","","",Moffatt 2010 Antimicrob. Agents Chemother. 54:4971,"",ChEMBL 26,https://dx.doi.org/10.1128/aac.00834-10,5315548,JL,"","","",""
SPK-0258361,[H][C@](NC(=O)[C@H](CCN)NC(=O)CCCCC(C)CC)([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@]([H])(NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258361-001,1.0 Sulfuric acid,"1,267.552","","","",PMID:20855724 - Cmpd : colistin sulfate,"","","","","","","",20855724,https://dx.doi.org/10.1128/aac.00834-10,"",Moffatt 2010 Antimicrob. Agents Chemother. 54:4971,colistin sulfate,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-15,Moffatt 2010 Antimicrob. Agents Chemother. 54:4971,"","Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.

DOI: https://dx.doi.org/10.1128/aac.00834-10","",Uploaded Data,> 128,"",> 101,"","",< 4.00,"","",Acinetobacter baumannii,ATCC 19606R-pWH1266,"","","","","","","","","","","","","",Moffatt 2010 Antimicrob. Agents Chemother. 54:4971,"",ChEMBL 26,https://dx.doi.org/10.1128/aac.00834-10,5315549,JL,"","","",""
SPK-0258361,[H][C@](NC(=O)[C@H](CCN)NC(=O)CCCCC(C)CC)([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@]([H])(NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258361-001,1.0 Sulfuric acid,"1,267.552","","","",PMID:20855724 - Cmpd : colistin sulfate,"","","","","","","",20855724,https://dx.doi.org/10.1128/aac.00834-10,"",Moffatt 2010 Antimicrob. Agents Chemother. 54:4971,colistin sulfate,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-15,Moffatt 2010 Antimicrob. Agents Chemother. 54:4971,"","Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.

DOI: https://dx.doi.org/10.1128/aac.00834-10","",Uploaded Data,> 128,"",> 101,"","",< 4.00,"","",Acinetobacter baumannii,isolate FADDI008R,"",Yes,"","","","","","","","","","","",Moffatt 2010 Antimicrob. Agents Chemother. 54:4971,"",ChEMBL 26,https://dx.doi.org/10.1128/aac.00834-10,5315562,JL,"","","",""
SPK-0258360,OC1=CC=CC=C1C1=CC=C(S1)[N+]([O-])=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258360-001,"No Salt, free base or acid",221.230,"","","",PMID:29110989 - Cmpd : 6d,"","","","","","","",29110989,https://dx.doi.org/10.1016/j.bmcl.2017.10.036,Published Article - data from ChEMBL26,Vo 2017 Bioorg Med Chem Lett 27:5235,6d,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-14,Vo 2017 Bioorg. Med. Chem. Lett. 27:5235,"","Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.10.036","",Curated Data,32.0,MIC,32.0,Test article,145,Visual,3.8,"","",Escherichia coli,MG1655,CGSC 6300; NB27004; ATCC 47076,No,Wild type,"F-, ?-, ilvG-, rfb50, rph-1",Commonly used lab strain,"","",DMSO,4.0,"37C, 24 hours, microtiter plate",MHB,"","CLSI, broth microdilution",Vo 2017 Bioorg. Med. Chem. Lett. 27:5235,https://app.collaborativedrug.com/vaults/4724/runs/443063,https://dx.doi.org/10.1016/j.bmcl.2017.10.036,Figure 6; JL,2021-02-21,2020-11-10,Vo 2017 Bioorg. Med. Chem. Lett. 27:5235,"","Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.10.036","",Uploaded Data,7.00,"",31.6,"","",4.50,"","",Bacillus subtilis,JH642,"","","","","","","","","","","","","",Vo 2017 Bioorg Med Chem Lett 27:5235,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.10.036,"",JL,Figure 6,"","",""
SPK-0258360,OC1=CC=CC=C1C1=CC=C(S1)[N+]([O-])=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258360-001,"No Salt, free base or acid",221.230,"","","",PMID:29110989 - Cmpd : 6d,"","","","","","","",29110989,https://dx.doi.org/10.1016/j.bmcl.2017.10.036,Published Article - data from ChEMBL26,Vo 2017 Bioorg Med Chem Lett 27:5235,6d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-10,Vo 2017 Bioorg. Med. Chem. Lett. 27:5235,"","Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.10.036","",Uploaded Data,32.0,"",145,"","",3.84,"","",Escherichia coli,MG1655,"","","","","","","","","","","","","",Vo 2017 Bioorg Med Chem Lett 27:5235,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.10.036,"",JL,Figure 6,"","",""
SPK-0258359,CC(C)(N)[C@H](NC1COCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2CO)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258359-001,"No Salt, free base or acid",489.576,"","","",PMID:28302397 - Cmpd : 39,"","","",CHEMBL4091763,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,39,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,4.00,"",8.17,"","",5.09,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233329,WK,"","","",""
SPK-0258359,CC(C)(N)[C@H](NC1COCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2CO)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258359-001,"No Salt, free base or acid",489.576,"","","",PMID:28302397 - Cmpd : 39,"","","",CHEMBL4091763,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,39,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,4.00,"",8.17,"","",5.09,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233459,WK,"","","",""
SPK-0258359,CC(C)(N)[C@H](NC1COCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2CO)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258359-001,"No Salt, free base or acid",489.576,"","","",PMID:28302397 - Cmpd : 39,"","","",CHEMBL4091763,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,39,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.500,"",1.02,"","",5.99,"","",Pseudomonas aeruginosa,isolate 839,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233515,WK,"","","",""
SPK-0258359,CC(C)(N)[C@H](NC1COCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2CO)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258359-001,"No Salt, free base or acid",489.576,"","","",PMID:28302397 - Cmpd : 39,"","","",CHEMBL4091763,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,39,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,16.0,"",32.7,"","",4.49,"","",Klebsiella pneumoniae,isolate 847,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233523,WK,"","","",""
SPK-0258358,CC(C)(N)[C@H](NC1COCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258358-001,"No Salt, free base or acid",478.593,"","","",PMID:28302397 - Cmpd : 38,"","","",CHEMBL4070896,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,38,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.500,"",1.04,"","",5.98,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233328,WK,"","","",""
SPK-0258358,CC(C)(N)[C@H](NC1COCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258358-001,"No Salt, free base or acid",478.593,"","","",PMID:28302397 - Cmpd : 38,"","","",CHEMBL4070896,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,38,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,4.00,"",8.36,"","",5.08,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233458,WK,"","","",""
SPK-0258358,CC(C)(N)[C@H](NC1COCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258358-001,"No Salt, free base or acid",478.593,"","","",PMID:28302397 - Cmpd : 38,"","","",CHEMBL4070896,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,38,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.250,"",0.522,"","",6.28,"","",Pseudomonas aeruginosa,isolate 839,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233514,WK,"","","",""
SPK-0258358,CC(C)(N)[C@H](NC1COCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258358-001,"No Salt, free base or acid",478.593,"","","",PMID:28302397 - Cmpd : 38,"","","",CHEMBL4070896,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,38,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,4.00,"",8.36,"","",5.08,"","",Klebsiella pneumoniae,isolate 847,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233522,WK,"","","",""
SPK-0258357,CC(C)(N)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258357-001,"No Salt, free base or acid",462.594,"","","",PMID:28302397 - Cmpd : 37,"","","",CHEMBL4083988,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,37,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.500,"",1.08,"","",5.97,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233327,WK,"","","",""
SPK-0258357,CC(C)(N)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258357-001,"No Salt, free base or acid",462.594,"","","",PMID:28302397 - Cmpd : 37,"","","",CHEMBL4083988,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,37,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,4.00,"",8.65,"","",5.06,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233457,WK,"","","",""
SPK-0258357,CC(C)(N)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258357-001,"No Salt, free base or acid",462.594,"","","",PMID:28302397 - Cmpd : 37,"","","",CHEMBL4083988,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,37,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.250,"",0.540,"","",6.27,"","",Pseudomonas aeruginosa,isolate 839,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233513,WK,"","","",""
SPK-0258357,CC(C)(N)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258357-001,"No Salt, free base or acid",462.594,"","","",PMID:28302397 - Cmpd : 37,"","","",CHEMBL4083988,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,37,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.500,"",1.08,"","",5.97,"","",Klebsiella pneumoniae,isolate 847,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233521,WK,"","","",""
SPK-0258356,CC(C)(O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCN(CCO)CC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258356-001,"No Salt, free base or acid",506.647,"","","",PMID:28302397 - Cmpd : 36,"","","",CHEMBL4062274,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,36,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,4.00,"",7.90,"","",5.10,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233326,WK,"","","",""
SPK-0258356,CC(C)(O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCN(CCO)CC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258356-001,"No Salt, free base or acid",506.647,"","","",PMID:28302397 - Cmpd : 36,"","","",CHEMBL4062274,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,36,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,4.00,"",7.90,"","",5.10,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233456,WK,"","","",""
SPK-0258356,CC(C)(O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCN(CCO)CC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258356-001,"No Salt, free base or acid",506.647,"","","",PMID:28302397 - Cmpd : 36,"","","",CHEMBL4062274,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,36,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.500,"",0.987,"","",6.01,"","",Pseudomonas aeruginosa,isolate 839,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233512,WK,"","","",""
SPK-0258356,CC(C)(O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCN(CCO)CC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258356-001,"No Salt, free base or acid",506.647,"","","",PMID:28302397 - Cmpd : 36,"","","",CHEMBL4062274,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,36,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,32.0,"",63.2,"","",4.20,"","",Klebsiella pneumoniae,isolate 847,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233520,WK,"","","",""
SPK-0258355,CC(C)(O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258355-001,"No Salt, free base or acid",463.578,"","","",PMID:28302397 - Cmpd : 35,"","","",CHEMBL4061199,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,35,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.250,"",0.539,"","",6.27,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233325,WK,"","","",""
SPK-0258355,CC(C)(O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258355-001,"No Salt, free base or acid",463.578,"","","",PMID:28302397 - Cmpd : 35,"","","",CHEMBL4061199,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,35,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,< 0.0300,"",< 0.0647,"","",> 7.19,"","",Klebsiella pneumoniae,isolate 847,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233388,WK,"","","",""
SPK-0258355,CC(C)(O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258355-001,"No Salt, free base or acid",463.578,"","","",PMID:28302397 - Cmpd : 35,"","","",CHEMBL4061199,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,35,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,32.0,"",69.0,"","",4.16,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233455,WK,"","","",""
SPK-0258355,CC(C)(O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258355-001,"No Salt, free base or acid",463.578,"","","",PMID:28302397 - Cmpd : 35,"","","",CHEMBL4061199,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,35,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.250,"",0.539,"","",6.27,"","",Pseudomonas aeruginosa,isolate 839,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233511,WK,"","","",""
SPK-0258354,C[C@@H](O)[C@H](NC(C)c1ccc(cc1)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258354-001,"No Salt, free base or acid",338.407,"","","",PMID:28302397 - Cmpd : 7,"","","",CHEMBL4076006,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,7,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,4.00,"",11.8,"","",4.93,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233297,WK,"","","",""
SPK-0258354,C[C@@H](O)[C@H](NC(C)c1ccc(cc1)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258354-001,"No Salt, free base or acid",338.407,"","","",PMID:28302397 - Cmpd : 7,"","","",CHEMBL4076006,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,7,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,1.00,"",2.96,"","",5.53,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233362,WK,"","","",""
SPK-0258354,C[C@@H](O)[C@H](NC(C)c1ccc(cc1)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258354-001,"No Salt, free base or acid",338.407,"","","",PMID:28302397 - Cmpd : 7,"","","",CHEMBL4076006,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,7,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,> 64.0,"",> 189,"","",< 3.72,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233427,WK,"","","",""
SPK-0258354,C[C@@H](O)[C@H](NC(C)c1ccc(cc1)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258354-001,"No Salt, free base or acid",338.407,"","","",PMID:28302397 - Cmpd : 7,"","","",CHEMBL4076006,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,7,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,64.0,"",189,"","",3.72,"","",Acinetobacter baumannii,focus ID 961025,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233482,WK,"","","",""
SPK-0258353,CCC(N[C@@H]([C@@H](C)O)C(=O)NO)c1ccc(cc1)C#Cc1ccccc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258353-001,"No Salt, free base or acid",352.434,"","","",PMID:28302397 - Cmpd : 8,"","","",CHEMBL4077329,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,8,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,4.00,"",11.3,"","",4.95,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233298,WK,"","","",""
SPK-0258353,CCC(N[C@@H]([C@@H](C)O)C(=O)NO)c1ccc(cc1)C#Cc1ccccc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258353-001,"No Salt, free base or acid",352.434,"","","",PMID:28302397 - Cmpd : 8,"","","",CHEMBL4077329,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,8,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,2.00,"",5.67,"","",5.25,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233363,WK,"","","",""
SPK-0258353,CCC(N[C@@H]([C@@H](C)O)C(=O)NO)c1ccc(cc1)C#Cc1ccccc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258353-001,"No Salt, free base or acid",352.434,"","","",PMID:28302397 - Cmpd : 8,"","","",CHEMBL4077329,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,8,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,> 64.0,"",> 182,"","",< 3.74,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233428,WK,"","","",""
SPK-0258353,CCC(N[C@@H]([C@@H](C)O)C(=O)NO)c1ccc(cc1)C#Cc1ccccc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258353-001,"No Salt, free base or acid",352.434,"","","",PMID:28302397 - Cmpd : 8,"","","",CHEMBL4077329,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,8,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,> 64.0,"",> 182,"","",< 3.74,"","",Acinetobacter baumannii,focus ID 961025,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233483,WK,"","","",""
SPK-0258352,CC(C)(N)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2CO)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258352-001,"No Salt, free base or acid",473.577,"","","",PMID:28302397 - Cmpd : 40,"","","",CHEMBL4092719,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,40,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.500,"",1.06,"","",5.98,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233330,WK,"","","",""
SPK-0258352,CC(C)(N)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2CO)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258352-001,"No Salt, free base or acid",473.577,"","","",PMID:28302397 - Cmpd : 40,"","","",CHEMBL4092719,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,40,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,1.00,"",2.11,"","",5.68,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233460,WK,"","","",""
SPK-0258352,CC(C)(N)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2CO)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258352-001,"No Salt, free base or acid",473.577,"","","",PMID:28302397 - Cmpd : 40,"","","",CHEMBL4092719,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,40,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.125,"",0.264,"","",6.58,"","",Pseudomonas aeruginosa,isolate 839,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233516,WK,"","","",""
SPK-0258352,CC(C)(N)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2CO)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258352-001,"No Salt, free base or acid",473.577,"","","",PMID:28302397 - Cmpd : 40,"","","",CHEMBL4092719,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,40,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,4.00,"",8.45,"","",5.07,"","",Klebsiella pneumoniae,isolate 847,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233524,WK,"","","",""
SPK-0258351,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2CO)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258351-001,"No Salt, free base or acid",460.534,"","","",PMID:28302397 - Cmpd : 34,"","","",CHEMBL4089353,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,34,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,1.00,"",2.17,"","",5.66,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233324,WK,"","","",""
SPK-0258351,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2CO)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258351-001,"No Salt, free base or acid",460.534,"","","",PMID:28302397 - Cmpd : 34,"","","",CHEMBL4089353,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,34,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,4.00,"",8.69,"","",5.06,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233454,WK,"","","",""
SPK-0258351,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2CO)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258351-001,"No Salt, free base or acid",460.534,"","","",PMID:28302397 - Cmpd : 34,"","","",CHEMBL4089353,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,34,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.500,"",1.09,"","",5.96,"","",Pseudomonas aeruginosa,isolate 839,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233510,WK,"","","",""
SPK-0258351,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2CO)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258351-001,"No Salt, free base or acid",460.534,"","","",PMID:28302397 - Cmpd : 34,"","","",CHEMBL4089353,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,34,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,4.00,"",8.69,"","",5.06,"","",Klebsiella pneumoniae,isolate 847,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233519,WK,"","","",""
SPK-0258350,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2CCO)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258350-001,"No Salt, free base or acid",474.561,"","","",PMID:28302397 - Cmpd : 33,"","","",CHEMBL4099505,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,33,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,1.00,"",2.11,"","",5.68,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233323,WK,"","","",""
SPK-0258350,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2CCO)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258350-001,"No Salt, free base or acid",474.561,"","","",PMID:28302397 - Cmpd : 33,"","","",CHEMBL4099505,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,33,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,4.00,"",8.43,"","",5.07,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233453,WK,"","","",""
SPK-0258350,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2CCO)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258350-001,"No Salt, free base or acid",474.561,"","","",PMID:28302397 - Cmpd : 33,"","","",CHEMBL4099505,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,33,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.125,"",0.263,"","",6.58,"","",Pseudomonas aeruginosa,isolate 839,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233509,WK,"","","",""
SPK-0258350,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2CCO)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258350-001,"No Salt, free base or acid",474.561,"","","",PMID:28302397 - Cmpd : 33,"","","",CHEMBL4099505,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,33,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,4.00,"",8.43,"","",5.07,"","",Klebsiella pneumoniae,isolate 847,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233518,WK,"","","",""
SPK-0258349,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2C)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258349-001,"No Salt, free base or acid",444.535,"","","",PMID:28302397 - Cmpd : 32,"","","",CHEMBL4081478,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,32,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.250,"",0.562,"","",6.25,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233322,WK,"","","",""
SPK-0258349,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2C)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258349-001,"No Salt, free base or acid",444.535,"","","",PMID:28302397 - Cmpd : 32,"","","",CHEMBL4081478,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,32,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.0600,"",0.135,"","",6.87,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233387,WK,"","","",""
SPK-0258349,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2C)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258349-001,"No Salt, free base or acid",444.535,"","","",PMID:28302397 - Cmpd : 32,"","","",CHEMBL4081478,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,32,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,8.00,"",18.0,"","",4.74,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233452,WK,"","","",""
SPK-0258349,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(Cn2ccnc2C)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258349-001,"No Salt, free base or acid",444.535,"","","",PMID:28302397 - Cmpd : 32,"","","",CHEMBL4081478,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,32,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.250,"",0.562,"","",6.25,"","",Pseudomonas aeruginosa,isolate 839,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233508,WK,"","","",""
SPK-0258348,COC1CCN(Cc2ccc(cc2)C#Cc2ccc3[C@H](CCc3c2)N[C@@H]([C@@H](C)O)C(=O)NO)CC1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258348-001,"No Salt, free base or acid",477.605,"","","",PMID:28302397 - Cmpd : 31,"","","",CHEMBL4068010,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,31,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.500,"",1.05,"","",5.98,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233321,WK,"","","",""
SPK-0258348,COC1CCN(Cc2ccc(cc2)C#Cc2ccc3[C@H](CCc3c2)N[C@@H]([C@@H](C)O)C(=O)NO)CC1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258348-001,"No Salt, free base or acid",477.605,"","","",PMID:28302397 - Cmpd : 31,"","","",CHEMBL4068010,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,31,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.0600,"",0.126,"","",6.90,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233386,WK,"","","",""
SPK-0258348,COC1CCN(Cc2ccc(cc2)C#Cc2ccc3[C@H](CCc3c2)N[C@@H]([C@@H](C)O)C(=O)NO)CC1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258348-001,"No Salt, free base or acid",477.605,"","","",PMID:28302397 - Cmpd : 31,"","","",CHEMBL4068010,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,31,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,8.00,"",16.8,"","",4.78,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233451,WK,"","","",""
SPK-0258348,COC1CCN(Cc2ccc(cc2)C#Cc2ccc3[C@H](CCc3c2)N[C@@H]([C@@H](C)O)C(=O)NO)CC1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258348-001,"No Salt, free base or acid",477.605,"","","",PMID:28302397 - Cmpd : 31,"","","",CHEMBL4068010,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,31,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,1.00,"",2.09,"","",5.68,"","",Pseudomonas aeruginosa,isolate 839,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233507,WK,"","","",""
SPK-0258347,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CC(O)C2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258347-001,"No Salt, free base or acid",435.524,"","","",PMID:28302397 - Cmpd : 30,"","","",CHEMBL4089198,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,30,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,4.00,"",9.18,"","",5.04,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233320,WK,"","","",""
SPK-0258347,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CC(O)C2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258347-001,"No Salt, free base or acid",435.524,"","","",PMID:28302397 - Cmpd : 30,"","","",CHEMBL4089198,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,30,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.125,"",0.287,"","",6.54,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233385,WK,"","","",""
SPK-0258347,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CC(O)C2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258347-001,"No Salt, free base or acid",435.524,"","","",PMID:28302397 - Cmpd : 30,"","","",CHEMBL4089198,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,30,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,4.00,"",9.18,"","",5.04,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233450,WK,"","","",""
SPK-0258347,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CC(O)C2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258347-001,"No Salt, free base or acid",435.524,"","","",PMID:28302397 - Cmpd : 30,"","","",CHEMBL4089198,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,30,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.500,"",1.15,"","",5.94,"","",Pseudomonas aeruginosa,isolate 839,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233506,WK,"","","",""
SPK-0258346,CNCCOCc1ccc(cc1)C#Cc1ccc2[C@H](CCc2c1)N[C@@H]([C@@H](C)O)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258346-001,"No Salt, free base or acid",437.540,"","","",PMID:28302397 - Cmpd : 29,"","","",CHEMBL4078871,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,29,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,4.00,"",9.14,"","",5.04,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233319,WK,"","","",""
SPK-0258346,CNCCOCc1ccc(cc1)C#Cc1ccc2[C@H](CCc2c1)N[C@@H]([C@@H](C)O)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258346-001,"No Salt, free base or acid",437.540,"","","",PMID:28302397 - Cmpd : 29,"","","",CHEMBL4078871,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,29,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.250,"",0.571,"","",6.24,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233384,WK,"","","",""
SPK-0258346,CNCCOCc1ccc(cc1)C#Cc1ccc2[C@H](CCc2c1)N[C@@H]([C@@H](C)O)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258346-001,"No Salt, free base or acid",437.540,"","","",PMID:28302397 - Cmpd : 29,"","","",CHEMBL4078871,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,29,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,16.0,"",36.6,"","",4.44,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233449,WK,"","","",""
SPK-0258346,CNCCOCc1ccc(cc1)C#Cc1ccc2[C@H](CCc2c1)N[C@@H]([C@@H](C)O)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258346-001,"No Salt, free base or acid",437.540,"","","",PMID:28302397 - Cmpd : 29,"","","",CHEMBL4078871,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,29,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,2.00,"",4.57,"","",5.34,"","",Pseudomonas aeruginosa,isolate 839,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233505,WK,"","","",""
SPK-0258345,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CC[C@@H](O)C2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258345-001,"No Salt, free base or acid",449.551,"","","",PMID:28302397 - Cmpd : 28,"","","",CHEMBL4096903,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,28,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,2.00,"",4.45,"","",5.35,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233318,WK,"","","",""
SPK-0258345,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CC[C@@H](O)C2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258345-001,"No Salt, free base or acid",449.551,"","","",PMID:28302397 - Cmpd : 28,"","","",CHEMBL4096903,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,28,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.500,"",1.11,"","",5.95,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233383,WK,"","","",""
SPK-0258345,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CC[C@@H](O)C2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258345-001,"No Salt, free base or acid",449.551,"","","",PMID:28302397 - Cmpd : 28,"","","",CHEMBL4096903,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,28,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,8.00,"",17.8,"","",4.75,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233448,WK,"","","",""
SPK-0258345,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CC[C@@H](O)C2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258345-001,"No Salt, free base or acid",449.551,"","","",PMID:28302397 - Cmpd : 28,"","","",CHEMBL4096903,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,28,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,1.00,"",2.22,"","",5.65,"","",Pseudomonas aeruginosa,isolate 839,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233504,WK,"","","",""
SPK-0258344,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCN(CCO)CC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258344-001,"No Salt, free base or acid",492.620,"","","",PMID:28302397 - Cmpd : 27,"","","",CHEMBL4086726,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,27,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,2.00,"",4.06,"","",5.39,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233317,WK,"","","",""
SPK-0258344,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCN(CCO)CC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258344-001,"No Salt, free base or acid",492.620,"","","",PMID:28302397 - Cmpd : 27,"","","",CHEMBL4086726,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,27,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,< 0.125,"",< 0.254,"","",> 6.60,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233382,WK,"","","",""
SPK-0258344,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCN(CCO)CC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258344-001,"No Salt, free base or acid",492.620,"","","",PMID:28302397 - Cmpd : 27,"","","",CHEMBL4086726,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,27,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,4.00,"",8.12,"","",5.09,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233447,WK,"","","",""
SPK-0258344,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCN(CCO)CC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258344-001,"No Salt, free base or acid",492.620,"","","",PMID:28302397 - Cmpd : 27,"","","",CHEMBL4086726,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,27,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,1.00,"",2.03,"","",5.69,"","",Pseudomonas aeruginosa,isolate 839,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233503,WK,"","","",""
SPK-0258343,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCCCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258343-001,"No Salt, free base or acid",447.579,"","","",PMID:28302397 - Cmpd : 26,"","","",CHEMBL4104633,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,26,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.500,"",1.12,"","",5.95,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233316,WK,"","","",""
SPK-0258343,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCCCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258343-001,"No Salt, free base or acid",447.579,"","","",PMID:28302397 - Cmpd : 26,"","","",CHEMBL4104633,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,26,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.500,"",1.12,"","",5.95,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233381,WK,"","","",""
SPK-0258343,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCCCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258343-001,"No Salt, free base or acid",447.579,"","","",PMID:28302397 - Cmpd : 26,"","","",CHEMBL4104633,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,26,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,16.0,"",35.7,"","",4.45,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233446,WK,"","","",""
SPK-0258343,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCCCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258343-001,"No Salt, free base or acid",447.579,"","","",PMID:28302397 - Cmpd : 26,"","","",CHEMBL4104633,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,26,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,2.00,"",4.47,"","",5.35,"","",Pseudomonas aeruginosa,isolate 839,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233502,WK,"","","",""
SPK-0258342,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCN(C)CC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258342-001,"No Salt, free base or acid",462.594,"","","",PMID:28302397 - Cmpd : 25,"","","",CHEMBL4094466,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,25,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.250,"",0.540,"","",6.27,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233315,WK,"","","",""
SPK-0258342,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCN(C)CC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258342-001,"No Salt, free base or acid",462.594,"","","",PMID:28302397 - Cmpd : 25,"","","",CHEMBL4094466,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,25,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.125,"",0.270,"","",6.57,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233380,WK,"","","",""
SPK-0258342,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCN(C)CC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258342-001,"No Salt, free base or acid",462.594,"","","",PMID:28302397 - Cmpd : 25,"","","",CHEMBL4094466,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,25,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,8.00,"",17.3,"","",4.76,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233445,WK,"","","",""
SPK-0258342,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCN(C)CC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258342-001,"No Salt, free base or acid",462.594,"","","",PMID:28302397 - Cmpd : 25,"","","",CHEMBL4094466,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,25,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,1.00,"",2.16,"","",5.67,"","",Pseudomonas aeruginosa,isolate 839,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233501,WK,"","","",""
SPK-0258341,C[C@@H](O)[C@H](NC1CCN(C)c2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258341-001,"No Salt, free base or acid",478.593,"","","",PMID:28302397 - Cmpd : 24,"","","",CHEMBL4066982,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,24,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,2.00,"",4.18,"","",5.38,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233314,WK,"","","",""
SPK-0258341,C[C@@H](O)[C@H](NC1CCN(C)c2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258341-001,"No Salt, free base or acid",478.593,"","","",PMID:28302397 - Cmpd : 24,"","","",CHEMBL4066982,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,24,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.125,"",0.261,"","",6.58,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233379,WK,"","","",""
SPK-0258341,C[C@@H](O)[C@H](NC1CCN(C)c2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258341-001,"No Salt, free base or acid",478.593,"","","",PMID:28302397 - Cmpd : 24,"","","",CHEMBL4066982,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,24,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,> 32.0,"",> 66.9,"","",< 4.17,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233444,WK,"","","",""
SPK-0258341,C[C@@H](O)[C@H](NC1CCN(C)c2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258341-001,"No Salt, free base or acid",478.593,"","","",PMID:28302397 - Cmpd : 24,"","","",CHEMBL4066982,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,24,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,> 32.0,"",> 66.9,"","",< 4.17,"","",Acinetobacter baumannii,focus ID 961025,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233499,WK,"","","",""
SPK-0258340,C[C@@H](O)[C@H](NC1COCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258340-001,"No Salt, free base or acid",465.550,"","","",PMID:28302397 - Cmpd : 23,"","","",CHEMBL4102207,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,23,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.250,"",0.537,"","",6.27,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233313,WK,"","","",""
SPK-0258340,C[C@@H](O)[C@H](NC1COCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258340-001,"No Salt, free base or acid",465.550,"","","",PMID:28302397 - Cmpd : 23,"","","",CHEMBL4102207,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,23,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,< 0.125,"",< 0.268,"","",> 6.57,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233378,WK,"","","",""
SPK-0258340,C[C@@H](O)[C@H](NC1COCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258340-001,"No Salt, free base or acid",465.550,"","","",PMID:28302397 - Cmpd : 23,"","","",CHEMBL4102207,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,23,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,64.0,"",137,"","",3.86,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233443,WK,"","","",""
SPK-0258340,C[C@@H](O)[C@H](NC1COCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258340-001,"No Salt, free base or acid",465.550,"","","",PMID:28302397 - Cmpd : 23,"","","",CHEMBL4102207,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,23,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,64.0,"",137,"","",3.86,"","",Acinetobacter baumannii,focus ID 961025,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233498,WK,"","","",""
SPK-0258339,C[C@@H](O)[C@H](NC1CCOc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258339-001,"No Salt, free base or acid",465.550,"","","",PMID:28302397 - Cmpd : 22,"","","",CHEMBL4077947,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,22,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,2.00,"",4.30,"","",5.37,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233312,WK,"","","",""
SPK-0258339,C[C@@H](O)[C@H](NC1CCOc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258339-001,"No Salt, free base or acid",465.550,"","","",PMID:28302397 - Cmpd : 22,"","","",CHEMBL4077947,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,22,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,< 0.125,"",< 0.268,"","",> 6.57,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233377,WK,"","","",""
SPK-0258339,C[C@@H](O)[C@H](NC1CCOc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258339-001,"No Salt, free base or acid",465.550,"","","",PMID:28302397 - Cmpd : 22,"","","",CHEMBL4077947,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,22,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,16.0,"",34.4,"","",4.46,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233442,WK,"","","",""
SPK-0258339,C[C@@H](O)[C@H](NC1CCOc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258339-001,"No Salt, free base or acid",465.550,"","","",PMID:28302397 - Cmpd : 22,"","","",CHEMBL4077947,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,22,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,64.0,"",137,"","",3.86,"","",Acinetobacter baumannii,focus ID 961025,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233497,WK,"","","",""
SPK-0258338,C[C@@H](O)[C@H](NC1CCCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258338-001,"No Salt, free base or acid",463.578,"","","",PMID:28302397 - Cmpd : 21,"","","",CHEMBL4071396,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,21,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.250,"",0.539,"","",6.27,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233311,WK,"","","",""
SPK-0258338,C[C@@H](O)[C@H](NC1CCCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258338-001,"No Salt, free base or acid",463.578,"","","",PMID:28302397 - Cmpd : 21,"","","",CHEMBL4071396,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,21,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,< 0.125,"",< 0.270,"","",> 6.57,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233376,WK,"","","",""
SPK-0258338,C[C@@H](O)[C@H](NC1CCCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258338-001,"No Salt, free base or acid",463.578,"","","",PMID:28302397 - Cmpd : 21,"","","",CHEMBL4071396,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,21,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,32.0,"",69.0,"","",4.16,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233441,WK,"","","",""
SPK-0258338,C[C@@H](O)[C@H](NC1CCCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258338-001,"No Salt, free base or acid",463.578,"","","",PMID:28302397 - Cmpd : 21,"","","",CHEMBL4071396,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,21,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,128,"",276,"","",3.56,"","",Acinetobacter baumannii,focus ID 961025,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233496,WK,"","","",""
SPK-0258337,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258337-001,"No Salt, free base or acid",449.551,"","","",PMID:28302397 - Cmpd : 20,"","","",CHEMBL4098438,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,20,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,< 0.125,"",< 0.278,"","",> 6.56,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233310,WK,"","","",""
SPK-0258337,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258337-001,"No Salt, free base or acid",449.551,"","","",PMID:28302397 - Cmpd : 20,"","","",CHEMBL4098438,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,20,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,< 0.125,"",< 0.278,"","",> 6.56,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233375,WK,"","","",""
SPK-0258337,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258337-001,"No Salt, free base or acid",449.551,"","","",PMID:28302397 - Cmpd : 20,"","","",CHEMBL4098438,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,20,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,8.00,"",17.8,"","",4.75,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233440,WK,"","","",""
SPK-0258337,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258337-001,"No Salt, free base or acid",449.551,"","","",PMID:28302397 - Cmpd : 20,"","","",CHEMBL4098438,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,20,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,32.0,"",71.2,"","",4.15,"","",Acinetobacter baumannii,focus ID 961025,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233495,WK,"","","",""
SPK-0258337,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258337-001,"No Salt, free base or acid",449.551,"","","",PMID:28302397 - Cmpd : 20,"","","",CHEMBL4098438,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,20,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.250,"",0.556,"","",6.25,"","",Pseudomonas aeruginosa,isolate 839,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233500,WK,"","","",""
SPK-0258337,C[C@@H](O)[C@H](N[C@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258337-001,"No Salt, free base or acid",449.551,"","","",PMID:28302397 - Cmpd : 20,"","","",CHEMBL4098438,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,20,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,2.00,"",4.45,"","",5.35,"","",Pseudomonas aeruginosa,isolate 847,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233517,WK,"","","",""
SPK-0258336,C[C@@H](O)[C@H](N[C@@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258336-001,"No Salt, free base or acid",449.551,"","","",PMID:28302397 - Cmpd : 19,"","","",CHEMBL4064896,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,19,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.500,"",1.11,"","",5.95,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233309,WK,"","","",""
SPK-0258336,C[C@@H](O)[C@H](N[C@@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258336-001,"No Salt, free base or acid",449.551,"","","",PMID:28302397 - Cmpd : 19,"","","",CHEMBL4064896,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,19,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.125,"",0.278,"","",6.56,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233374,WK,"","","",""
SPK-0258336,C[C@@H](O)[C@H](N[C@@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258336-001,"No Salt, free base or acid",449.551,"","","",PMID:28302397 - Cmpd : 19,"","","",CHEMBL4064896,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,19,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,128,"",285,"","",3.55,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233439,WK,"","","",""
SPK-0258336,C[C@@H](O)[C@H](N[C@@H]1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258336-001,"No Salt, free base or acid",449.551,"","","",PMID:28302397 - Cmpd : 19,"","","",CHEMBL4064896,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,19,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,64.0,"",142,"","",3.85,"","",Acinetobacter baumannii,focus ID 961025,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233494,WK,"","","",""
SPK-0258335,C[C@@H](O)[C@H](NC1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258335-001,"No Salt, free base or acid",449.551,"","","",PMID:28302397 - Cmpd : 18,"","","",CHEMBL4095059,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,18,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.250,"",0.556,"","",6.25,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233308,WK,"","","",""
SPK-0258335,C[C@@H](O)[C@H](NC1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258335-001,"No Salt, free base or acid",449.551,"","","",PMID:28302397 - Cmpd : 18,"","","",CHEMBL4095059,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,18,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.125,"",0.278,"","",6.56,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233373,WK,"","","",""
SPK-0258335,C[C@@H](O)[C@H](NC1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258335-001,"No Salt, free base or acid",449.551,"","","",PMID:28302397 - Cmpd : 18,"","","",CHEMBL4095059,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,18,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,8.00,"",17.8,"","",4.75,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233438,WK,"","","",""
SPK-0258335,C[C@@H](O)[C@H](NC1CCc2cc(ccc12)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258335-001,"No Salt, free base or acid",449.551,"","","",PMID:28302397 - Cmpd : 18,"","","",CHEMBL4095059,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,18,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,> 64.0,"",> 142,"","",< 3.85,"","",Acinetobacter baumannii,focus ID 961025,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233493,WK,"","","",""
SPK-0258334,C[C@@H](O)[C@H](NC1CN(C)Cc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258334-001,"No Salt, free base or acid",379.460,"","","",PMID:28302397 - Cmpd : 17,"","","",CHEMBL4074829,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,17,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,2.00,"",5.27,"","",5.28,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233307,WK,"","","",""
SPK-0258334,C[C@@H](O)[C@H](NC1CN(C)Cc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258334-001,"No Salt, free base or acid",379.460,"","","",PMID:28302397 - Cmpd : 17,"","","",CHEMBL4074829,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,17,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.500,"",1.32,"","",5.88,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233372,WK,"","","",""
SPK-0258334,C[C@@H](O)[C@H](NC1CN(C)Cc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258334-001,"No Salt, free base or acid",379.460,"","","",PMID:28302397 - Cmpd : 17,"","","",CHEMBL4074829,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,17,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,> 128,"",> 337,"","",< 3.47,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233437,WK,"","","",""
SPK-0258334,C[C@@H](O)[C@H](NC1CN(C)Cc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258334-001,"No Salt, free base or acid",379.460,"","","",PMID:28302397 - Cmpd : 17,"","","",CHEMBL4074829,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,17,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,> 128,"",> 337,"","",< 3.47,"","",Acinetobacter baumannii,focus ID 961025,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233492,WK,"","","",""
SPK-0258333,C[C@@H](O)[C@H](NC1CCN(C)c2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258333-001,"No Salt, free base or acid",379.460,"","","",PMID:28302397 - Cmpd : 16,"","","",CHEMBL4102818,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,16,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,8.00,"",21.1,"","",4.68,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233306,WK,"","","",""
SPK-0258333,C[C@@H](O)[C@H](NC1CCN(C)c2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258333-001,"No Salt, free base or acid",379.460,"","","",PMID:28302397 - Cmpd : 16,"","","",CHEMBL4102818,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,16,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,1.00,"",2.64,"","",5.58,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233371,WK,"","","",""
SPK-0258333,C[C@@H](O)[C@H](NC1CCN(C)c2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258333-001,"No Salt, free base or acid",379.460,"","","",PMID:28302397 - Cmpd : 16,"","","",CHEMBL4102818,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,16,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,> 128,"",> 337,"","",< 3.47,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233436,WK,"","","",""
SPK-0258333,C[C@@H](O)[C@H](NC1CCN(C)c2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258333-001,"No Salt, free base or acid",379.460,"","","",PMID:28302397 - Cmpd : 16,"","","",CHEMBL4102818,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,16,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,> 128,"",> 337,"","",< 3.47,"","",Acinetobacter baumannii,focus ID 961025,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233491,WK,"","","",""
SPK-0258332,C[C@@H](O)[C@H](NC1COCc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258332-001,"No Salt, free base or acid",366.417,"","","",PMID:28302397 - Cmpd : 15,"","","",CHEMBL4098674,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,15,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.250,"",0.682,"","",6.17,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233305,WK,"","","",""
SPK-0258332,C[C@@H](O)[C@H](NC1COCc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258332-001,"No Salt, free base or acid",366.417,"","","",PMID:28302397 - Cmpd : 15,"","","",CHEMBL4098674,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,15,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,< 0.125,"",< 0.341,"","",> 6.47,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233370,WK,"","","",""
SPK-0258332,C[C@@H](O)[C@H](NC1COCc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258332-001,"No Salt, free base or acid",366.417,"","","",PMID:28302397 - Cmpd : 15,"","","",CHEMBL4098674,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,15,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,64.0,"",175,"","",3.76,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233435,WK,"","","",""
SPK-0258332,C[C@@H](O)[C@H](NC1COCc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258332-001,"No Salt, free base or acid",366.417,"","","",PMID:28302397 - Cmpd : 15,"","","",CHEMBL4098674,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,15,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,32.0,"",87.3,"","",4.06,"","",Acinetobacter baumannii,focus ID 961025,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233490,WK,"","","",""
SPK-0258331,C[C@@H](O)[C@H](NC1CCOc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258331-001,"No Salt, free base or acid",366.417,"","","",PMID:28302397 - Cmpd : 14,"","","",CHEMBL4070767,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,14,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,2.00,"",5.46,"","",5.26,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233304,WK,"","","",""
SPK-0258331,C[C@@H](O)[C@H](NC1CCOc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258331-001,"No Salt, free base or acid",366.417,"","","",PMID:28302397 - Cmpd : 14,"","","",CHEMBL4070767,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,14,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,< 0.125,"",< 0.341,"","",> 6.47,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233369,WK,"","","",""
SPK-0258331,C[C@@H](O)[C@H](NC1CCOc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258331-001,"No Salt, free base or acid",366.417,"","","",PMID:28302397 - Cmpd : 14,"","","",CHEMBL4070767,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,14,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,128,"",349,"","",3.46,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233434,WK,"","","",""
SPK-0258331,C[C@@H](O)[C@H](NC1CCOc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258331-001,"No Salt, free base or acid",366.417,"","","",PMID:28302397 - Cmpd : 14,"","","",CHEMBL4070767,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,14,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,32.0,"",87.3,"","",4.06,"","",Acinetobacter baumannii,focus ID 961025,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233489,WK,"","","",""
SPK-0258330,C[C@@H](O)[C@H](NC1CCCCc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258330-001,"No Salt, free base or acid",378.472,"","","",PMID:28302397 - Cmpd : 13,"","","",CHEMBL4103054,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,13,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,16.0,"",42.3,"","",4.37,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233303,WK,"","","",""
SPK-0258330,C[C@@H](O)[C@H](NC1CCCCc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258330-001,"No Salt, free base or acid",378.472,"","","",PMID:28302397 - Cmpd : 13,"","","",CHEMBL4103054,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,13,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,2.00,"",5.28,"","",5.28,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233368,WK,"","","",""
SPK-0258330,C[C@@H](O)[C@H](NC1CCCCc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258330-001,"No Salt, free base or acid",378.472,"","","",PMID:28302397 - Cmpd : 13,"","","",CHEMBL4103054,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,13,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,> 128,"",> 338,"","",< 3.47,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233433,WK,"","","",""
SPK-0258330,C[C@@H](O)[C@H](NC1CCCCc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258330-001,"No Salt, free base or acid",378.472,"","","",PMID:28302397 - Cmpd : 13,"","","",CHEMBL4103054,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,13,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,> 128,"",> 338,"","",< 3.47,"","",Acinetobacter baumannii,focus ID 961025,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233488,WK,"","","",""
SPK-0258329,C[C@@H](O)[C@H](NC1CCCc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258329-001,"No Salt, free base or acid",364.445,"","","",PMID:28302397 - Cmpd : 12,"","","",CHEMBL4087371,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,12,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,1.00,"",2.74,"","",5.56,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233302,WK,"","","",""
SPK-0258329,C[C@@H](O)[C@H](NC1CCCc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258329-001,"No Salt, free base or acid",364.445,"","","",PMID:28302397 - Cmpd : 12,"","","",CHEMBL4087371,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,12,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.250,"",0.686,"","",6.16,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233367,WK,"","","",""
SPK-0258329,C[C@@H](O)[C@H](NC1CCCc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258329-001,"No Salt, free base or acid",364.445,"","","",PMID:28302397 - Cmpd : 12,"","","",CHEMBL4087371,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,12,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,32.0,"",87.8,"","",4.06,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233432,WK,"","","",""
SPK-0258329,C[C@@H](O)[C@H](NC1CCCc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258329-001,"No Salt, free base or acid",364.445,"","","",PMID:28302397 - Cmpd : 12,"","","",CHEMBL4087371,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,12,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,16.0,"",43.9,"","",4.36,"","",Acinetobacter baumannii,focus ID 961025,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233487,WK,"","","",""
SPK-0258328,C[C@@H](O)[C@H](NC1CCc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258328-001,"No Salt, free base or acid",350.418,"","","",PMID:28302397 - Cmpd : 11,"","","",CHEMBL4077504,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,11,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.500,"",1.43,"","",5.85,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233301,WK,"","","",""
SPK-0258328,C[C@@H](O)[C@H](NC1CCc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258328-001,"No Salt, free base or acid",350.418,"","","",PMID:28302397 - Cmpd : 11,"","","",CHEMBL4077504,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,11,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.125,"",0.357,"","",6.45,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233366,WK,"","","",""
SPK-0258328,C[C@@H](O)[C@H](NC1CCc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258328-001,"No Salt, free base or acid",350.418,"","","",PMID:28302397 - Cmpd : 11,"","","",CHEMBL4077504,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,11,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,32.0,"",91.3,"","",4.04,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233431,WK,"","","",""
SPK-0258328,C[C@@H](O)[C@H](NC1CCc2cc(ccc12)C#Cc1ccccc1)C(=O)NO,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258328-001,"No Salt, free base or acid",350.418,"","","",PMID:28302397 - Cmpd : 11,"","","",CHEMBL4077504,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,11,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,16.0,"",45.7,"","",4.34,"","",Acinetobacter baumannii,focus ID 961025,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233486,WK,"","","",""
SPK-0258327,CCCCC(N[C@@H]([C@@H](C)O)C(=O)NO)c1ccc(cc1)C#Cc1ccccc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258327-001,"No Salt, free base or acid",380.488,"","","",PMID:28302397 - Cmpd : 10,"","","",CHEMBL4076631,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,10,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,64.0,"",168,"","",3.77,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233300,WK,"","","",""
SPK-0258327,CCCCC(N[C@@H]([C@@H](C)O)C(=O)NO)c1ccc(cc1)C#Cc1ccccc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258327-001,"No Salt, free base or acid",380.488,"","","",PMID:28302397 - Cmpd : 10,"","","",CHEMBL4076631,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,10,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,2.00,"",5.26,"","",5.28,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233365,WK,"","","",""
SPK-0258327,CCCCC(N[C@@H]([C@@H](C)O)C(=O)NO)c1ccc(cc1)C#Cc1ccccc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258327-001,"No Salt, free base or acid",380.488,"","","",PMID:28302397 - Cmpd : 10,"","","",CHEMBL4076631,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,10,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,> 128,"",> 336,"","",< 3.47,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233430,WK,"","","",""
SPK-0258327,CCCCC(N[C@@H]([C@@H](C)O)C(=O)NO)c1ccc(cc1)C#Cc1ccccc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258327-001,"No Salt, free base or acid",380.488,"","","",PMID:28302397 - Cmpd : 10,"","","",CHEMBL4076631,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,10,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,> 128,"",> 336,"","",< 3.47,"","",Acinetobacter baumannii,focus ID 961025,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233485,WK,"","","",""
SPK-0258326,CCCC(N[C@@H]([C@@H](C)O)C(=O)NO)c1ccc(cc1)C#Cc1ccccc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258326-001,"No Salt, free base or acid",366.461,"","","",PMID:28302397 - Cmpd : 9,"","","",CHEMBL4100209,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,9,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,2.00,"",5.46,"","",5.26,"","",Escherichia coli,ATCC25922,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233299,WK,"","","",""
SPK-0258326,CCCC(N[C@@H]([C@@H](C)O)C(=O)NO)c1ccc(cc1)C#Cc1ccccc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258326-001,"No Salt, free base or acid",366.461,"","","",PMID:28302397 - Cmpd : 9,"","","",CHEMBL4100209,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,9,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,0.250,"",0.682,"","",6.17,"","",Klebsiella pneumoniae,ATCC 4352,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233364,WK,"","","",""
SPK-0258326,CCCC(N[C@@H]([C@@H](C)O)C(=O)NO)c1ccc(cc1)C#Cc1ccccc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258326-001,"No Salt, free base or acid",366.461,"","","",PMID:28302397 - Cmpd : 9,"","","",CHEMBL4100209,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,9,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,64.0,"",175,"","",3.76,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001,No,Wild type,"","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233429,WK,"","","",""
SPK-0258326,CCCC(N[C@@H]([C@@H](C)O)C(=O)NO)c1ccc(cc1)C#Cc1ccccc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258326-001,"No Salt, free base or acid",366.461,"","","",PMID:28302397 - Cmpd : 9,"","","",CHEMBL4100209,"","","",28302397,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,Published Article - data from ChEMBL26,Zhang 2017 Bioorg Med Chem Lett 27:1670,9,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-11-15,Zhang 2017 Bioorg. Med. Chem. Lett. 27:1670,"","Structure-based discovery of LpxC inhibitors.

DOI: https://dx.doi.org/10.1016/j.bmcl.2017.03.006","",Uploaded Data,32.0,"",87.3,"","",4.06,"","",Acinetobacter baumannii,focus ID 961025,"","","","","","","","","","","","","",Zhang 2017 Bioorg Med Chem Lett 27:1670,"",ChEMBL 26,https://dx.doi.org/10.1016/j.bmcl.2017.03.006,18233484,WK,"","","",""
SPK-0258325,CNc1cc(=O)n(C)c2-c3ccccc3\C(=C/c3ccncc3)c12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258325-001,"No Salt, free base or acid",315.376,"","","",PMID:29596745 - Cmpd : 4,"","","",CHEMBL4204128,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,4,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,1.00,"",3.17,"","",5.50,"","",Escherichia coli,JC7623 ?tolC FQ-S,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473473,KVT,Table 6,"","",""
SPK-0258325,CNc1cc(=O)n(C)c2-c3ccccc3\C(=C/c3ccncc3)c12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258325-001,"No Salt, free base or acid",315.376,"","","",PMID:29596745 - Cmpd : 4,"","","",CHEMBL4204128,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,4,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,2.00,"",6.34,"","",5.20,"","",Escherichia coli,W4753 ?tolC FQ-R GyrA S83L D87N ParC S80I ParE S458A,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473480,KVT,Table 6,"","",""
SPK-0258324,Fc1cc2c(cc1-c1ccccn1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258324-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3i,"","","",CHEMBL4209965,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3i,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 35218,1532,No,Wild type,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473250,KVT,Table 1,"","",""
SPK-0258324,Fc1cc2c(cc1-c1ccccn1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258324-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3i,"","","",CHEMBL4209965,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3i,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 200,"","",< 3.70,"","",Escherichia coli,MG1655 (K12),"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473264,KVT,Table 1,"","",""
SPK-0258324,Fc1cc2c(cc1-c1ccccn1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258324-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3i,"","","",CHEMBL4209965,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3i,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.5,"","",4.90,"","",Escherichia coli,MG1655 ?tolC,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473278,KVT,Table 1,"","",""
SPK-0258324,Fc1cc2c(cc1-c1ccccn1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258324-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3i,"","","",CHEMBL4209965,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3i,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 200,"","",< 3.70,"","",Escherichia coli,CGSC 5163,D22,No,Hyperpermeable,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473292,KVT,Table 1,"","",""
SPK-0258324,Fc1cc2c(cc1-c1ccccn1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258324-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3i,"","","",CHEMBL4209965,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3i,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 200,"","",< 3.70,"","",Pseudomonas aeruginosa,PAO1,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473306,KVT,Table 1,"","",""
SPK-0258324,Fc1cc2c(cc1-c1ccccn1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258324-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3i,"","","",CHEMBL4209965,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3i,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 200,"","",< 3.70,"","",Pseudomonas aeruginosa,PAO750,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473320,KVT,Table 1,"","",""
SPK-0258324,Fc1cc2c(cc1-c1ccccn1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258324-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3i,"","","",CHEMBL4209965,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3i,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 200,"","",< 3.70,"","",Staphylococcus aureus,ATCC 33592,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473334,KVT,Table 1,"","",""
SPK-0258323,Fc1cc2c(cc1-c1cccnc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258323-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3h,"","","",CHEMBL4205083,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3h,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",49.9,"","",4.30,"","",Escherichia coli,ATCC 35218,1532,No,Wild type,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473249,KVT,Table 1,"","",""
SPK-0258323,Fc1cc2c(cc1-c1cccnc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258323-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3h,"","","",CHEMBL4205083,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3h,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,32.0,"",99.9,"","",4.00,"","",Escherichia coli,MG1655 (K12),"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473263,KVT,Table 1,"","",""
SPK-0258323,Fc1cc2c(cc1-c1cccnc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258323-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3h,"","","",CHEMBL4205083,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3h,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,< 0.125,"",< 0.390,"","",> 6.41,"","",Escherichia coli,MG1655 ?tolC,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473277,KVT,Table 1,"","",""
SPK-0258323,Fc1cc2c(cc1-c1cccnc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258323-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3h,"","","",CHEMBL4205083,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3h,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",25.0,"","",4.60,"","",Escherichia coli,CGSC 5163,D22,No,Hyperpermeable,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473291,KVT,Table 1,"","",""
SPK-0258323,Fc1cc2c(cc1-c1cccnc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258323-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3h,"","","",CHEMBL4205083,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3h,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 200,"","",< 3.70,"","",Pseudomonas aeruginosa,PAO1,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473305,KVT,Table 1,"","",""
SPK-0258323,Fc1cc2c(cc1-c1cccnc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258323-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3h,"","","",CHEMBL4205083,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3h,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.5,"","",4.90,"","",Pseudomonas aeruginosa,PAO750,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473319,KVT,Table 1,"","",""
SPK-0258323,Fc1cc2c(cc1-c1cccnc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258323-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3h,"","","",CHEMBL4205083,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3h,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,64.0,"",200,"","",3.70,"","",Staphylococcus aureus,ATCC 33592,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473333,KVT,Table 1,"","",""
SPK-0258322,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1cncn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258322-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3g,"","","",CHEMBL4215314,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3g,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,64.0,"",200,"","",3.70,"","",Escherichia coli,ATCC 35218,1532,No,Wild type,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473248,KVT,Table 1,"","",""
SPK-0258322,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1cncn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258322-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3g,"","","",CHEMBL4215314,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3g,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 200,"","",< 3.70,"","",Escherichia coli,MG1655 (K12),"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473262,KVT,Table 1,"","",""
SPK-0258322,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1cncn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258322-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3g,"","","",CHEMBL4215314,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3g,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.250,"",0.780,"","",6.11,"","",Escherichia coli,MG1655 ?tolC,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473276,KVT,Table 1,"","",""
SPK-0258322,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1cncn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258322-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3g,"","","",CHEMBL4215314,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3g,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,64.0,"",200,"","",3.70,"","",Escherichia coli,CGSC 5163,D22,No,Hyperpermeable,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473290,KVT,Table 1,"","",""
SPK-0258322,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1cncn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258322-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3g,"","","",CHEMBL4215314,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3g,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 200,"","",< 3.70,"","",Pseudomonas aeruginosa,PAO1,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473304,KVT,Table 1,"","",""
SPK-0258322,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1cncn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258322-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3g,"","","",CHEMBL4215314,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3g,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,32.0,"",99.9,"","",4.00,"","",Pseudomonas aeruginosa,PAO750,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473318,KVT,Table 1,"","",""
SPK-0258322,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1cncn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258322-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3g,"","","",CHEMBL4215314,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3g,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,64.0,"",200,"","",3.70,"","",Staphylococcus aureus,ATCC 33592,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473332,KVT,Table 1,"","",""
SPK-0258321,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1ncnn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258321-001,"No Salt, free base or acid",321.315,"","","",PMID:29596745 - Cmpd : 3f,"","","",CHEMBL4210370,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3f,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,32.0,"",99.6,"","",4.00,"","",Escherichia coli,ATCC 35218,1532,No,Wild type,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473247,KVT,Table 1,"","",""
SPK-0258321,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1ncnn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258321-001,"No Salt, free base or acid",321.315,"","","",PMID:29596745 - Cmpd : 3f,"","","",CHEMBL4210370,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3f,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 199,"","",< 3.70,"","",Escherichia coli,MG1655 (K12),"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473261,KVT,Table 1,"","",""
SPK-0258321,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1ncnn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258321-001,"No Salt, free base or acid",321.315,"","","",PMID:29596745 - Cmpd : 3f,"","","",CHEMBL4210370,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3f,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,< 0.125,"",< 0.389,"","",> 6.41,"","",Escherichia coli,MG1655 ?tolC,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473275,KVT,Table 1,"","",""
SPK-0258321,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1ncnn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258321-001,"No Salt, free base or acid",321.315,"","","",PMID:29596745 - Cmpd : 3f,"","","",CHEMBL4210370,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3f,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,32.0,"",99.6,"","",4.00,"","",Escherichia coli,CGSC 5163,D22,No,Hyperpermeable,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473289,KVT,Table 1,"","",""
SPK-0258321,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1ncnn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258321-001,"No Salt, free base or acid",321.315,"","","",PMID:29596745 - Cmpd : 3f,"","","",CHEMBL4210370,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3f,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 199,"","",< 3.70,"","",Pseudomonas aeruginosa,PAO1,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473303,KVT,Table 1,"","",""
SPK-0258321,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1ncnn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258321-001,"No Salt, free base or acid",321.315,"","","",PMID:29596745 - Cmpd : 3f,"","","",CHEMBL4210370,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3f,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,32.0,"",99.6,"","",4.00,"","",Pseudomonas aeruginosa,PAO750,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473317,KVT,Table 1,"","",""
SPK-0258321,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1ncnn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258321-001,"No Salt, free base or acid",321.315,"","","",PMID:29596745 - Cmpd : 3f,"","","",CHEMBL4210370,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3f,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",49.8,"","",4.30,"","",Staphylococcus aureus,ATCC 33592,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473331,KVT,Table 1,"","",""
SPK-0258320,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3[nH]cnc3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258320-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3d,"","","",CHEMBL4214772,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3d,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Escherichia coli,ATCC 35218,1532,No,Wild type,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473245,KVT,Table 1,"","",""
SPK-0258320,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3[nH]cnc3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258320-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3d,"","","",CHEMBL4214772,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,64.0,"",196,"","",3.71,"","",Escherichia coli,MG1655 (K12),"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473259,KVT,Table 1,"","",""
SPK-0258320,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3[nH]cnc3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258320-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3d,"","","",CHEMBL4214772,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.500,"",1.53,"","",5.82,"","",Escherichia coli,MG1655 ?tolC,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473273,KVT,Table 1,"","",""
SPK-0258320,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3[nH]cnc3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258320-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3d,"","","",CHEMBL4214772,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Escherichia coli,CGSC 5163,D22,No,Hyperpermeable,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473287,KVT,Table 1,"","",""
SPK-0258320,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3[nH]cnc3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258320-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3d,"","","",CHEMBL4214772,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,64.0,"",196,"","",3.71,"","",Pseudomonas aeruginosa,PAO1,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473301,KVT,Table 1,"","",""
SPK-0258320,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3[nH]cnc3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258320-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3d,"","","",CHEMBL4214772,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.500,"",1.53,"","",5.82,"","",Pseudomonas aeruginosa,PAO750,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473315,KVT,Table 1,"","",""
SPK-0258320,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3[nH]cnc3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258320-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3d,"","","",CHEMBL4214772,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Staphylococcus aureus,ATCC 33592,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473329,KVT,Table 1,"","",""
SPK-0258320,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3[nH]cnc3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258320-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3d,"","","",CHEMBL4214772,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",24.4,"","",4.61,"","",Staphylococcus aureus,ATCC 33592,"","","","","","",50% calf fetal serum,"","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S3,"","",""
SPK-0258320,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3[nH]cnc3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258320-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3d,"","","",CHEMBL4214772,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",24.4,"","",4.61,"","",Staphylococcus aureus,ATCC 33592,"","","","","","",50% mouse serum,"","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S3,"","",""
SPK-0258320,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3[nH]cnc3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258320-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3d,"","","",CHEMBL4214772,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",24.4,"","",4.61,"","",Staphylococcus aureus,ATCC 33592,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S3,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",49.9,"","",4.30,"","",Escherichia coli,ATCC 35218,1532,No,Wild type,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473246,KVT,Table 1,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,32.0,"",99.9,"","",4.00,"","",Escherichia coli,MG1655 (K12),"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473260,KVT,Table 1,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,< 0.125,"",< 0.390,"","",> 6.41,"","",Escherichia coli,MG1655 ?tolC,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473274,KVT,Table 1,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",25.0,"","",4.60,"","",Escherichia coli,CGSC 5163,D22,No,Hyperpermeable,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473288,KVT,Table 1,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 200,"","",< 3.70,"","",Pseudomonas aeruginosa,PAO1,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473302,KVT,Table 1,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",25.0,"","",4.60,"","",Pseudomonas aeruginosa,PAO750,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473316,KVT,Table 1,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.5,"","",4.90,"","",Staphylococcus aureus,ATCC 33592,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473330,KVT,Table 1,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.0630,"",0.197,"","",6.71,"","",Escherichia coli,JC7623 ?tolC FQ-S,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473471,KVT,Table 6,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.500,"",1.56,"","",5.81,"","",Escherichia coli,W4753 ?tolC FQ-R GyrA S83L D87N ParC S80I ParE S458A,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473478,KVT,Table 6,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",25.0,"","",4.60,"","",Staphylococcus aureus,ATCC 33592,"","","","","","",50% calf fetal serum,"","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S3,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",49.9,"","",4.30,"","",Staphylococcus aureus,ATCC 33592,"","","","","","",50% mouse serum,"","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S3,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.125,"",0.390,"","",6.41,"","",Escherichia coli,ATCC 25922 ?tolC,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S4,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,2.00,"",6.24,"","",5.20,"","",Escherichia coli,ATCC 25922 ?tolC (selection at 0.5?g/mL),"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S4,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",25.0,"","",4.60,"","",Staphylococcus aureus,RN4220,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",25.0,"","",4.60,"","",Staphylococcus aureus,RN4220 GyrA D83N,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,32.0,"",99.9,"","",4.00,"","",Staphylococcus aureus,RN4220 GyrA D83N ParC D79N,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",25.0,"","",4.60,"","",Staphylococcus aureus,RN4220 GyrA M121K,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",25.0,"","",4.60,"","",Staphylococcus aureus,RN4220 GyrA Y87F,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258319,Fc1cc2c(cc1-c1ccncc1)n(C1CC1)c(=O)c1nccn21,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258319-001,"No Salt, free base or acid",320.327,"","","",PMID:29596745 - Cmpd : 3e,"","","",CHEMBL4203118,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",25.0,"","",4.60,"","",Staphylococcus aureus,ATCC 33592,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S3,"","",""
SPK-0258318,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3cncn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258318-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3c,"","","",CHEMBL4206524,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3c,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Escherichia coli,ATCC 35218,1532,No,Wild type,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473244,KVT,Table 1,"","",""
SPK-0258318,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3cncn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258318-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3c,"","","",CHEMBL4206524,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,32.0,"",97.8,"","",4.01,"","",Escherichia coli,MG1655 (K12),"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473258,KVT,Table 1,"","",""
SPK-0258318,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3cncn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258318-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3c,"","","",CHEMBL4206524,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,1.00,"",3.05,"","",5.52,"","",Escherichia coli,MG1655 ?tolC,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473272,KVT,Table 1,"","",""
SPK-0258318,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3cncn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258318-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3c,"","","",CHEMBL4206524,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Escherichia coli,CGSC 5163,D22,No,Hyperpermeable,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473286,KVT,Table 1,"","",""
SPK-0258318,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3cncn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258318-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3c,"","","",CHEMBL4206524,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 196,"","",< 3.71,"","",Pseudomonas aeruginosa,PAO1,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473300,KVT,Table 1,"","",""
SPK-0258318,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3cncn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258318-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3c,"","","",CHEMBL4206524,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,1.00,"",3.05,"","",5.52,"","",Pseudomonas aeruginosa,PAO750,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473314,KVT,Table 1,"","",""
SPK-0258318,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3cncn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258318-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3c,"","","",CHEMBL4206524,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Staphylococcus aureus,ATCC 33592,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473328,KVT,Table 1,"","",""
SPK-0258318,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3cncn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258318-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3c,"","","",CHEMBL4206524,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",24.4,"","",4.61,"","",Staphylococcus aureus,ATCC 33592,"","","","","","",50% calf fetal serum,"","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S3,"","",""
SPK-0258318,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3cncn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258318-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3c,"","","",CHEMBL4206524,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",24.4,"","",4.61,"","",Staphylococcus aureus,ATCC 33592,"","","","","","",50% mouse serum,"","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S3,"","",""
SPK-0258318,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3cncn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258318-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3c,"","","",CHEMBL4206524,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Staphylococcus aureus,RN4220,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258318,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3cncn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258318-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3c,"","","",CHEMBL4206524,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Staphylococcus aureus,RN4220 GyrA D83N,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258318,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3cncn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258318-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3c,"","","",CHEMBL4206524,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Staphylococcus aureus,RN4220 GyrA D83N ParC D79N,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258318,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3cncn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258318-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3c,"","","",CHEMBL4206524,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Staphylococcus aureus,RN4220 GyrA M121K,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258318,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3cncn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258318-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3c,"","","",CHEMBL4206524,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Staphylococcus aureus,RN4220 GyrA Y87F,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258318,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3cncn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258318-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3c,"","","",CHEMBL4206524,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Staphylococcus aureus,ATCC 33592,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S3,"","",""
SPK-0258317,Cn1cc(-c2ccc(NC(=O)Cc3ccc(Cl)cc3)cc2)n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258317-001,"No Salt, free base or acid",392.840,"","","",PMID:29596745 - Cmpd : 2a,"","","",CHEMBL4206009,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,2a,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 32.0,"",> 81.5,"","",< 4.09,"","",Escherichia coli,ATCC 35218,1532,No,Wild type,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473241,KVT,Table 1,"","",""
SPK-0258317,Cn1cc(-c2ccc(NC(=O)Cc3ccc(Cl)cc3)cc2)n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258317-001,"No Salt, free base or acid",392.840,"","","",PMID:29596745 - Cmpd : 2a,"","","",CHEMBL4206009,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,2a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 32.0,"",> 81.5,"","",< 4.09,"","",Escherichia coli,MG1655 (K12),"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473255,KVT,Table 1,"","",""
SPK-0258317,Cn1cc(-c2ccc(NC(=O)Cc3ccc(Cl)cc3)cc2)n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258317-001,"No Salt, free base or acid",392.840,"","","",PMID:29596745 - Cmpd : 2a,"","","",CHEMBL4206009,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,2a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,1.00,"",2.55,"","",5.59,"","",Escherichia coli,MG1655 ?tolC,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473269,KVT,Table 1,"","",""
SPK-0258317,Cn1cc(-c2ccc(NC(=O)Cc3ccc(Cl)cc3)cc2)n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258317-001,"No Salt, free base or acid",392.840,"","","",PMID:29596745 - Cmpd : 2a,"","","",CHEMBL4206009,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,2a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,32.0,"",81.5,"","",4.09,"","",Escherichia coli,CGSC 5163,D22,No,Hyperpermeable,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473283,KVT,Table 1,"","",""
SPK-0258317,Cn1cc(-c2ccc(NC(=O)Cc3ccc(Cl)cc3)cc2)n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258317-001,"No Salt, free base or acid",392.840,"","","",PMID:29596745 - Cmpd : 2a,"","","",CHEMBL4206009,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,2a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 32.0,"",> 81.5,"","",< 4.09,"","",Pseudomonas aeruginosa,PAO1,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473297,KVT,Table 1,"","",""
SPK-0258317,Cn1cc(-c2ccc(NC(=O)Cc3ccc(Cl)cc3)cc2)n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258317-001,"No Salt, free base or acid",392.840,"","","",PMID:29596745 - Cmpd : 2a,"","","",CHEMBL4206009,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,2a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 32.0,"",> 81.5,"","",< 4.09,"","",Pseudomonas aeruginosa,PAO750,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473311,KVT,Table 1,"","",""
SPK-0258317,Cn1cc(-c2ccc(NC(=O)Cc3ccc(Cl)cc3)cc2)n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258317-001,"No Salt, free base or acid",392.840,"","","",PMID:29596745 - Cmpd : 2a,"","","",CHEMBL4206009,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,2a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 32.0,"",> 81.5,"","",< 4.09,"","",Staphylococcus aureus,ATCC 33592,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473325,KVT,Table 1,"","",""
SPK-0258317,Cn1cc(-c2ccc(NC(=O)Cc3ccc(Cl)cc3)cc2)n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258317-001,"No Salt, free base or acid",392.840,"","","",PMID:29596745 - Cmpd : 2a,"","","",CHEMBL4206009,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,2a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.125,"",0.318,"","",6.50,"","",Escherichia coli,JC7623 ?tolC FQ-S,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473469,KVT,Table 6,"","",""
SPK-0258317,Cn1cc(-c2ccc(NC(=O)Cc3ccc(Cl)cc3)cc2)n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258317-001,"No Salt, free base or acid",392.840,"","","",PMID:29596745 - Cmpd : 2a,"","","",CHEMBL4206009,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,2a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",10.2,"","",4.99,"","",Escherichia coli,W4753 ?tolC FQ-R GyrA S83L D87N ParC S80I ParE S458A,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473476,KVT,Table 6,"","",""
SPK-0258317,Cn1cc(-c2ccc(NC(=O)Cc3ccc(Cl)cc3)cc2)n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258317-001,"No Salt, free base or acid",392.840,"","","",PMID:29596745 - Cmpd : 2a,"","","",CHEMBL4206009,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,2a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 163,"","",< 3.79,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258317,Cn1cc(-c2ccc(NC(=O)Cc3ccc(Cl)cc3)cc2)n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258317-001,"No Salt, free base or acid",392.840,"","","",PMID:29596745 - Cmpd : 2a,"","","",CHEMBL4206009,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,2a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,64.0,"",163,"","",3.79,"","",Escherichia coli,JC7623,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258317,Cn1cc(-c2ccc(NC(=O)Cc3ccc(Cl)cc3)cc2)n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258317-001,"No Salt, free base or acid",392.840,"","","",PMID:29596745 - Cmpd : 2a,"","","",CHEMBL4206009,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,2a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",20.4,"","",4.69,"","",Acinetobacter baumannii,BM4652,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258317,Cn1cc(-c2ccc(NC(=O)Cc3ccc(Cl)cc3)cc2)n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258317-001,"No Salt, free base or acid",392.840,"","","",PMID:29596745 - Cmpd : 2a,"","","",CHEMBL4206009,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,2a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 163,"","",< 3.79,"","",Acinetobacter baumannii,BM4454,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258317,Cn1cc(-c2ccc(NC(=O)Cc3ccc(Cl)cc3)cc2)n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258317-001,"No Salt, free base or acid",392.840,"","","",PMID:29596745 - Cmpd : 2a,"","","",CHEMBL4206009,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,2a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 163,"","",< 3.79,"","",Klebsiella pneumoniae,1161486,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258317,Cn1cc(-c2ccc(NC(=O)Cc3ccc(Cl)cc3)cc2)n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258317-001,"No Salt, free base or acid",392.840,"","","",PMID:29596745 - Cmpd : 2a,"","","",CHEMBL4206009,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,2a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.500,"",1.27,"","",5.90,"","",Klebsiella pneumoniae,1161486a,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258317,Cn1cc(-c2ccc(NC(=O)Cc3ccc(Cl)cc3)cc2)n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258317-001,"No Salt, free base or acid",392.840,"","","",PMID:29596745 - Cmpd : 2a,"","","",CHEMBL4206009,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,2a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 163,"","",< 3.79,"","",Klebsiella pneumoniae,NCTC 13443,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258317,Cn1cc(-c2ccc(NC(=O)Cc3ccc(Cl)cc3)cc2)n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258317-001,"No Salt, free base or acid",392.840,"","","",PMID:29596745 - Cmpd : 2a,"","","",CHEMBL4206009,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,2a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 163,"","",< 3.79,"","",Klebsiella pneumoniae,NCTC 13438,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258317,Cn1cc(-c2ccc(NC(=O)Cc3ccc(Cl)cc3)cc2)n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258317-001,"No Salt, free base or acid",392.840,"","","",PMID:29596745 - Cmpd : 2a,"","","",CHEMBL4206009,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,2a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,64.0,"",163,"","",3.79,"","",Pseudomonas aeruginosa,18S/H,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258316,Cn1c2c3ccccc3\c(=C/c3ccncc3)c2n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258316-001,"No Salt, free base or acid",326.359,"","","",PMID:29596745 - Cmpd : 1b,"","","",CHEMBL4215756,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1b,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 196,"","",< 3.71,"","",Escherichia coli,ATCC 35218,1532,No,Wild type,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473240,KVT,Table 1,"","",""
SPK-0258316,Cn1c2c3ccccc3\c(=C/c3ccncc3)c2n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258316-001,"No Salt, free base or acid",326.359,"","","",PMID:29596745 - Cmpd : 1b,"","","",CHEMBL4215756,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 196,"","",< 3.71,"","",Escherichia coli,MG1655 (K12),"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473254,KVT,Table 1,"","",""
SPK-0258316,Cn1c2c3ccccc3\c(=C/c3ccncc3)c2n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258316-001,"No Salt, free base or acid",326.359,"","","",PMID:29596745 - Cmpd : 1b,"","","",CHEMBL4215756,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,< 0.125,"",< 0.383,"","",> 6.42,"","",Escherichia coli,MG1655 ?tolC,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473268,KVT,Table 1,"","",""
SPK-0258316,Cn1c2c3ccccc3\c(=C/c3ccncc3)c2n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258316-001,"No Salt, free base or acid",326.359,"","","",PMID:29596745 - Cmpd : 1b,"","","",CHEMBL4215756,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 196,"","",< 3.71,"","",Escherichia coli,CGSC 5163,D22,No,Hyperpermeable,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473282,KVT,Table 1,"","",""
SPK-0258316,Cn1c2c3ccccc3\c(=C/c3ccncc3)c2n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258316-001,"No Salt, free base or acid",326.359,"","","",PMID:29596745 - Cmpd : 1b,"","","",CHEMBL4215756,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 196,"","",< 3.71,"","",Pseudomonas aeruginosa,PAO1,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473296,KVT,Table 1,"","",""
SPK-0258316,Cn1c2c3ccccc3\c(=C/c3ccncc3)c2n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258316-001,"No Salt, free base or acid",326.359,"","","",PMID:29596745 - Cmpd : 1b,"","","",CHEMBL4215756,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 196,"","",< 3.71,"","",Pseudomonas aeruginosa,PAO750,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473310,KVT,Table 1,"","",""
SPK-0258316,Cn1c2c3ccccc3\c(=C/c3ccncc3)c2n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258316-001,"No Salt, free base or acid",326.359,"","","",PMID:29596745 - Cmpd : 1b,"","","",CHEMBL4215756,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.0160,"",0.0490,"","",7.31,"","",Escherichia coli,JC7623 ?tolC FQ-S,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473468,KVT,Table 6,"","",""
SPK-0258316,Cn1c2c3ccccc3\c(=C/c3ccncc3)c2n2ccnc2c1=O,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258316-001,"No Salt, free base or acid",326.359,"","","",PMID:29596745 - Cmpd : 1b,"","","",CHEMBL4215756,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.250,"",0.766,"","",6.12,"","",Escherichia coli,W4753 ?tolC FQ-R GyrA S83L D87N ParC S80I ParE S458A,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473475,KVT,Table 6,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,2.00,"",6.09,"","",5.22,"","",Escherichia coli,ATCC 35218,1532,No,Wild type,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473243,KVT,Table 1,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.2,"","",4.91,"","",Escherichia coli,MG1655 (K12),"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473257,KVT,Table 1,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,< 0.125,"",< 0.381,"","",> 6.42,"","",Escherichia coli,MG1655 ?tolC,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473271,KVT,Table 1,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,1.00,"",3.05,"","",5.52,"","",Escherichia coli,CGSC 5163,D22,No,Hyperpermeable,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473285,KVT,Table 1,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 195,"","",< 3.71,"","",Pseudomonas aeruginosa,PAO1,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473299,KVT,Table 1,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,1.00,"",3.05,"","",5.52,"","",Pseudomonas aeruginosa,PAO750,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473313,KVT,Table 1,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.2,"","",4.91,"","",Staphylococcus aureus,ATCC 33592,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473327,KVT,Table 1,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.2,"","",4.91,"","",Acinetobacter baumannii,BM4652,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473355,KVT,Table S2,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.500,"",1.52,"","",5.82,"","",Klebsiella pneumoniae,1161486a,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473357,KVT,Table S2,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 195,"","",< 3.71,"","",Acinetobacter baumannii,BM4454,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473359,KVT,Table S2,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,32.0,"",97.5,"","",4.01,"","",Klebsiella pneumoniae,1161486,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473361,KVT,Table S2,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,2.00,"",6.09,"","",5.22,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,2.00,"",6.09,"","",5.22,"","",Escherichia coli,JC7623,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.2,"","",4.91,"","",Acinetobacter baumannii,BM4652,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.2,"","",4.91,"","",Acinetobacter baumannii,BM4454,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,32.0,"",97.5,"","",4.01,"","",Klebsiella pneumoniae,1161486,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.500,"",1.52,"","",5.82,"","",Klebsiella pneumoniae,1161486a,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 195,"","",< 3.71,"","",Klebsiella pneumoniae,NCTC 13443,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 195,"","",< 3.71,"","",Klebsiella pneumoniae,NCTC 13438,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.7,"","",4.31,"","",Pseudomonas aeruginosa,18S/H,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,2.00,"",6.09,"","",5.22,"","",Staphylococcus aureus,ATCC 33592,"","","","","","",50% calf fetal serum,"","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S3,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,2.00,"",6.09,"","",5.22,"","",Staphylococcus aureus,ATCC 33592,"","","","","","",50% mouse serum,"","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S3,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.2,"","",4.91,"","",Staphylococcus aureus,RN4220,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.2,"","",4.91,"","",Staphylococcus aureus,RN4220 GyrA D83N,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.7,"","",4.31,"","",Staphylococcus aureus,RN4220 GyrA D83N ParC D79N,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.2,"","",4.91,"","",Staphylococcus aureus,RN4220 GyrA M121K,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.2,"","",4.91,"","",Staphylococcus aureus,RN4220 GyrA Y87F,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 195,"","",< 3.71,"","",Acinetobacter baumannii,BM4454,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258315,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3ncnn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258315-001,"No Salt, free base or acid",328.351,"","","",PMID:29596745 - Cmpd : 3b,"","","",CHEMBL4218256,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.2,"","",4.91,"","",Staphylococcus aureus,ATCC 33592,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S3,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.2,"","",4.91,"","",Escherichia coli,ATCC 35218,1532,No,Wild type,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473242,KVT,Table 1,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",24.4,"","",4.61,"","",Escherichia coli,MG1655 (K12),"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473256,KVT,Table 1,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,< 0.125,"",< 0.382,"","",> 6.42,"","",Escherichia coli,MG1655 ?tolC,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473270,KVT,Table 1,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,2.00,"",6.11,"","",5.21,"","",Escherichia coli,CGSC 5163,D22,No,Hyperpermeable,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473284,KVT,Table 1,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,32.0,"",97.8,"","",4.01,"","",Pseudomonas aeruginosa,PAO1,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473298,KVT,Table 1,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,< 0.125,"",< 0.382,"","",> 6.42,"","",Pseudomonas aeruginosa,PAO750,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473312,KVT,Table 1,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",24.4,"","",4.61,"","",Staphylococcus aureus,ATCC 33592,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473326,KVT,Table 1,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.2,"","",4.91,"","",Acinetobacter baumannii,BM4652,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473354,KVT,Table S2,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.500,"",1.53,"","",5.82,"","",Klebsiella pneumoniae,1161486a,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473356,KVT,Table S2,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 196,"","",< 3.71,"","",Acinetobacter baumannii,BM4454,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473358,KVT,Table S2,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,32.0,"",97.8,"","",4.01,"","",Klebsiella pneumoniae,1161486,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473360,KVT,Table 5,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.2,"","",4.91,"","",Staphylococcus aureus,RN4220,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473427,KVT,Table 5,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.2,"","",4.91,"","",Staphylococcus aureus,RN4220 GyrA D83N,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473429,KVT,Table 5,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Staphylococcus aureus,RN4220 GyrA D83N ParC D79N,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473431,KVT,Table 5,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.2,"","",4.91,"","",Staphylococcus aureus,RN4220 GyrB D437N,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473433,KVT,Table 5,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",24.4,"","",4.61,"","",Staphylococcus aureus,RN4220 ParC S80F,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473435,KVT,Table 5,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Staphylococcus aureus,RN4220 ParC S80F GyrA S84L,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473437,KVT,Table 5,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Klebsiella pneumoniae,1161486,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473439,KVT,Table 5,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,64.0,"",196,"","",3.71,"","",Klebsiella pneumoniae,1161486 GyrA S83I,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473441,KVT,Table 5,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,128,"",391,"","",3.41,"","",Klebsiella pneumoniae,1161486 GyrA S83I ParC S80I,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473443,KVT,Table 5,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,64.0,"",196,"","",3.71,"","",Klebsiella pneumoniae,1161486 GyrA S83F D87V ParC S80I,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473445,KVT,Table 5,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,512,"",1.56E+03,"","",2.81,"","",Escherichia coli,MG1655 GyrA S83L D87N ParC S80I,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473447,KVT,Table 5,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.125,"",0.382,"","",6.42,"","",Escherichia coli,JC7623 ?tolC FQ-S,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473470,KVT,Table 6,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,2.00,"",6.11,"","",5.21,"","",Escherichia coli,W4753 ?tolC FQ-R GyrA S83L D87N ParC S80I ParE S458A,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473477,KVT,Table 6,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 196,"","",< 3.71,"","",Acinetobacter baumannii,BM4454,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,32.0,"",97.8,"","",4.01,"","",Klebsiella pneumoniae,1161486,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.500,"",1.53,"","",5.82,"","",Klebsiella pneumoniae,1161486a,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 196,"","",< 3.71,"","",Klebsiella pneumoniae,NCTC 13443,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 196,"","",< 3.71,"","",Klebsiella pneumoniae,NCTC 13438,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Pseudomonas aeruginosa,18S/H,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,2.00,"",6.11,"","",5.21,"","",Staphylococcus aureus,ATCC 33592,"","","","","","",50% calf fetal serum,"","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S3,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,2.00,"",6.11,"","",5.21,"","",Staphylococcus aureus,ATCC 33592,"","","","","","",50% mouse serum,"","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S3,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Escherichia coli,ATCC 25922 hisS V334E (selection at 32?g/mL),"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S4,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Escherichia coli,ATCC 25922 ?tolC DR76_3503 Q47H (selection at 1?g/mL),"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S4,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.2,"","",4.91,"","",Escherichia coli,ATCC 25922 ?tolC (selection at 1?g/mL),"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S4,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.2,"","",4.91,"","",Staphylococcus aureus,RN4220 GyrA M121K,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,8.00,"",24.4,"","",4.61,"","",Staphylococcus aureus,RN4220 GyrA Y87F,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",12.2,"","",4.91,"","",Staphylococcus aureus,ATCC 33592,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S3,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,16.0,"",48.9,"","",4.31,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S4,"","",""
SPK-0258314,N[C@H]1CCN(C1)c1cc2n(C3CC3)c(=O)c3nccn3c2cc1F,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258314-001,"No Salt, free base or acid",327.363,"","","",PMID:29596745 - Cmpd : 3a,"","","",CHEMBL4210894,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,3a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.500,"",1.53,"","",5.82,"","",Escherichia coli,ATCC 25922 ?tolC,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S4,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 167,"","",< 3.78,"","",Escherichia coli,ATCC 35218,1532,No,Wild type,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473239,KVT,Table 1,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 167,"","",< 3.78,"","",Escherichia coli,MG1655 (K12),"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473253,KVT,Table 1,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,< 0.125,"",< 0.327,"","",> 6.49,"","",Escherichia coli,MG1655 ?tolC,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473267,KVT,Table 1,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 167,"","",< 3.78,"","",Escherichia coli,CGSC 5163,D22,No,Hyperpermeable,"","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473281,KVT,Table 1,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 167,"","",< 3.78,"","",Pseudomonas aeruginosa,PAO1,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473295,KVT,Table 1,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 167,"","",< 3.78,"","",Pseudomonas aeruginosa,PAO750,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473309,KVT,Table 1,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.250,"",0.654,"","",6.18,"","",Staphylococcus aureus,ATCC 33592,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473323,KVT,Table 1,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.0630,"",0.165,"","",6.78,"","",Escherichia coli,JC7623 ?tolC FQ-S,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473467,KVT,Table 6,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,2.00,"",5.23,"","",5.28,"","",Escherichia coli,W4753 ?tolC FQ-R GyrA S83L D87N ParC S80I ParE S458A,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,18473474,KVT,Table 6,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 167,"","",< 3.78,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,64.0,"",167,"","",3.78,"","",Escherichia coli,JC7623,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,32.0,"",83.7,"","",4.08,"","",Acinetobacter baumannii,BM4652,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 167,"","",< 3.78,"","",Acinetobacter baumannii,BM4454,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 167,"","",< 3.78,"","",Klebsiella pneumoniae,1161486,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.500,"",1.31,"","",5.88,"","",Klebsiella pneumoniae,1161486a,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 167,"","",< 3.78,"","",Klebsiella pneumoniae,NCTC 13443,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 167,"","",< 3.78,"","",Klebsiella pneumoniae,NCTC 13438,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,> 64.0,"",> 167,"","",< 3.78,"","",Pseudomonas aeruginosa,18S/H,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S2,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",10.5,"","",4.98,"","",Staphylococcus aureus,ATCC 33592,"","","","","","",50% calf fetal serum,"","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S3,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,4.00,"",10.5,"","",4.98,"","",Staphylococcus aureus,ATCC 33592,"","","","","","",50% mouse serum,"","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S3,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.250,"",0.654,"","",6.18,"","",Staphylococcus aureus,RN4220,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.250,"",0.654,"","",6.18,"","",Staphylococcus aureus,RN4220 GyrA D83N,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.500,"",1.31,"","",5.88,"","",Staphylococcus aureus,RN4220 GyrA D83N ParC D79N,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.250,"",0.654,"","",6.18,"","",Staphylococcus aureus,RN4220 GyrA M121K,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,0.125,"",0.327,"","",6.49,"","",Staphylococcus aureus,RN4220 GyrA Y87F,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S5,"","",""
SPK-0258313,CC(=O)Nc1ccc(\C=c2/c3ccccc3c3n(C)c(=O)c4nccn4c23)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258313-001,"No Salt, free base or acid",382.423,"","","",PMID:29596745 - Cmpd : 1a,"","","",CHEMBL4211958,"","","",29596745,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,Published Article - data from ChEMBL26,Jeannot 2018 J Med Chem 61:3565,1a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-02,Jeannot 2018 J. Med. Chem. 61:3565,"","Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.7b01892","",Uploaded Data,< 0.125,"",< 0.327,"","",> 6.49,"","",Staphylococcus aureus,ATCC 33592,"","","","","","","","","","","","","",Jeannot 2018 J Med Chem 61:3565,"",ChEMBL 26,https://dx.doi.org/10.1021/acs.jmedchem.7b01892,"",KVT,Table S3,"","",""
SPK-0258311,Cc1ccc(F)cc1S(=O)(=O)NC1CCN(Cc2ccc(cc2)-c2ccccc2)C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258311-001,"No Salt, free base or acid",424.530,"","","",PMID:21552338 - Cmpd : 3,"","","",CHEMBL1824654,"","","",21552338,https://dx.doi.org/10.1021/ml1002822,Published Article - data from ChEMBL24,Foss 2011 ACS Med. Chem. Lett. 2:289,3,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-03,Foss 2011 ACS Med. Chem. Lett. 2:289,"","N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.

DOI: https://dx.doi.org/10.1021/ml1002822","",Uploaded Data,1.06,"",2.50,"","",5.60,"","",Escherichia coli,BW25113 delta tolC,"","","","","","","","","","","","","",Foss 2011 ACS Med. Chem. Lett. 2:289,"",ChEMBL 26,https://dx.doi.org/10.1021/ml1002822,6342382,KT,"","","",Yes
SPK-0258311,Cc1ccc(F)cc1S(=O)(=O)NC1CCN(Cc2ccc(cc2)-c2ccccc2)C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258311-001,"No Salt, free base or acid",424.530,"","","",PMID:21552338 - Cmpd : 3,"","","",CHEMBL1824654,"","","",21552338,https://dx.doi.org/10.1021/ml1002822,Published Article - data from ChEMBL24,Foss 2011 ACS Med. Chem. Lett. 2:289,3,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-03,Foss 2011 ACS Med. Chem. Lett. 2:289,"","N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.

DOI: https://dx.doi.org/10.1021/ml1002822","",Uploaded Data,8.49,"",20.0,"","",4.70,"","",Escherichia coli,CGSC 7636,BW25113; ARPX; NB27176,No,Wild type,"î(araD-araB)567, îlacZ4787(::rrnB-3), ª-, rph-1, î(rhaD-rhaB)568, hsdR514",Commonly used lab strain; parent strain for Keio collection of single gene knockout mutants,"","60 uM MC-207,100","","","","","","",Foss 2011 ACS Med. Chem. Lett. 2:289,"",ChEMBL 26,https://dx.doi.org/10.1021/ml1002822,6342387,KT,"","","",Yes
SPK-0258311,Cc1ccc(F)cc1S(=O)(=O)NC1CCN(Cc2ccc(cc2)-c2ccccc2)C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258311-001,"No Salt, free base or acid",424.530,"","","",PMID:21552338 - Cmpd : 3,"","","",CHEMBL1824654,"","","",21552338,https://dx.doi.org/10.1021/ml1002822,Published Article - data from ChEMBL24,Foss 2011 ACS Med. Chem. Lett. 2:289,3,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-03,Foss 2011 ACS Med. Chem. Lett. 2:289,"","N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.

DOI: https://dx.doi.org/10.1021/ml1002822","",Uploaded Data,8.49,"",20.0,"","",4.70,"","",Pseudomonas aeruginosa,K,"","","","","","","60 uM MC-207,100","","","","","","",Foss 2011 ACS Med. Chem. Lett. 2:289,"",ChEMBL 26,https://dx.doi.org/10.1021/ml1002822,6342391,KT,"","","",Yes
SPK-0258311,Cc1ccc(F)cc1S(=O)(=O)NC1CCN(Cc2ccc(cc2)-c2ccccc2)C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258311-001,"No Salt, free base or acid",424.530,"","","",PMID:21552338 - Cmpd : 3,"","","",CHEMBL1824654,"","","",21552338,https://dx.doi.org/10.1021/ml1002822,Published Article - data from ChEMBL24,Foss 2011 ACS Med. Chem. Lett. 2:289,3,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-03,Foss 2011 ACS Med. Chem. Lett. 2:289,"","N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.

DOI: https://dx.doi.org/10.1021/ml1002822","",Uploaded Data,4.25,"",10.0,"","",5.00,"","",Salmonella enterica,ATCC 19585,"","","","","","","","","","","","","",Foss 2011 ACS Med. Chem. Lett. 2:289,"",ChEMBL 26,https://dx.doi.org/10.1021/ml1002822,6342395,KT,"","","",Yes
SPK-0258311,Cc1ccc(F)cc1S(=O)(=O)NC1CCN(Cc2ccc(cc2)-c2ccccc2)C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258311-001,"No Salt, free base or acid",424.530,"","","",PMID:21552338 - Cmpd : 3,"","","",CHEMBL1824654,"","","",21552338,https://dx.doi.org/10.1021/ml1002822,Published Article - data from ChEMBL24,Foss 2011 ACS Med. Chem. Lett. 2:289,3,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-03,Foss 2011 ACS Med. Chem. Lett. 2:289,"","N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.

DOI: https://dx.doi.org/10.1021/ml1002822","",Uploaded Data,8.49,"",20.0,"","",4.70,"","",Staphylococcus aureus,FRI 100,"","","","","","","","","","","","","",Foss 2011 ACS Med. Chem. Lett. 2:289,"",ChEMBL 26,https://dx.doi.org/10.1021/ml1002822,6342399,KT,"","","",Yes
SPK-0258311,Cc1ccc(F)cc1S(=O)(=O)NC1CCN(Cc2ccc(cc2)-c2ccccc2)C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258311-001,"No Salt, free base or acid",424.530,"","","",PMID:21552338 - Cmpd : 3,"","","",CHEMBL1824654,"","","",21552338,https://dx.doi.org/10.1021/ml1002822,Published Article - data from ChEMBL24,Foss 2011 ACS Med. Chem. Lett. 2:289,3,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-03,Foss 2011 ACS Med. Chem. Lett. 2:289,"","N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.

DOI: https://dx.doi.org/10.1021/ml1002822","",Uploaded Data,4.25,"",10.0,"","",5.00,"","",Streptococcus pneumoniae,ATCC 10813,"","","","","","","","","","","","","",Foss 2011 ACS Med. Chem. Lett. 2:289,"",ChEMBL 26,https://dx.doi.org/10.1021/ml1002822,6342403,KT,"","","",Yes
SPK-0258311,Cc1ccc(F)cc1S(=O)(=O)NC1CCN(Cc2ccc(cc2)-c2ccccc2)C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258311-001,"No Salt, free base or acid",424.530,"","","",PMID:21552338 - Cmpd : 3,"","","",CHEMBL1824654,"","","",21552338,https://dx.doi.org/10.1021/ml1002822,Published Article - data from ChEMBL24,Foss 2011 ACS Med. Chem. Lett. 2:289,3,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-03,Foss 2011 ACS Med. Chem. Lett. 2:289,"","N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.

DOI: https://dx.doi.org/10.1021/ml1002822","",Uploaded Data,> 67.9,"",> 160,"","",< 3.80,"","",Enterococcus faecalis,1131,"","","","","","","","","","","","","",Foss 2011 ACS Med. Chem. Lett. 2:289,"",ChEMBL 26,https://dx.doi.org/10.1021/ml1002822,6343351,KT,"","","",Yes
SPK-0258311,Cc1ccc(F)cc1S(=O)(=O)NC1CCN(Cc2ccc(cc2)-c2ccccc2)C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258311-001,"No Salt, free base or acid",424.530,"","","",PMID:21552338 - Cmpd : 3,"","","",CHEMBL1824654,"","","",21552338,https://dx.doi.org/10.1021/ml1002822,Published Article - data from ChEMBL24,Foss 2011 ACS Med. Chem. Lett. 2:289,3,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-03,Foss 2011 ACS Med. Chem. Lett. 2:289,"","N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.

DOI: https://dx.doi.org/10.1021/ml1002822","",Uploaded Data,4.25,"",10.0,"","",5.00,"","",Salmonella enterica,ATCC 19585,"","","","","","","","","","","","","",Foss 2011 ACS Med. Chem. Lett. 2:289,"",ChEMBL 26,https://dx.doi.org/10.1021/ml1002822,6343367,KT,"","","",Yes
SPK-0258310,CC(C)Cc1ccc(CN2CCC(C2)NS(=O)(=O)c2cc(F)ccc2C)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258310-001,"No Salt, free base or acid",404.540,"","","",PMID:21552338 - Cmpd : 2,"","","",CHEMBL1824653,"","","",21552338,https://dx.doi.org/10.1021/ml1002822,Published Article - data from ChEMBL24,Foss 2011 ACS Med. Chem. Lett. 2:289,2,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-03,Foss 2011 ACS Med. Chem. Lett. 2:289,"","N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.

DOI: https://dx.doi.org/10.1021/ml1002822","",Uploaded Data,2.02,"",4.99,"","",5.30,"","",Escherichia coli,BW25113 delta tolC,"","","","","","","","","","","","","",Foss 2011 ACS Med. Chem. Lett. 2:289,"",ChEMBL 26,https://dx.doi.org/10.1021/ml1002822,6342381,KT,"","","",Yes
SPK-0258310,CC(C)Cc1ccc(CN2CCC(C2)NS(=O)(=O)c2cc(F)ccc2C)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258310-001,"No Salt, free base or acid",404.540,"","","",PMID:21552338 - Cmpd : 2,"","","",CHEMBL1824653,"","","",21552338,https://dx.doi.org/10.1021/ml1002822,Published Article - data from ChEMBL24,Foss 2011 ACS Med. Chem. Lett. 2:289,2,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-03,Foss 2011 ACS Med. Chem. Lett. 2:289,"","N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.

DOI: https://dx.doi.org/10.1021/ml1002822","",Uploaded Data,16.2,"",40.0,"","",4.40,"","",Escherichia coli,CGSC 7636,BW25113; ARPX; NB27176,No,Wild type,"î(araD-araB)567, îlacZ4787(::rrnB-3), ª-, rph-1, î(rhaD-rhaB)568, hsdR514",Commonly used lab strain; parent strain for Keio collection of single gene knockout mutants,"","60 uM MC-207,110","","","","","","",Foss 2011 ACS Med. Chem. Lett. 2:289,"",ChEMBL 26,https://dx.doi.org/10.1021/ml1002822,6342386,KT,"","","",Yes
SPK-0258310,CC(C)Cc1ccc(CN2CCC(C2)NS(=O)(=O)c2cc(F)ccc2C)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258310-001,"No Salt, free base or acid",404.540,"","","",PMID:21552338 - Cmpd : 2,"","","",CHEMBL1824653,"","","",21552338,https://dx.doi.org/10.1021/ml1002822,Published Article - data from ChEMBL24,Foss 2011 ACS Med. Chem. Lett. 2:289,2,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-03,Foss 2011 ACS Med. Chem. Lett. 2:289,"","N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.

DOI: https://dx.doi.org/10.1021/ml1002822","",Uploaded Data,16.2,"",40.0,"","",4.40,"","",Pseudomonas aeruginosa,K,"","","","","","","60 uM MC-207,110","","","","","","",Foss 2011 ACS Med. Chem. Lett. 2:289,"",ChEMBL 26,https://dx.doi.org/10.1021/ml1002822,6342390,KT,"","","",Yes
SPK-0258310,CC(C)Cc1ccc(CN2CCC(C2)NS(=O)(=O)c2cc(F)ccc2C)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258310-001,"No Salt, free base or acid",404.540,"","","",PMID:21552338 - Cmpd : 2,"","","",CHEMBL1824653,"","","",21552338,https://dx.doi.org/10.1021/ml1002822,Published Article - data from ChEMBL24,Foss 2011 ACS Med. Chem. Lett. 2:289,2,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-03,Foss 2011 ACS Med. Chem. Lett. 2:289,"","N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.

DOI: https://dx.doi.org/10.1021/ml1002822","",Uploaded Data,8.09,"",20.0,"","",4.70,"","",Salmonella enterica,ATCC 19585,"","","","","","","","","","","","","",Foss 2011 ACS Med. Chem. Lett. 2:289,"",ChEMBL 26,https://dx.doi.org/10.1021/ml1002822,6342394,KT,"","","",Yes
SPK-0258310,CC(C)Cc1ccc(CN2CCC(C2)NS(=O)(=O)c2cc(F)ccc2C)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258310-001,"No Salt, free base or acid",404.540,"","","",PMID:21552338 - Cmpd : 2,"","","",CHEMBL1824653,"","","",21552338,https://dx.doi.org/10.1021/ml1002822,Published Article - data from ChEMBL24,Foss 2011 ACS Med. Chem. Lett. 2:289,2,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-03,Foss 2011 ACS Med. Chem. Lett. 2:289,"","N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.

DOI: https://dx.doi.org/10.1021/ml1002822","",Uploaded Data,32.4,"",80.1,"","",4.10,"","",Staphylococcus aureus,FRI 100,"","","","","","","","","","","","","",Foss 2011 ACS Med. Chem. Lett. 2:289,"",ChEMBL 26,https://dx.doi.org/10.1021/ml1002822,6342398,KT,"","","",Yes
SPK-0258310,CC(C)Cc1ccc(CN2CCC(C2)NS(=O)(=O)c2cc(F)ccc2C)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258310-001,"No Salt, free base or acid",404.540,"","","",PMID:21552338 - Cmpd : 2,"","","",CHEMBL1824653,"","","",21552338,https://dx.doi.org/10.1021/ml1002822,Published Article - data from ChEMBL24,Foss 2011 ACS Med. Chem. Lett. 2:289,2,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-03,Foss 2011 ACS Med. Chem. Lett. 2:289,"","N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.

DOI: https://dx.doi.org/10.1021/ml1002822","",Uploaded Data,8.09,"",20.0,"","",4.70,"","",Streptococcus pneumoniae,ATCC 10813,"","","","","","","","","","","","","",Foss 2011 ACS Med. Chem. Lett. 2:289,"",ChEMBL 26,https://dx.doi.org/10.1021/ml1002822,6342402,KT,"","","",Yes
SPK-0258310,CC(C)Cc1ccc(CN2CCC(C2)NS(=O)(=O)c2cc(F)ccc2C)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258310-001,"No Salt, free base or acid",404.540,"","","",PMID:21552338 - Cmpd : 2,"","","",CHEMBL1824653,"","","",21552338,https://dx.doi.org/10.1021/ml1002822,Published Article - data from ChEMBL24,Foss 2011 ACS Med. Chem. Lett. 2:289,2,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-03,Foss 2011 ACS Med. Chem. Lett. 2:289,"","N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.

DOI: https://dx.doi.org/10.1021/ml1002822","",Uploaded Data,> 64.7,"",> 160,"","",< 3.80,"","",Enterococcus faecalis,1131,"","","","","","","","","","","","","",Foss 2011 ACS Med. Chem. Lett. 2:289,"",ChEMBL 26,https://dx.doi.org/10.1021/ml1002822,6343350,KT,"","","",Yes
SPK-0258310,CC(C)Cc1ccc(CN2CCC(C2)NS(=O)(=O)c2cc(F)ccc2C)cc1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258310-001,"No Salt, free base or acid",404.540,"","","",PMID:21552338 - Cmpd : 2,"","","",CHEMBL1824653,"","","",21552338,https://dx.doi.org/10.1021/ml1002822,Published Article - data from ChEMBL24,Foss 2011 ACS Med. Chem. Lett. 2:289,2,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2020-12-03,Foss 2011 ACS Med. Chem. Lett. 2:289,"","N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.

DOI: https://dx.doi.org/10.1021/ml1002822","",Uploaded Data,8.09,"",20.0,"","",4.70,"","",Salmonella enterica,ATCC 19585,"","","","","","","","","","","","","",Foss 2011 ACS Med. Chem. Lett. 2:289,"",ChEMBL 26,https://dx.doi.org/10.1021/ml1002822,6343366,KT,"","","",Yes
SPK-0258309,COC1=CN=C2C=CC(=O)N(C[C@H](O)[C@@H]3CC[C@H](CO3)NCC3=NC4=C(OCC(=O)N4)C=C3)C2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258309-001,"No Salt, free base or acid",481.509,"","","",PMID:28406300 - Cmpd : S4,"","","","","","","",28406300,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Published Article - data from ChEMBL26,Surivet 2017 J Med Chem 60:3776,S4,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-03-06,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Curated Data,0.500,Mean,0.500,Test article,1.04,Visual,6.0,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.5,CLSI methods,CAMHB,"","CLSI, broth microdilution",Surivet 2017 J. Med. Chem. 60:3776,https://app.collaborativedrug.com/vaults/4724/runs/440762,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Table S-10; TKW,2021-01-04,2020-11-27,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Uploaded Data,0.500,"",1.04,"","",5.98,"","",Staphylococcus aureus,ATCC 29213,"","","","","","","","","","","","","","","","","","",JL,Table S-10,"","",""
SPK-0258309,COC1=CN=C2C=CC(=O)N(C[C@H](O)[C@@H]3CC[C@H](CO3)NCC3=NC4=C(OCC(=O)N4)C=C3)C2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258309-001,"No Salt, free base or acid",481.509,"","","",PMID:28406300 - Cmpd : S4,"","","","","","","",28406300,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Published Article - data from ChEMBL26,Surivet 2017 J Med Chem 60:3776,S4,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-03-06,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Curated Data,2.00,Mean,2.00,Test article,4.15,Visual,5.4,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","",DMSO,2.5,CLSI methods,CAMHB,"","CLSI, broth microdilution",Surivet 2017 J. Med. Chem. 60:3776,https://app.collaborativedrug.com/vaults/4724/runs/440762,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Table S-10; TKW,2021-01-04,2020-11-27,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Uploaded Data,2.00,"",4.15,"","",5.38,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","","","","","","",JL,Table S-10,"","",""
SPK-0258309,COC1=CN=C2C=CC(=O)N(C[C@H](O)[C@@H]3CC[C@H](CO3)NCC3=NC4=C(OCC(=O)N4)C=C3)C2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258309-001,"No Salt, free base or acid",481.509,"","","",PMID:28406300 - Cmpd : S4,"","","","","","","",28406300,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Published Article - data from ChEMBL26,Surivet 2017 J Med Chem 60:3776,S4,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-03-06,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Curated Data,8.00,Mean,8.00,Test article,16.6,Visual,4.8,"","",Acinetobacter baumannii,T6474,"",Yes,Not characterized,GyrA (S83L); ParC (S80L),From the Actelion or JMI Laboratories strain collection,Fluoroquinolone resistant,"",DMSO,2.5,CLSI methods,CAMHB,"","CLSI, broth microdilution",Surivet 2017 J. Med. Chem. 60:3776,https://app.collaborativedrug.com/vaults/4724/runs/440762,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Table S-10; TKW,2021-01-04,2020-11-27,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Uploaded Data,8.00,"",16.6,"","",4.78,"","",Acinetobacter baumannii,T6474,"","","","","","","","","","","","","","","","","","",JL,Table S-10,"","",""
SPK-0258309,COC1=CN=C2C=CC(=O)N(C[C@H](O)[C@@H]3CC[C@H](CO3)NCC3=NC4=C(OCC(=O)N4)C=C3)C2=C1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258309-001,"No Salt, free base or acid",481.509,"","","",PMID:28406300 - Cmpd : S4,"","","","","","","",28406300,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Published Article - data from ChEMBL26,Surivet 2017 J Med Chem 60:3776,S4,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-03-06,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Curated Data,> 16.0,Mean,> 16.0,Test article,> 33.2,Visual,< 4.5,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001; ARC003,No,Wild type,"",CLSI reference strain; 6 AME negative,"","",DMSO,2.5,CLSI methods,CAMHB,"","CLSI, broth microdilution",Surivet 2017 J. Med. Chem. 60:3776,https://app.collaborativedrug.com/vaults/4724/runs/440762,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Table S-10; TKW,2021-01-04,2020-11-27,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Uploaded Data,> 16.0,"",> 33.2,"","",< 4.48,"","",Pseudomonas aeruginosa,27853,"","","","","","","","","","","","","","","","","","",JL,Table S-10,"","",""
SPK-0258308,COC1=CC=C2N=CC=C(C[C@H](N)[C@@H]3CC[C@H](CO3)NCC3=NN=C4OCCSC4=C3)C2=N1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258308-001,"No Salt, free base or acid",468.580,"","","",PMID:28406300 - Cmpd : S3,"","","","","","","",28406300,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Published Article - data from ChEMBL26,Surivet 2017 J Med Chem 60:3776,S3,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-03-06,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Curated Data,0.250,Mean,0.250,Test article,0.534,Visual,6.3,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.5,CLSI methods,CAMHB,"","CLSI, broth microdilution",Surivet 2017 J. Med. Chem. 60:3776,https://app.collaborativedrug.com/vaults/4724/runs/440762,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Table S-9; TKW,2021-01-04,2020-11-27,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Uploaded Data,0.250,"",0.534,"","",6.27,"","",Staphylococcus aureus,ATCC 29213,"","","","","","","","","","","","","","","","","","",JL,Table S-9,"","",""
SPK-0258308,COC1=CC=C2N=CC=C(C[C@H](N)[C@@H]3CC[C@H](CO3)NCC3=NN=C4OCCSC4=C3)C2=N1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258308-001,"No Salt, free base or acid",468.580,"","","",PMID:28406300 - Cmpd : S3,"","","","","","","",28406300,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Published Article - data from ChEMBL26,Surivet 2017 J Med Chem 60:3776,S3,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-03-06,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Curated Data,8.00,Mean,8.00,Test article,17.1,Visual,4.8,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","",DMSO,2.5,CLSI methods,CAMHB,"","CLSI, broth microdilution",Surivet 2017 J. Med. Chem. 60:3776,https://app.collaborativedrug.com/vaults/4724/runs/440762,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Table S-9; TKW,2021-01-04,2020-11-27,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Uploaded Data,8.00,"",17.1,"","",4.77,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","","","","","","",JL,Table S-9,"","",""
SPK-0258308,COC1=CC=C2N=CC=C(C[C@H](N)[C@@H]3CC[C@H](CO3)NCC3=NN=C4OCCSC4=C3)C2=N1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258308-001,"No Salt, free base or acid",468.580,"","","",PMID:28406300 - Cmpd : S3,"","","","","","","",28406300,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Published Article - data from ChEMBL26,Surivet 2017 J Med Chem 60:3776,S3,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-03-06,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Curated Data,> 8.00,Mean,> 8.00,Test article,> 17.1,Visual,< 4.8,"","",Acinetobacter baumannii,T6474,"",Yes,Not characterized,GyrA (S83L); ParC (S80L),From the Actelion or JMI Laboratories strain collection,Fluoroquinolone resistant,"",DMSO,2.5,CLSI methods,CAMHB,"","CLSI, broth microdilution",Surivet 2017 J. Med. Chem. 60:3776,https://app.collaborativedrug.com/vaults/4724/runs/440762,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Table S-9; TKW,2021-01-04,2020-11-27,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Uploaded Data,> 8.00,"",> 17.1,"","",< 4.77,"","",Acinetobacter baumannii,T6474,"","","","","","","","","","","","","","","","","","",JL,Table S-9,"","",""
SPK-0258308,COC1=CC=C2N=CC=C(C[C@H](N)[C@@H]3CC[C@H](CO3)NCC3=NN=C4OCCSC4=C3)C2=N1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258308-001,"No Salt, free base or acid",468.580,"","","",PMID:28406300 - Cmpd : S3,"","","","","","","",28406300,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Published Article - data from ChEMBL26,Surivet 2017 J Med Chem 60:3776,S3,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-03-06,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Curated Data,> 8.00,Mean,> 8.00,Test article,> 17.1,Visual,< 4.8,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001; ARC003,No,Wild type,"",CLSI reference strain; 6 AME negative,"","",DMSO,2.5,CLSI methods,CAMHB,"","CLSI, broth microdilution",Surivet 2017 J. Med. Chem. 60:3776,https://app.collaborativedrug.com/vaults/4724/runs/440762,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Table S-9; TKW,2021-01-04,2020-11-27,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Uploaded Data,> 8.00,"",> 17.1,"","",< 4.77,"","",Pseudomonas aeruginosa,27853,"","","","","","","","","","","","","","","","","","",JL,Table S-9,"","",""
SPK-0258307,COC1=CC=C2N=CC=C(C[C@H](N)[C@@H]3CC[C@H](CO3)NCC3=NC=C4OCCSC4=C3)C2=N1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258307-001,"No Salt, free base or acid",467.590,"","","",PMID:28406300 - Cmpd : S2,"","","","","","","",28406300,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Published Article - data from ChEMBL26,Surivet 2017 J Med Chem 60:3776,S2,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-03-06,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Curated Data,0.0600,Mean,0.0600,Test article,0.128,Visual,6.9,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.5,CLSI methods,CAMHB,"","CLSI, broth microdilution",Surivet 2017 J. Med. Chem. 60:3776,https://app.collaborativedrug.com/vaults/4724/runs/440762,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Table S-9; TKW,2021-01-04,2020-11-27,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Uploaded Data,0.0600,"",0.128,"","",6.89,"","",Staphylococcus aureus,ATCC 29213,"","","","","","","","","","","","","","","","","","",JL,Table S-9,"","",""
SPK-0258307,COC1=CC=C2N=CC=C(C[C@H](N)[C@@H]3CC[C@H](CO3)NCC3=NC=C4OCCSC4=C3)C2=N1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258307-001,"No Salt, free base or acid",467.590,"","","",PMID:28406300 - Cmpd : S2,"","","","","","","",28406300,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Published Article - data from ChEMBL26,Surivet 2017 J Med Chem 60:3776,S2,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-03-06,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Curated Data,2.00,Mean,2.00,Test article,4.28,Visual,5.4,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","",DMSO,2.5,CLSI methods,CAMHB,"","CLSI, broth microdilution",Surivet 2017 J. Med. Chem. 60:3776,https://app.collaborativedrug.com/vaults/4724/runs/440762,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Table S-9; TKW,2021-01-04,2020-11-27,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Uploaded Data,2.00,"",4.28,"","",5.37,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","","","","","","",JL,Table S-9,"","",""
SPK-0258307,COC1=CC=C2N=CC=C(C[C@H](N)[C@@H]3CC[C@H](CO3)NCC3=NC=C4OCCSC4=C3)C2=N1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258307-001,"No Salt, free base or acid",467.590,"","","",PMID:28406300 - Cmpd : S2,"","","","","","","",28406300,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Published Article - data from ChEMBL26,Surivet 2017 J Med Chem 60:3776,S2,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-03-06,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Curated Data,2.00,Mean,2.00,Test article,4.28,Visual,5.4,"","",Acinetobacter baumannii,T6474,"",Yes,Not characterized,GyrA (S83L); ParC (S80L),From the Actelion or JMI Laboratories strain collection,Fluoroquinolone resistant,"",DMSO,2.5,CLSI methods,CAMHB,"","CLSI, broth microdilution",Surivet 2017 J. Med. Chem. 60:3776,https://app.collaborativedrug.com/vaults/4724/runs/440762,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Table S-9; TKW,2021-01-04,2020-11-27,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Uploaded Data,2.00,"",4.28,"","",5.37,"","",Acinetobacter baumannii,T6474,"","","","","","","","","","","","","","","","","","",JL,Table S-9,"","",""
SPK-0258307,COC1=CC=C2N=CC=C(C[C@H](N)[C@@H]3CC[C@H](CO3)NCC3=NC=C4OCCSC4=C3)C2=N1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258307-001,"No Salt, free base or acid",467.590,"","","",PMID:28406300 - Cmpd : S2,"","","","","","","",28406300,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Published Article - data from ChEMBL26,Surivet 2017 J Med Chem 60:3776,S2,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-03-06,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Curated Data,> 8.00,Mean,> 8.00,Test article,> 17.1,Visual,< 4.8,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001; ARC003,No,Wild type,"",CLSI reference strain; 6 AME negative,"","",DMSO,2.5,CLSI methods,CAMHB,"","CLSI, broth microdilution",Surivet 2017 J. Med. Chem. 60:3776,https://app.collaborativedrug.com/vaults/4724/runs/440762,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Table S-9; TKW,2021-01-04,2020-11-27,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Uploaded Data,> 8.00,"",> 17.1,"","",< 4.77,"","",Pseudomonas aeruginosa,27853,"","","","","","","","","","","","","","","","","","",JL,Table S-9,"","",""
SPK-0258306,COC1=CC=C2N=CC(F)=C(C[C@H](N)[C@@H]3CC[C@H](CO3)NCC3=NC=C4OCCOC4=C3)C2=N1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258306-001,"No Salt, free base or acid",469.517,"","","",PMID:28406300 - Cmpd : S1,"","","","","","","",28406300,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Published Article - data from ChEMBL26,Surivet 2017 J Med Chem 60:3776,S1,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-03-06,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Curated Data,0.0600,Mean,0.0600,Test article,0.128,Visual,6.9,"","",Staphylococcus aureus,ATCC 29213,ASAU001; Wichita,No,NA / Gram Positive,"",CLSI reference strain,Beta-lactamase positive; Methicillin susceptible (MSSA); Oxacillin sensitive,"",DMSO,2.5,CLSI methods,CAMHB,"","CLSI, broth microdilution",Surivet 2017 J. Med. Chem. 60:3776,https://app.collaborativedrug.com/vaults/4724/runs/440762,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Table S-9; TKW,2021-01-04,2020-11-27,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Uploaded Data,0.0600,"",0.128,"","",6.89,"","",Staphylococcus aureus,ATCC 29213,"","","","","","","","","","","","","","","","","","",JL,Table S-9,"","",""
SPK-0258306,COC1=CC=C2N=CC(F)=C(C[C@H](N)[C@@H]3CC[C@H](CO3)NCC3=NC=C4OCCOC4=C3)C2=N1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258306-001,"No Salt, free base or acid",469.517,"","","",PMID:28406300 - Cmpd : S1,"","","","","","","",28406300,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Published Article - data from ChEMBL26,Surivet 2017 J Med Chem 60:3776,S1,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-03-06,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Curated Data,1.00,Mean,1.00,Test article,2.13,Visual,5.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","",DMSO,2.5,CLSI methods,CAMHB,"","CLSI, broth microdilution",Surivet 2017 J. Med. Chem. 60:3776,https://app.collaborativedrug.com/vaults/4724/runs/440762,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Table S-9; TKW,2021-01-04,2020-11-27,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Uploaded Data,1.00,"",2.13,"","",5.67,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","","","","","","",JL,Table S-9,"","",""
SPK-0258306,COC1=CC=C2N=CC(F)=C(C[C@H](N)[C@@H]3CC[C@H](CO3)NCC3=NC=C4OCCOC4=C3)C2=N1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258306-001,"No Salt, free base or acid",469.517,"","","",PMID:28406300 - Cmpd : S1,"","","","","","","",28406300,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Published Article - data from ChEMBL26,Surivet 2017 J Med Chem 60:3776,S1,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-03-06,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Curated Data,0.250,Mean,0.250,Test article,0.532,Visual,6.3,"","",Acinetobacter baumannii,T6474,"",Yes,Not characterized,GyrA (S83L); ParC (S80L),From the Actelion or JMI Laboratories strain collection,Fluoroquinolone resistant,"",DMSO,2.5,CLSI methods,CAMHB,"","CLSI, broth microdilution",Surivet 2017 J. Med. Chem. 60:3776,https://app.collaborativedrug.com/vaults/4724/runs/440762,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Table S-9; TKW,2021-01-04,2020-11-27,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Uploaded Data,0.250,"",0.532,"","",6.27,"","",Acinetobacter baumannii,T6474,"","","","","","","","","","","","","","","","","","",JL,Table S-9,"","",""
SPK-0258306,COC1=CC=C2N=CC(F)=C(C[C@H](N)[C@@H]3CC[C@H](CO3)NCC3=NC=C4OCCOC4=C3)C2=N1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0258306-001,"No Salt, free base or acid",469.517,"","","",PMID:28406300 - Cmpd : S1,"","","","","","","",28406300,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Published Article - data from ChEMBL26,Surivet 2017 J Med Chem 60:3776,S1,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-03-06,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Curated Data,8.00,Mean,8.00,Test article,17.0,Visual,4.8,"","",Pseudomonas aeruginosa,ATCC 27853,APAE001; NB52001; ARC003,No,Wild type,"",CLSI reference strain; 6 AME negative,"","",DMSO,2.5,CLSI methods,CAMHB,"","CLSI, broth microdilution",Surivet 2017 J. Med. Chem. 60:3776,https://app.collaborativedrug.com/vaults/4724/runs/440762,https://dx.doi.org/10.1021/acs.jmedchem.6b01831,Table S-9; TKW,2021-01-04,2020-11-27,Surivet 2017 J. Med. Chem. 60:3776,"","Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acs.jmedchem.6b01831","",Uploaded Data,8.00,"",17.0,"","",4.77,"","",Pseudomonas aeruginosa,27853,"","","","","","","","","","","","","","","","","","",JL,Table S-9,"","",""
SPK-0256471,Nc1nc(c[nH]1)-c1c[nH]c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256471-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17b,"","","",CHEMBL4213261,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17b,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,7.84,MIC,7.84,Test article,25.0,Visual,4.6,"","",Staphylococcus aureus,ATCC 43300,F-182,Yes,NA / Gram Positive,SCCmec: Type II; spa type Ridom: t007; spa type Kreiswirth: WGKKKKAOM; pvl gene amplification: Negative,"",Methicillin resistant (MRSA),"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S5; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,7.84,"",25.0,"","",4.60,"","",Staphylococcus aureus,ATCC 43300,F-182,Yes,NA / Gram Positive,"","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552801,JL,Supp pg S5,"","",Yes
SPK-0256471,Nc1nc(c[nH]1)-c1c[nH]c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256471-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17b,"","","",CHEMBL4213261,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,15.7,MIC,15.7,Test article,50.1,Visual,4.3,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,15.7,"",50.1,"","",4.30,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256471,Nc1nc(c[nH]1)-c1c[nH]c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256471-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17b,"","","",CHEMBL4213261,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,62.7,MIC,62.7,Test article,200,Visual,3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,62.7,"",200,"","",3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256471,Nc1nc(c[nH]1)-c1c[nH]c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256471-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17b,"","","",CHEMBL4213261,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,62.7,MIC,62.7,Test article,200,Visual,3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,62.7,"",200,"","",3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256471,Nc1nc(c[nH]1)-c1c[nH]c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256471-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17b,"","","",CHEMBL4213261,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,31.4,MIC,31.4,Test article,100,Visual,4.0,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,31.4,"",100,"","",4.00,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256471,Nc1nc(c[nH]1)-c1c[nH]c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256471-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17b,"","","",CHEMBL4213261,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,62.7,MIC,62.7,Test article,200,Visual,3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,62.7,"",200,"","",3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256471,Nc1nc(c[nH]1)-c1c[nH]c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256471-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17b,"","","",CHEMBL4213261,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,62.7,MIC,62.7,Test article,200,Visual,3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,62.7,"",200,"","",3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256471,Nc1nc(c[nH]1)-c1c[nH]c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256471-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17b,"","","",CHEMBL4213261,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,62.7,MIC,62.7,Test article,200,Visual,3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,62.7,"",200,"","",3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256471,Nc1nc(c[nH]1)-c1c[nH]c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256471-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17b,"","","",CHEMBL4213261,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,62.7,MIC,62.7,Test article,200,Visual,3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,62.7,"",200,"","",3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256471,Nc1nc(c[nH]1)-c1c[nH]c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256471-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17b,"","","",CHEMBL4213261,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,31.4,MIC,31.4,Test article,100,Visual,4.0,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,31.4,"",100,"","",4.00,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256471,Nc1nc(c[nH]1)-c1c[nH]c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256471-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17b,"","","",CHEMBL4213261,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,62.7,MIC,62.7,Test article,200,Visual,3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,62.7,"",200,"","",3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256471,Nc1nc(c[nH]1)-c1c[nH]c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256471-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17b,"","","",CHEMBL4213261,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,62.7,MIC,62.7,Test article,200,Visual,3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,62.7,"",200,"","",3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256470,Nc1nc(c[nH]1)-c1c[nH]c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256470-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17a,"","","",CHEMBL4209682,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17a,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,7.84,MIC,7.84,Test article,25.0,Visual,4.6,"","",Staphylococcus aureus,ATCC 43300,F-182,Yes,NA / Gram Positive,SCCmec: Type II; spa type Ridom: t007; spa type Kreiswirth: WGKKKKAOM; pvl gene amplification: Negative,"",Methicillin resistant (MRSA),"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S5; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,7.84,"",25.0,"","",4.60,"","",Staphylococcus aureus,ATCC 43300,F-182,Yes,NA / Gram Positive,"","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552802,JL,Supp pg S5,"","",Yes
SPK-0256470,Nc1nc(c[nH]1)-c1c[nH]c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256470-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17a,"","","",CHEMBL4209682,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,15.7,MIC,15.7,Test article,50.1,Visual,4.3,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,15.7,"",50.1,"","",4.30,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256470,Nc1nc(c[nH]1)-c1c[nH]c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256470-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17a,"","","",CHEMBL4209682,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,62.7,MIC,62.7,Test article,200,Visual,3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,62.7,"",200,"","",3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256470,Nc1nc(c[nH]1)-c1c[nH]c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256470-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17a,"","","",CHEMBL4209682,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,62.7,MIC,62.7,Test article,200,Visual,3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,62.7,"",200,"","",3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256470,Nc1nc(c[nH]1)-c1c[nH]c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256470-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17a,"","","",CHEMBL4209682,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,31.4,MIC,31.4,Test article,100,Visual,4.0,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,31.4,"",100,"","",4.00,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256470,Nc1nc(c[nH]1)-c1c[nH]c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256470-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17a,"","","",CHEMBL4209682,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,62.7,MIC,62.7,Test article,200,Visual,3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,62.7,"",200,"","",3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256470,Nc1nc(c[nH]1)-c1c[nH]c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256470-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17a,"","","",CHEMBL4209682,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,62.7,MIC,62.7,Test article,200,Visual,3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,62.7,"",200,"","",3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256470,Nc1nc(c[nH]1)-c1c[nH]c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256470-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17a,"","","",CHEMBL4209682,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 62.7,MIC,> 62.7,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 62.7,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256470,Nc1nc(c[nH]1)-c1c[nH]c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256470-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17a,"","","",CHEMBL4209682,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,31.4,MIC,31.4,Test article,100,Visual,4.0,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,31.4,"",100,"","",4.00,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256470,Nc1nc(c[nH]1)-c1c[nH]c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256470-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17a,"","","",CHEMBL4209682,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,31.4,MIC,31.4,Test article,100,Visual,4.0,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,31.4,"",100,"","",4.00,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256470,Nc1nc(c[nH]1)-c1c[nH]c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256470-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17a,"","","",CHEMBL4209682,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,62.7,MIC,62.7,Test article,200,Visual,3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,62.7,"",200,"","",3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256470,Nc1nc(c[nH]1)-c1c[nH]c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256470-001,1.0 Hydrochloride,313.585,"","","",PMID:30034604 - Cmpd : 17a,"","","",CHEMBL4209682,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,17a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,62.7,MIC,62.7,Test article,200,Visual,3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,62.7,"",200,"","",3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256469,CCNc1nccc(n1)-c1cn(C)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256469-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13n,"","","",CHEMBL4214596,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13n,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552689,JL,Supp pg S31-S33,"","",Yes
SPK-0256469,CCNc1nccc(n1)-c1cn(C)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256469-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13n,"","","",CHEMBL4214596,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552718,JL,Supp pg S31-S33,"","",Yes
SPK-0256469,CCNc1nccc(n1)-c1cn(C)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256469-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13n,"","","",CHEMBL4214596,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552747,JL,Supp pg S31-S33,"","",Yes
SPK-0256469,CCNc1nccc(n1)-c1cn(C)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256469-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13n,"","","",CHEMBL4214596,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552885,JL,Supp pg S31-S33,"","",Yes
SPK-0256469,CCNc1nccc(n1)-c1cn(C)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256469-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13n,"","","",CHEMBL4214596,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552917,JL,Supp pg S31-S33,"","",Yes
SPK-0256469,CCNc1nccc(n1)-c1cn(C)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256469-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13n,"","","",CHEMBL4214596,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552949,JL,Supp pg S31-S33,"","",Yes
SPK-0256469,CCNc1nccc(n1)-c1cn(C)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256469-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13n,"","","",CHEMBL4214596,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552981,JL,Supp pg S31-S33,"","",Yes
SPK-0256469,CCNc1nccc(n1)-c1cn(C)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256469-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13n,"","","",CHEMBL4214596,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553013,JL,Supp pg S31-S33,"","",Yes
SPK-0256469,CCNc1nccc(n1)-c1cn(C)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256469-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13n,"","","",CHEMBL4214596,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553045,JL,Supp pg S31-S33,"","",Yes
SPK-0256469,CCNc1nccc(n1)-c1cn(C)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256469-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13n,"","","",CHEMBL4214596,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553077,JL,Supp pg S31-S33,"","",Yes
SPK-0256469,CCNc1nccc(n1)-c1cn(C)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256469-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13n,"","","",CHEMBL4214596,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553109,JL,Supp pg S31-S33,"","",Yes
SPK-0256468,CCCn1cc(-c2ccnc(N)n2)c2ccc(I)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256468-001,1.0 Hydrochloride,414.677,"","","",PMID:30034604 - Cmpd : 13m,"","","",CHEMBL4205303,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13m,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 82.9,MIC,> 82.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 82.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552690,JL,Supp pg S31-S33,"","",Yes
SPK-0256468,CCCn1cc(-c2ccnc(N)n2)c2ccc(I)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256468-001,1.0 Hydrochloride,414.677,"","","",PMID:30034604 - Cmpd : 13m,"","","",CHEMBL4205303,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 82.9,MIC,> 82.9,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 82.9,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552719,JL,Supp pg S31-S33,"","",Yes
SPK-0256468,CCCn1cc(-c2ccnc(N)n2)c2ccc(I)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256468-001,1.0 Hydrochloride,414.677,"","","",PMID:30034604 - Cmpd : 13m,"","","",CHEMBL4205303,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 82.9,MIC,> 82.9,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 82.9,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552748,JL,Supp pg S31-S33,"","",Yes
SPK-0256468,CCCn1cc(-c2ccnc(N)n2)c2ccc(I)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256468-001,1.0 Hydrochloride,414.677,"","","",PMID:30034604 - Cmpd : 13m,"","","",CHEMBL4205303,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 82.9,MIC,> 82.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 82.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552884,JL,Supp pg S31-S33,"","",Yes
SPK-0256468,CCCn1cc(-c2ccnc(N)n2)c2ccc(I)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256468-001,1.0 Hydrochloride,414.677,"","","",PMID:30034604 - Cmpd : 13m,"","","",CHEMBL4205303,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 82.9,MIC,> 82.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 82.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552916,JL,Supp pg S31-S33,"","",Yes
SPK-0256468,CCCn1cc(-c2ccnc(N)n2)c2ccc(I)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256468-001,1.0 Hydrochloride,414.677,"","","",PMID:30034604 - Cmpd : 13m,"","","",CHEMBL4205303,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 82.9,MIC,> 82.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 82.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552948,JL,Supp pg S31-S33,"","",Yes
SPK-0256468,CCCn1cc(-c2ccnc(N)n2)c2ccc(I)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256468-001,1.0 Hydrochloride,414.677,"","","",PMID:30034604 - Cmpd : 13m,"","","",CHEMBL4205303,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 82.9,MIC,> 82.9,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 82.9,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552980,JL,Supp pg S31-S33,"","",Yes
SPK-0256468,CCCn1cc(-c2ccnc(N)n2)c2ccc(I)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256468-001,1.0 Hydrochloride,414.677,"","","",PMID:30034604 - Cmpd : 13m,"","","",CHEMBL4205303,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 82.9,MIC,> 82.9,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 82.9,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553012,JL,Supp pg S31-S33,"","",Yes
SPK-0256468,CCCn1cc(-c2ccnc(N)n2)c2ccc(I)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256468-001,1.0 Hydrochloride,414.677,"","","",PMID:30034604 - Cmpd : 13m,"","","",CHEMBL4205303,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 82.9,MIC,> 82.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 82.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553044,JL,Supp pg S31-S33,"","",Yes
SPK-0256468,CCCn1cc(-c2ccnc(N)n2)c2ccc(I)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256468-001,1.0 Hydrochloride,414.677,"","","",PMID:30034604 - Cmpd : 13m,"","","",CHEMBL4205303,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 82.9,MIC,> 82.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 82.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553076,JL,Supp pg S31-S33,"","",Yes
SPK-0256468,CCCn1cc(-c2ccnc(N)n2)c2ccc(I)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256468-001,1.0 Hydrochloride,414.677,"","","",PMID:30034604 - Cmpd : 13m,"","","",CHEMBL4205303,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 82.9,MIC,> 82.9,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 82.9,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553108,JL,Supp pg S31-S33,"","",Yes
SPK-0256467,CC(C)Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256467-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13l,"","","",CHEMBL4210208,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13l,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552691,JL,Supp pg S31-S33,"","",Yes
SPK-0256467,CC(C)Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256467-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13l,"","","",CHEMBL4210208,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552720,JL,Supp pg S31-S33,"","",Yes
SPK-0256467,CC(C)Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256467-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13l,"","","",CHEMBL4210208,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552749,JL,Supp pg S31-S33,"","",Yes
SPK-0256467,CC(C)Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256467-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13l,"","","",CHEMBL4210208,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552805,JL,Supp pg S31-S33,"","",Yes
SPK-0256467,CC(C)Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256467-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13l,"","","",CHEMBL4210208,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552915,JL,Supp pg S31-S33,"","",Yes
SPK-0256467,CC(C)Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256467-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13l,"","","",CHEMBL4210208,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552947,JL,Supp pg S31-S33,"","",Yes
SPK-0256467,CC(C)Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256467-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13l,"","","",CHEMBL4210208,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552979,JL,Supp pg S31-S33,"","",Yes
SPK-0256467,CC(C)Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256467-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13l,"","","",CHEMBL4210208,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553011,JL,Supp pg S31-S33,"","",Yes
SPK-0256467,CC(C)Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256467-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13l,"","","",CHEMBL4210208,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553043,JL,Supp pg S31-S33,"","",Yes
SPK-0256467,CC(C)Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256467-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13l,"","","",CHEMBL4210208,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553075,JL,Supp pg S31-S33,"","",Yes
SPK-0256467,CC(C)Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256467-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13l,"","","",CHEMBL4210208,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553107,JL,Supp pg S31-S33,"","",Yes
SPK-0256466,CC(C)Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256466-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13k,"","","",CHEMBL4216184,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13k,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552692,JL,Supp pg S31-S33,"","",Yes
SPK-0256466,CC(C)Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256466-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13k,"","","",CHEMBL4216184,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552721,JL,Supp pg S31-S33,"","",Yes
SPK-0256466,CC(C)Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256466-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13k,"","","",CHEMBL4216184,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552750,JL,Supp pg S31-S33,"","",Yes
SPK-0256466,CC(C)Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256466-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13k,"","","",CHEMBL4216184,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552806,JL,Supp pg S31-S33,"","",Yes
SPK-0256466,CC(C)Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256466-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13k,"","","",CHEMBL4216184,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552914,JL,Supp pg S31-S33,"","",Yes
SPK-0256466,CC(C)Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256466-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13k,"","","",CHEMBL4216184,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552946,JL,Supp pg S31-S33,"","",Yes
SPK-0256466,CC(C)Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256466-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13k,"","","",CHEMBL4216184,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552978,JL,Supp pg S31-S33,"","",Yes
SPK-0256466,CC(C)Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256466-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13k,"","","",CHEMBL4216184,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553010,JL,Supp pg S31-S33,"","",Yes
SPK-0256466,CC(C)Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256466-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13k,"","","",CHEMBL4216184,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553042,JL,Supp pg S31-S33,"","",Yes
SPK-0256466,CC(C)Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256466-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13k,"","","",CHEMBL4216184,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553074,JL,Supp pg S31-S33,"","",Yes
SPK-0256466,CC(C)Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256466-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13k,"","","",CHEMBL4216184,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553106,JL,Supp pg S31-S33,"","",Yes
SPK-0256465,CCCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256465-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13j,"","","",CHEMBL4211221,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13j,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552693,JL,Supp pg S31-S33,"","",Yes
SPK-0256465,CCCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256465-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13j,"","","",CHEMBL4211221,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13j,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552722,JL,Supp pg S31-S33,"","",Yes
SPK-0256465,CCCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256465-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13j,"","","",CHEMBL4211221,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13j,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552751,JL,Supp pg S31-S33,"","",Yes
SPK-0256465,CCCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256465-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13j,"","","",CHEMBL4211221,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13j,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552807,JL,Supp pg S31-S33,"","",Yes
SPK-0256465,CCCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256465-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13j,"","","",CHEMBL4211221,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13j,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552913,JL,Supp pg S31-S33,"","",Yes
SPK-0256465,CCCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256465-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13j,"","","",CHEMBL4211221,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13j,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552945,JL,Supp pg S31-S33,"","",Yes
SPK-0256465,CCCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256465-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13j,"","","",CHEMBL4211221,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13j,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552977,JL,Supp pg S31-S33,"","",Yes
SPK-0256465,CCCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256465-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13j,"","","",CHEMBL4211221,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13j,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553009,JL,Supp pg S31-S33,"","",Yes
SPK-0256465,CCCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256465-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13j,"","","",CHEMBL4211221,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13j,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553041,JL,Supp pg S31-S33,"","",Yes
SPK-0256465,CCCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256465-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13j,"","","",CHEMBL4211221,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13j,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553073,JL,Supp pg S31-S33,"","",Yes
SPK-0256465,CCCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256465-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13j,"","","",CHEMBL4211221,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13j,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553105,JL,Supp pg S31-S33,"","",Yes
SPK-0256464,Nc1nccc(n1)-c1cn(Cc2ccccc2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256464-001,1.0 Hydrochloride,415.721,"","","",PMID:30034604 - Cmpd : 13i,"","","",CHEMBL4213676,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13i,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 83.1,MIC,> 83.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 83.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552694,JL,Supp pg S31-S33,"","",Yes
SPK-0256464,Nc1nccc(n1)-c1cn(Cc2ccccc2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256464-001,1.0 Hydrochloride,415.721,"","","",PMID:30034604 - Cmpd : 13i,"","","",CHEMBL4213676,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13i,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 83.1,MIC,> 83.1,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 83.1,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552723,JL,Supp pg S31-S33,"","",Yes
SPK-0256464,Nc1nccc(n1)-c1cn(Cc2ccccc2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256464-001,1.0 Hydrochloride,415.721,"","","",PMID:30034604 - Cmpd : 13i,"","","",CHEMBL4213676,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13i,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 83.1,MIC,> 83.1,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 83.1,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552752,JL,Supp pg S31-S33,"","",Yes
SPK-0256464,Nc1nccc(n1)-c1cn(Cc2ccccc2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256464-001,1.0 Hydrochloride,415.721,"","","",PMID:30034604 - Cmpd : 13i,"","","",CHEMBL4213676,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13i,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 83.1,MIC,> 83.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 83.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552808,JL,Supp pg S31-S33,"","",Yes
SPK-0256464,Nc1nccc(n1)-c1cn(Cc2ccccc2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256464-001,1.0 Hydrochloride,415.721,"","","",PMID:30034604 - Cmpd : 13i,"","","",CHEMBL4213676,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13i,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 83.1,MIC,> 83.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 83.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552912,JL,Supp pg S31-S33,"","",Yes
SPK-0256464,Nc1nccc(n1)-c1cn(Cc2ccccc2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256464-001,1.0 Hydrochloride,415.721,"","","",PMID:30034604 - Cmpd : 13i,"","","",CHEMBL4213676,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13i,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 83.1,MIC,> 83.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 83.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552944,JL,Supp pg S31-S33,"","",Yes
SPK-0256464,Nc1nccc(n1)-c1cn(Cc2ccccc2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256464-001,1.0 Hydrochloride,415.721,"","","",PMID:30034604 - Cmpd : 13i,"","","",CHEMBL4213676,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13i,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 83.1,MIC,> 83.1,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 83.1,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552976,JL,Supp pg S31-S33,"","",Yes
SPK-0256464,Nc1nccc(n1)-c1cn(Cc2ccccc2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256464-001,1.0 Hydrochloride,415.721,"","","",PMID:30034604 - Cmpd : 13i,"","","",CHEMBL4213676,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13i,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 83.1,MIC,> 83.1,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 83.1,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553008,JL,Supp pg S31-S33,"","",Yes
SPK-0256464,Nc1nccc(n1)-c1cn(Cc2ccccc2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256464-001,1.0 Hydrochloride,415.721,"","","",PMID:30034604 - Cmpd : 13i,"","","",CHEMBL4213676,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13i,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 83.1,MIC,> 83.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 83.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553040,JL,Supp pg S31-S33,"","",Yes
SPK-0256464,Nc1nccc(n1)-c1cn(Cc2ccccc2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256464-001,1.0 Hydrochloride,415.721,"","","",PMID:30034604 - Cmpd : 13i,"","","",CHEMBL4213676,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13i,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 83.1,MIC,> 83.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 83.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553072,JL,Supp pg S31-S33,"","",Yes
SPK-0256464,Nc1nccc(n1)-c1cn(Cc2ccccc2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256464-001,1.0 Hydrochloride,415.721,"","","",PMID:30034604 - Cmpd : 13i,"","","",CHEMBL4213676,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13i,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 83.1,MIC,> 83.1,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 83.1,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553104,JL,Supp pg S31-S33,"","",Yes
SPK-0256463,CCCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256463-001,1.0 Hydrochloride,395.731,"","","",PMID:30034604 - Cmpd : 13h,"","","",CHEMBL4207284,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13h,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 79.1,MIC,> 79.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 79.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552695,JL,Supp pg S31-S33,"","",Yes
SPK-0256463,CCCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256463-001,1.0 Hydrochloride,395.731,"","","",PMID:30034604 - Cmpd : 13h,"","","",CHEMBL4207284,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13h,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 79.1,MIC,> 79.1,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 79.1,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552724,JL,Supp pg S31-S33,"","",Yes
SPK-0256463,CCCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256463-001,1.0 Hydrochloride,395.731,"","","",PMID:30034604 - Cmpd : 13h,"","","",CHEMBL4207284,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13h,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 79.1,MIC,> 79.1,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 79.1,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552753,JL,Supp pg S31-S33,"","",Yes
SPK-0256463,CCCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256463-001,1.0 Hydrochloride,395.731,"","","",PMID:30034604 - Cmpd : 13h,"","","",CHEMBL4207284,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13h,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 79.1,MIC,> 79.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 79.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552809,JL,Supp pg S31-S33,"","",Yes
SPK-0256463,CCCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256463-001,1.0 Hydrochloride,395.731,"","","",PMID:30034604 - Cmpd : 13h,"","","",CHEMBL4207284,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13h,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 79.1,MIC,> 79.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 79.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552911,JL,Supp pg S31-S33,"","",Yes
SPK-0256463,CCCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256463-001,1.0 Hydrochloride,395.731,"","","",PMID:30034604 - Cmpd : 13h,"","","",CHEMBL4207284,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13h,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 79.1,MIC,> 79.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 79.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552943,JL,Supp pg S31-S33,"","",Yes
SPK-0256463,CCCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256463-001,1.0 Hydrochloride,395.731,"","","",PMID:30034604 - Cmpd : 13h,"","","",CHEMBL4207284,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13h,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 79.1,MIC,> 79.1,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 79.1,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552975,JL,Supp pg S31-S33,"","",Yes
SPK-0256463,CCCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256463-001,1.0 Hydrochloride,395.731,"","","",PMID:30034604 - Cmpd : 13h,"","","",CHEMBL4207284,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13h,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 79.1,MIC,> 79.1,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 79.1,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553007,JL,Supp pg S31-S33,"","",Yes
SPK-0256463,CCCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256463-001,1.0 Hydrochloride,395.731,"","","",PMID:30034604 - Cmpd : 13h,"","","",CHEMBL4207284,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13h,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 79.1,MIC,> 79.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 79.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553039,JL,Supp pg S31-S33,"","",Yes
SPK-0256463,CCCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256463-001,1.0 Hydrochloride,395.731,"","","",PMID:30034604 - Cmpd : 13h,"","","",CHEMBL4207284,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13h,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 79.1,MIC,> 79.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 79.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553071,JL,Supp pg S31-S33,"","",Yes
SPK-0256463,CCCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256463-001,1.0 Hydrochloride,395.731,"","","",PMID:30034604 - Cmpd : 13h,"","","",CHEMBL4207284,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13h,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 79.1,MIC,> 79.1,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 79.1,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553103,JL,Supp pg S31-S33,"","",Yes
SPK-0256462,Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256462-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13g,"","","",CHEMBL4209279,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13g,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552696,JL,Supp pg S31-S33,"","",Yes
SPK-0256462,Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256462-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13g,"","","",CHEMBL4209279,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13g,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552725,JL,Supp pg S31-S33,"","",Yes
SPK-0256462,Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256462-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13g,"","","",CHEMBL4209279,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13g,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552754,JL,Supp pg S31-S33,"","",Yes
SPK-0256462,Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256462-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13g,"","","",CHEMBL4209279,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13g,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552810,JL,Supp pg S31-S33,"","",Yes
SPK-0256462,Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256462-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13g,"","","",CHEMBL4209279,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13g,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552910,JL,Supp pg S31-S33,"","",Yes
SPK-0256462,Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256462-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13g,"","","",CHEMBL4209279,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13g,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552942,JL,Supp pg S31-S33,"","",Yes
SPK-0256462,Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256462-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13g,"","","",CHEMBL4209279,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13g,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552974,JL,Supp pg S31-S33,"","",Yes
SPK-0256462,Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256462-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13g,"","","",CHEMBL4209279,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13g,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553006,JL,Supp pg S31-S33,"","",Yes
SPK-0256462,Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256462-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13g,"","","",CHEMBL4209279,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13g,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553038,JL,Supp pg S31-S33,"","",Yes
SPK-0256462,Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256462-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13g,"","","",CHEMBL4209279,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13g,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553070,JL,Supp pg S31-S33,"","",Yes
SPK-0256462,Cn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256462-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13g,"","","",CHEMBL4209279,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13g,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553102,JL,Supp pg S31-S33,"","",Yes
SPK-0256461,CCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256461-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13f,"","","",CHEMBL4204404,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13f,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,36.8,MIC,36.8,Test article,100,Visual,4.0,"","",Staphylococcus aureus,ATCC 43300,F-182,Yes,NA / Gram Positive,SCCmec: Type II; spa type Ridom: t007; spa type Kreiswirth: WGKKKKAOM; pvl gene amplification: Negative,"",Methicillin resistant (MRSA),"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Table 1; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,36.8,"",100,"","",4.00,"","",Staphylococcus aureus,ATCC 43300,F-182,Yes,NA / Gram Positive,"","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552675,JL,Table 1,"","",Yes
SPK-0256461,CCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256461-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13f,"","","",CHEMBL4204404,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13f,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552697,JL,Supp pg S31-S33,"","",Yes
SPK-0256461,CCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256461-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13f,"","","",CHEMBL4204404,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13f,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552726,JL,Supp pg S31-S33,"","",Yes
SPK-0256461,CCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256461-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13f,"","","",CHEMBL4204404,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13f,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552755,JL,Supp pg S31-S33,"","",Yes
SPK-0256461,CCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256461-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13f,"","","",CHEMBL4204404,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13f,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552811,JL,Supp pg S31-S33,"","",Yes
SPK-0256461,CCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256461-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13f,"","","",CHEMBL4204404,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13f,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552909,JL,Supp pg S31-S33,"","",Yes
SPK-0256461,CCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256461-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13f,"","","",CHEMBL4204404,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13f,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552941,JL,Supp pg S31-S33,"","",Yes
SPK-0256461,CCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256461-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13f,"","","",CHEMBL4204404,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13f,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552973,JL,Supp pg S31-S33,"","",Yes
SPK-0256461,CCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256461-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13f,"","","",CHEMBL4204404,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13f,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553005,JL,Supp pg S31-S33,"","",Yes
SPK-0256461,CCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256461-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13f,"","","",CHEMBL4204404,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13f,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553037,JL,Supp pg S31-S33,"","",Yes
SPK-0256461,CCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256461-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13f,"","","",CHEMBL4204404,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13f,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553069,JL,Supp pg S31-S33,"","",Yes
SPK-0256461,CCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256461-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13f,"","","",CHEMBL4204404,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13f,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553101,JL,Supp pg S31-S33,"","",Yes
SPK-0256460,CCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256460-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13e,"","","",CHEMBL4217358,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13e,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,70.7,MIC,70.7,Test article,200,Visual,3.7,"","",Staphylococcus aureus,ATCC 43300,F-182,Yes,NA / Gram Positive,SCCmec: Type II; spa type Ridom: t007; spa type Kreiswirth: WGKKKKAOM; pvl gene amplification: Negative,"",Methicillin resistant (MRSA),"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Table 1; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,70.7,"",200,"","",3.70,"","",Staphylococcus aureus,ATCC 43300,F-182,Yes,NA / Gram Positive,"","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552676,JL,Table 1,"","",Yes
SPK-0256460,CCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256460-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13e,"","","",CHEMBL4217358,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552698,JL,Supp pg S31-S33,"","",Yes
SPK-0256460,CCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256460-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13e,"","","",CHEMBL4217358,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552727,JL,Supp pg S31-S33,"","",Yes
SPK-0256460,CCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256460-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13e,"","","",CHEMBL4217358,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552756,JL,Supp pg S31-S33,"","",Yes
SPK-0256460,CCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256460-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13e,"","","",CHEMBL4217358,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552812,JL,Supp pg S31-S33,"","",Yes
SPK-0256460,CCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256460-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13e,"","","",CHEMBL4217358,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552908,JL,Supp pg S31-S33,"","",Yes
SPK-0256460,CCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256460-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13e,"","","",CHEMBL4217358,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552940,JL,Supp pg S31-S33,"","",Yes
SPK-0256460,CCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256460-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13e,"","","",CHEMBL4217358,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552972,JL,Supp pg S31-S33,"","",Yes
SPK-0256460,CCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256460-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13e,"","","",CHEMBL4217358,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553004,JL,Supp pg S31-S33,"","",Yes
SPK-0256460,CCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256460-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13e,"","","",CHEMBL4217358,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553036,JL,Supp pg S31-S33,"","",Yes
SPK-0256460,CCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256460-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13e,"","","",CHEMBL4217358,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553068,JL,Supp pg S31-S33,"","",Yes
SPK-0256460,CCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256460-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13e,"","","",CHEMBL4217358,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13e,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553100,JL,Supp pg S31-S33,"","",Yes
SPK-0256459,CCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256459-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13d,"","","",CHEMBL4216603,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13d,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,70.7,MIC,70.7,Test article,200,Visual,3.7,"","",Staphylococcus aureus,ATCC 43300,F-182,Yes,NA / Gram Positive,SCCmec: Type II; spa type Ridom: t007; spa type Kreiswirth: WGKKKKAOM; pvl gene amplification: Negative,"",Methicillin resistant (MRSA),"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Table 1; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,70.7,"",200,"","",3.70,"","",Staphylococcus aureus,ATCC 43300,F-182,Yes,NA / Gram Positive,"","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552677,JL,Table 1,"","",Yes
SPK-0256459,CCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256459-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13d,"","","",CHEMBL4216603,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552699,JL,Supp pg S31-S33,"","",Yes
SPK-0256459,CCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256459-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13d,"","","",CHEMBL4216603,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552728,JL,Supp pg S31-S33,"","",Yes
SPK-0256459,CCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256459-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13d,"","","",CHEMBL4216603,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552757,JL,Supp pg S31-S33,"","",Yes
SPK-0256459,CCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256459-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13d,"","","",CHEMBL4216603,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552813,JL,Supp pg S31-S33,"","",Yes
SPK-0256459,CCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256459-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13d,"","","",CHEMBL4216603,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552907,JL,Supp pg S31-S33,"","",Yes
SPK-0256459,CCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256459-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13d,"","","",CHEMBL4216603,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552939,JL,Supp pg S31-S33,"","",Yes
SPK-0256459,CCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256459-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13d,"","","",CHEMBL4216603,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552971,JL,Supp pg S31-S33,"","",Yes
SPK-0256459,CCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256459-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13d,"","","",CHEMBL4216603,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553003,JL,Supp pg S31-S33,"","",Yes
SPK-0256459,CCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256459-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13d,"","","",CHEMBL4216603,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553035,JL,Supp pg S31-S33,"","",Yes
SPK-0256459,CCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256459-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13d,"","","",CHEMBL4216603,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553067,JL,Supp pg S31-S33,"","",Yes
SPK-0256459,CCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256459-001,1.0 Hydrochloride,353.650,"","","",PMID:30034604 - Cmpd : 13d,"","","",CHEMBL4216603,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13d,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 70.7,MIC,> 70.7,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 70.7,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553099,JL,Supp pg S31-S33,"","",Yes
SPK-0256458,Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256458-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13c,"","","",CHEMBL4207595,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13c,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,67.9,MIC,67.9,Test article,200,Visual,3.7,"","",Staphylococcus aureus,ATCC 43300,F-182,Yes,NA / Gram Positive,SCCmec: Type II; spa type Ridom: t007; spa type Kreiswirth: WGKKKKAOM; pvl gene amplification: Negative,"",Methicillin resistant (MRSA),"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Table 1; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,67.9,"",200,"","",3.70,"","",Staphylococcus aureus,ATCC 43300,F-182,Yes,NA / Gram Positive,"","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552678,JL,Table 1,"","",Yes
SPK-0256458,Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256458-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13c,"","","",CHEMBL4207595,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552700,JL,Supp pg S31-S33,"","",Yes
SPK-0256458,Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256458-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13c,"","","",CHEMBL4207595,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552729,JL,Supp pg S31-S33,"","",Yes
SPK-0256458,Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256458-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13c,"","","",CHEMBL4207595,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552758,JL,Supp pg S31-S33,"","",Yes
SPK-0256458,Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256458-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13c,"","","",CHEMBL4207595,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552814,JL,Supp pg S31-S33,"","",Yes
SPK-0256458,Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256458-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13c,"","","",CHEMBL4207595,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552906,JL,Supp pg S31-S33,"","",Yes
SPK-0256458,Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256458-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13c,"","","",CHEMBL4207595,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552938,JL,Supp pg S31-S33,"","",Yes
SPK-0256458,Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256458-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13c,"","","",CHEMBL4207595,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552970,JL,Supp pg S31-S33,"","",Yes
SPK-0256458,Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256458-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13c,"","","",CHEMBL4207595,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553002,JL,Supp pg S31-S33,"","",Yes
SPK-0256458,Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256458-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13c,"","","",CHEMBL4207595,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553034,JL,Supp pg S31-S33,"","",Yes
SPK-0256458,Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256458-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13c,"","","",CHEMBL4207595,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553066,JL,Supp pg S31-S33,"","",Yes
SPK-0256458,Cn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256458-001,1.0 Hydrochloride,339.623,"","","",PMID:30034604 - Cmpd : 13c,"","","",CHEMBL4207595,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13c,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 67.9,MIC,> 67.9,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 67.9,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553098,JL,Supp pg S31-S33,"","",Yes
SPK-0256457,CCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256457-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13b,"","","",CHEMBL4211324,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13b,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,19.1,MIC,19.1,Test article,50.0,Visual,4.3,"","",Staphylococcus aureus,ATCC 43300,F-182,Yes,NA / Gram Positive,SCCmec: Type II; spa type Ridom: t007; spa type Kreiswirth: WGKKKKAOM; pvl gene amplification: Negative,"",Methicillin resistant (MRSA),"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Table 1; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,19.1,"",50.0,"","",4.30,"","",Staphylococcus aureus,ATCC 43300,F-182,Yes,NA / Gram Positive,"","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552679,JL,Table 1,"","",Yes
SPK-0256457,CCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256457-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13b,"","","",CHEMBL4211324,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552701,JL,Supp pg S31-S33,"","",Yes
SPK-0256457,CCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256457-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13b,"","","",CHEMBL4211324,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552730,JL,Supp pg S31-S33,"","",Yes
SPK-0256457,CCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256457-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13b,"","","",CHEMBL4211324,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552759,JL,Supp pg S31-S33,"","",Yes
SPK-0256457,CCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256457-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13b,"","","",CHEMBL4211324,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552815,JL,Supp pg S31-S33,"","",Yes
SPK-0256457,CCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256457-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13b,"","","",CHEMBL4211324,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552905,JL,Supp pg S31-S33,"","",Yes
SPK-0256457,CCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256457-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13b,"","","",CHEMBL4211324,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552937,JL,Supp pg S31-S33,"","",Yes
SPK-0256457,CCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256457-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13b,"","","",CHEMBL4211324,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552969,JL,Supp pg S31-S33,"","",Yes
SPK-0256457,CCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256457-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13b,"","","",CHEMBL4211324,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553001,JL,Supp pg S31-S33,"","",Yes
SPK-0256457,CCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256457-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13b,"","","",CHEMBL4211324,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553033,JL,Supp pg S31-S33,"","",Yes
SPK-0256457,CCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256457-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13b,"","","",CHEMBL4211324,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553065,JL,Supp pg S31-S33,"","",Yes
SPK-0256457,CCCCn1cc(-c2ccnc(N)n2)c2cc(Br)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256457-001,1.0 Hydrochloride,381.704,"","","",PMID:30034604 - Cmpd : 13b,"","","",CHEMBL4211324,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13b,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 76.3,MIC,> 76.3,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 76.3,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553097,JL,Supp pg S31-S33,"","",Yes
SPK-0256456,CCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256456-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13a,"","","",CHEMBL4213398,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13a,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,73.5,MIC,73.5,Test article,200,Visual,3.7,"","",Staphylococcus aureus,ATCC 43300,F-182,Yes,NA / Gram Positive,SCCmec: Type II; spa type Ridom: t007; spa type Kreiswirth: WGKKKKAOM; pvl gene amplification: Negative,"",Methicillin resistant (MRSA),"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Table 1; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,73.5,"",200,"","",3.70,"","",Staphylococcus aureus,ATCC 43300,F-182,Yes,NA / Gram Positive,"","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552680,JL,Table 1,"","",Yes
SPK-0256456,CCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256456-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13a,"","","",CHEMBL4213398,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256456,CCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256456-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13a,"","","",CHEMBL4213398,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256456,CCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256456-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13a,"","","",CHEMBL4213398,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,36.8,MIC,36.8,Test article,100,Visual,4.0,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,36.8,"",100,"","",4.00,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256456,CCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256456-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13a,"","","",CHEMBL4213398,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,36.8,MIC,36.8,Test article,100,Visual,4.0,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,36.8,"",100,"","",4.00,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256456,CCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256456-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13a,"","","",CHEMBL4213398,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256456,CCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256456-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13a,"","","",CHEMBL4213398,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256456,CCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256456-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13a,"","","",CHEMBL4213398,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,73.5,MIC,73.5,Test article,200,Visual,3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,73.5,"",200,"","",3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256456,CCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256456-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13a,"","","",CHEMBL4213398,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256456,CCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256456-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13a,"","","",CHEMBL4213398,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 73.5,MIC,> 73.5,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 73.5,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256456,CCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256456-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13a,"","","",CHEMBL4213398,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,73.5,MIC,73.5,Test article,200,Visual,3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,73.5,"",200,"","",3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256456,CCCn1cc(-c2ccnc(N)n2)c2ccc(Br)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256456-001,1.0 Hydrochloride,367.677,"","","",PMID:30034604 - Cmpd : 13a,"","","",CHEMBL4213398,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,13a,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,73.5,MIC,73.5,Test article,200,Visual,3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,73.5,"",200,"","",3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,"",JL,Supp pg S31-S33,"","",""
SPK-0256455,Nc1nccc(n1)-c1c[nH]c2ccccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256455-001,1.0 Hydrochloride,246.700,"","","",PMID:30034604 - Cmpd : 9o,"","","",CHEMBL4218319,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9o,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 49.3,MIC,> 49.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 49.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552702,JL,Supp pg S31-S33,"","",Yes
SPK-0256455,Nc1nccc(n1)-c1c[nH]c2ccccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256455-001,1.0 Hydrochloride,246.700,"","","",PMID:30034604 - Cmpd : 9o,"","","",CHEMBL4218319,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9o,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 49.3,MIC,> 49.3,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 49.3,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552731,JL,Supp pg S31-S33,"","",Yes
SPK-0256455,Nc1nccc(n1)-c1c[nH]c2ccccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256455-001,1.0 Hydrochloride,246.700,"","","",PMID:30034604 - Cmpd : 9o,"","","",CHEMBL4218319,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9o,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 49.3,MIC,> 49.3,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 49.3,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552760,JL,Supp pg S31-S33,"","",Yes
SPK-0256455,Nc1nccc(n1)-c1c[nH]c2ccccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256455-001,1.0 Hydrochloride,246.700,"","","",PMID:30034604 - Cmpd : 9o,"","","",CHEMBL4218319,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9o,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 49.3,MIC,> 49.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 49.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552817,JL,Supp pg S31-S33,"","",Yes
SPK-0256455,Nc1nccc(n1)-c1c[nH]c2ccccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256455-001,1.0 Hydrochloride,246.700,"","","",PMID:30034604 - Cmpd : 9o,"","","",CHEMBL4218319,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9o,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 49.3,MIC,> 49.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 49.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552903,JL,Supp pg S31-S33,"","",Yes
SPK-0256455,Nc1nccc(n1)-c1c[nH]c2ccccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256455-001,1.0 Hydrochloride,246.700,"","","",PMID:30034604 - Cmpd : 9o,"","","",CHEMBL4218319,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9o,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 49.3,MIC,> 49.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 49.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552935,JL,Supp pg S31-S33,"","",Yes
SPK-0256455,Nc1nccc(n1)-c1c[nH]c2ccccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256455-001,1.0 Hydrochloride,246.700,"","","",PMID:30034604 - Cmpd : 9o,"","","",CHEMBL4218319,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9o,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 49.3,MIC,> 49.3,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 49.3,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552967,JL,Supp pg S31-S33,"","",Yes
SPK-0256455,Nc1nccc(n1)-c1c[nH]c2ccccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256455-001,1.0 Hydrochloride,246.700,"","","",PMID:30034604 - Cmpd : 9o,"","","",CHEMBL4218319,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9o,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 49.3,MIC,> 49.3,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 49.3,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552999,JL,Supp pg S31-S33,"","",Yes
SPK-0256455,Nc1nccc(n1)-c1c[nH]c2ccccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256455-001,1.0 Hydrochloride,246.700,"","","",PMID:30034604 - Cmpd : 9o,"","","",CHEMBL4218319,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9o,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 49.3,MIC,> 49.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 49.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553031,JL,Supp pg S31-S33,"","",Yes
SPK-0256455,Nc1nccc(n1)-c1c[nH]c2ccccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256455-001,1.0 Hydrochloride,246.700,"","","",PMID:30034604 - Cmpd : 9o,"","","",CHEMBL4218319,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9o,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 49.3,MIC,> 49.3,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 49.3,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553063,JL,Supp pg S31-S33,"","",Yes
SPK-0256455,Nc1nccc(n1)-c1c[nH]c2ccccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256455-001,1.0 Hydrochloride,246.700,"","","",PMID:30034604 - Cmpd : 9o,"","","",CHEMBL4218319,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9o,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 49.3,MIC,> 49.3,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 49.3,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553095,JL,Supp pg S31-S33,"","",Yes
SPK-0256454,Cc1ccc2[nH]cc(-c3ccnc(N)n3)c2c1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256454-001,1.0 Hydrochloride,260.727,"","","",PMID:30034604 - Cmpd : 9n,"","","",CHEMBL4215900,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9n,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.1,MIC,> 52.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552703,JL,Supp pg S31-S33,"","",Yes
SPK-0256454,Cc1ccc2[nH]cc(-c3ccnc(N)n3)c2c1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256454-001,1.0 Hydrochloride,260.727,"","","",PMID:30034604 - Cmpd : 9n,"","","",CHEMBL4215900,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.1,MIC,> 52.1,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.1,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552732,JL,Supp pg S31-S33,"","",Yes
SPK-0256454,Cc1ccc2[nH]cc(-c3ccnc(N)n3)c2c1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256454-001,1.0 Hydrochloride,260.727,"","","",PMID:30034604 - Cmpd : 9n,"","","",CHEMBL4215900,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.1,MIC,> 52.1,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.1,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552761,JL,Supp pg S31-S33,"","",Yes
SPK-0256454,Cc1ccc2[nH]cc(-c3ccnc(N)n3)c2c1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256454-001,1.0 Hydrochloride,260.727,"","","",PMID:30034604 - Cmpd : 9n,"","","",CHEMBL4215900,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.1,MIC,> 52.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552818,JL,Supp pg S31-S33,"","",Yes
SPK-0256454,Cc1ccc2[nH]cc(-c3ccnc(N)n3)c2c1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256454-001,1.0 Hydrochloride,260.727,"","","",PMID:30034604 - Cmpd : 9n,"","","",CHEMBL4215900,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.1,MIC,> 52.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552902,JL,Supp pg S31-S33,"","",Yes
SPK-0256454,Cc1ccc2[nH]cc(-c3ccnc(N)n3)c2c1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256454-001,1.0 Hydrochloride,260.727,"","","",PMID:30034604 - Cmpd : 9n,"","","",CHEMBL4215900,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.1,MIC,> 52.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552934,JL,Supp pg S31-S33,"","",Yes
SPK-0256454,Cc1ccc2[nH]cc(-c3ccnc(N)n3)c2c1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256454-001,1.0 Hydrochloride,260.727,"","","",PMID:30034604 - Cmpd : 9n,"","","",CHEMBL4215900,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.1,MIC,> 52.1,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.1,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552966,JL,Supp pg S31-S33,"","",Yes
SPK-0256454,Cc1ccc2[nH]cc(-c3ccnc(N)n3)c2c1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256454-001,1.0 Hydrochloride,260.727,"","","",PMID:30034604 - Cmpd : 9n,"","","",CHEMBL4215900,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.1,MIC,> 52.1,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.1,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552998,JL,Supp pg S31-S33,"","",Yes
SPK-0256454,Cc1ccc2[nH]cc(-c3ccnc(N)n3)c2c1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256454-001,1.0 Hydrochloride,260.727,"","","",PMID:30034604 - Cmpd : 9n,"","","",CHEMBL4215900,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.1,MIC,> 52.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553030,JL,Supp pg S31-S33,"","",Yes
SPK-0256454,Cc1ccc2[nH]cc(-c3ccnc(N)n3)c2c1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256454-001,1.0 Hydrochloride,260.727,"","","",PMID:30034604 - Cmpd : 9n,"","","",CHEMBL4215900,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.1,MIC,> 52.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553062,JL,Supp pg S31-S33,"","",Yes
SPK-0256454,Cc1ccc2[nH]cc(-c3ccnc(N)n3)c2c1,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256454-001,1.0 Hydrochloride,260.727,"","","",PMID:30034604 - Cmpd : 9n,"","","",CHEMBL4215900,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9n,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.1,MIC,> 52.1,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.1,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553094,JL,Supp pg S31-S33,"","",Yes
SPK-0256453,Nc1nccc(n1)-c1c[nH]c2cc(F)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256453-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9m,"","","",CHEMBL4204240,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9m,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552704,JL,Supp pg S31-S33,"","",Yes
SPK-0256453,Nc1nccc(n1)-c1c[nH]c2cc(F)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256453-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9m,"","","",CHEMBL4204240,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552733,JL,Supp pg S31-S33,"","",Yes
SPK-0256453,Nc1nccc(n1)-c1c[nH]c2cc(F)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256453-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9m,"","","",CHEMBL4204240,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552762,JL,Supp pg S31-S33,"","",Yes
SPK-0256453,Nc1nccc(n1)-c1c[nH]c2cc(F)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256453-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9m,"","","",CHEMBL4204240,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552819,JL,Supp pg S31-S33,"","",Yes
SPK-0256453,Nc1nccc(n1)-c1c[nH]c2cc(F)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256453-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9m,"","","",CHEMBL4204240,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552901,JL,Supp pg S31-S33,"","",Yes
SPK-0256453,Nc1nccc(n1)-c1c[nH]c2cc(F)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256453-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9m,"","","",CHEMBL4204240,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552933,JL,Supp pg S31-S33,"","",Yes
SPK-0256453,Nc1nccc(n1)-c1c[nH]c2cc(F)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256453-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9m,"","","",CHEMBL4204240,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552965,JL,Supp pg S31-S33,"","",Yes
SPK-0256453,Nc1nccc(n1)-c1c[nH]c2cc(F)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256453-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9m,"","","",CHEMBL4204240,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552997,JL,Supp pg S31-S33,"","",Yes
SPK-0256453,Nc1nccc(n1)-c1c[nH]c2cc(F)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256453-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9m,"","","",CHEMBL4204240,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553029,JL,Supp pg S31-S33,"","",Yes
SPK-0256453,Nc1nccc(n1)-c1c[nH]c2cc(F)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256453-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9m,"","","",CHEMBL4204240,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553061,JL,Supp pg S31-S33,"","",Yes
SPK-0256453,Nc1nccc(n1)-c1c[nH]c2cc(F)ccc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256453-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9m,"","","",CHEMBL4204240,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9m,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553093,JL,Supp pg S31-S33,"","",Yes
SPK-0256452,Nc1nccc(n1)-c1c[nH]c2ccc(F)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256452-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9l,"","","",CHEMBL4203692,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9l,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552705,JL,Supp pg S31-S33,"","",Yes
SPK-0256452,Nc1nccc(n1)-c1c[nH]c2ccc(F)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256452-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9l,"","","",CHEMBL4203692,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552734,JL,Supp pg S31-S33,"","",Yes
SPK-0256452,Nc1nccc(n1)-c1c[nH]c2ccc(F)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256452-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9l,"","","",CHEMBL4203692,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552763,JL,Supp pg S31-S33,"","",Yes
SPK-0256452,Nc1nccc(n1)-c1c[nH]c2ccc(F)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256452-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9l,"","","",CHEMBL4203692,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552820,JL,Supp pg S31-S33,"","",Yes
SPK-0256452,Nc1nccc(n1)-c1c[nH]c2ccc(F)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256452-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9l,"","","",CHEMBL4203692,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552900,JL,Supp pg S31-S33,"","",Yes
SPK-0256452,Nc1nccc(n1)-c1c[nH]c2ccc(F)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256452-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9l,"","","",CHEMBL4203692,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552932,JL,Supp pg S31-S33,"","",Yes
SPK-0256452,Nc1nccc(n1)-c1c[nH]c2ccc(F)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256452-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9l,"","","",CHEMBL4203692,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552964,JL,Supp pg S31-S33,"","",Yes
SPK-0256452,Nc1nccc(n1)-c1c[nH]c2ccc(F)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256452-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9l,"","","",CHEMBL4203692,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552996,JL,Supp pg S31-S33,"","",Yes
SPK-0256452,Nc1nccc(n1)-c1c[nH]c2ccc(F)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256452-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9l,"","","",CHEMBL4203692,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553028,JL,Supp pg S31-S33,"","",Yes
SPK-0256452,Nc1nccc(n1)-c1c[nH]c2ccc(F)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256452-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9l,"","","",CHEMBL4203692,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 5075,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553060,JL,Supp pg S31-S33,"","",Yes
SPK-0256452,Nc1nccc(n1)-c1c[nH]c2ccc(F)cc12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256452-001,1.0 Hydrochloride,264.690,"","","",PMID:30034604 - Cmpd : 9l,"","","",CHEMBL4203692,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9l,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 52.9,MIC,> 52.9,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,ATCC BAA-2146,"1000527, 7561",Yes,Not characterized,ndm-1,ndm-1 reference strain; isolated from human urine,Carbapenem resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 52.9,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,ATCC 2146,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553092,JL,Supp pg S31-S33,"","",Yes
SPK-0256451,Nc1nccc(n1)-c1c[nH]c2cccc(Br)c12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256451-001,1.0 Hydrochloride,325.596,"","","",PMID:30034604 - Cmpd : 9k,"","","",CHEMBL4208568,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9k,"","","","","","","","","","","","","","","","","","","","","","",2021-03-23,Charlie Weatherall,SPARK,SPARK Terms of Use and Data Downloads,"",Uploaded Data,"By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 65.1,MIC,> 65.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM005,ATCC 17978/pMQ124XLAB1-mcr-1,No,Wild type,ATCC 17978 mcr-1,Carries mcr-1 expression plasmid in ATCC 17978 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 65.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552706,JL,Supp pg S31-S33,"","",Yes
SPK-0256451,Nc1nccc(n1)-c1c[nH]c2cccc(Br)c12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256451-001,1.0 Hydrochloride,325.596,"","","",PMID:30034604 - Cmpd : 9k,"","","",CHEMBL4208568,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 65.1,MIC,> 65.1,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,HM006,ATCC 25922/pMQ124-mcr-1,No,Wild type,ATCC 25922 mcr-1,Carries mcr-1 expression plasmid in ATCC 25922 background. Described in Liu 2017 Antimicrob Agents Chemother 61:e00580-17.,Colistin resistant due to engineered mcr-1 expression,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 65.1,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922 mcr-1,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552735,JL,Supp pg S31-S33,"","",Yes
SPK-0256451,Nc1nccc(n1)-c1c[nH]c2cccc(Br)c12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256451-001,1.0 Hydrochloride,325.596,"","","",PMID:30034604 - Cmpd : 9k,"","","",CHEMBL4208568,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 65.1,MIC,> 65.1,Test article,> 200,Visual,< 3.7,"","",Escherichia coli,ATCC 25922,AECO001; NB27001,No,Wild type,"",CLSI reference strain,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 65.1,"",> 200,"","",< 3.70,"","",Escherichia coli,ATCC 25922,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552764,JL,Supp pg S31-S33,"","",Yes
SPK-0256451,Nc1nccc(n1)-c1c[nH]c2cccc(Br)c12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256451-001,1.0 Hydrochloride,325.596,"","","",PMID:30034604 - Cmpd : 9k,"","","",CHEMBL4208568,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 65.1,MIC,> 65.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 17978,5377; NCDC KC 755,No,Wild type,"","","","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 65.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,17978,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552821,JL,Supp pg S31-S33,"","",Yes
SPK-0256451,Nc1nccc(n1)-c1c[nH]c2cccc(Br)c12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256451-001,1.0 Hydrochloride,325.596,"","","",PMID:30034604 - Cmpd : 9k,"","","",CHEMBL4208568,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 65.1,MIC,> 65.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM001,3941,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 65.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 3941,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552899,JL,Supp pg S31-S33,"","",Yes
SPK-0256451,Nc1nccc(n1)-c1c[nH]c2cccc(Br)c12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256451-001,1.0 Hydrochloride,325.596,"","","",PMID:30034604 - Cmpd : 9k,"","","",CHEMBL4208568,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 65.1,MIC,> 65.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,HM002,4106,Yes,Not characterized,"",From Walter Reed Army Institute of Research,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 65.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,isolate 4106,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552931,JL,Supp pg S31-S33,"","",Yes
SPK-0256451,Nc1nccc(n1)-c1c[nH]c2cccc(Br)c12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256451-001,1.0 Hydrochloride,325.596,"","","",PMID:30034604 - Cmpd : 9k,"","","",CHEMBL4208568,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 65.1,MIC,> 65.1,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM003,C3,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 65.1,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate C3,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552963,JL,Supp pg S31-S33,"","",Yes
SPK-0256451,Nc1nccc(n1)-c1c[nH]c2cccc(Br)c12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256451-001,1.0 Hydrochloride,325.596,"","","",PMID:30034604 - Cmpd : 9k,"","","",CHEMBL4208568,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 65.1,MIC,> 65.1,Test article,> 200,Visual,< 3.7,"","",Klebsiella pneumoniae,HM004,B9,Yes,Not characterized,"",From University of Pittsburgh,Colistin resistant,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 65.1,"",> 200,"","",< 3.70,"","",Klebsiella pneumoniae,isolate B9,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18552995,JL,Supp pg S31-S33,"","",Yes
SPK-0256451,Nc1nccc(n1)-c1c[nH]c2cccc(Br)c12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256451-001,1.0 Hydrochloride,325.596,"","","",PMID:30034604 - Cmpd : 9k,"","","",CHEMBL4208568,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 65.1,MIC,> 65.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,ATCC 19606,CIP 70.34; DSM 6974; 2208; 81,Yes,Wild type,"",CLSI reference strain; Quality control strain for food safety testing,"","","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/441971,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Supp pg S31-S33; CH,2020-01-02,2020-11-21,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Uploaded Data,> 65.1,"",> 200,"","",< 3.70,"","",Acinetobacter baumannii,ATCC 19606,"","","","","","","","","","","","","",Huggins 2018 ACS Med Chem Lett 9:702,"",ChEMBL 26,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,18553027,JL,Supp pg S31-S33,"","",Yes
SPK-0256451,Nc1nccc(n1)-c1c[nH]c2cccc(Br)c12,"","By accessing the SPARK data, you agree to these SPARK Data Terms of Use:
https://www.collaborativedrug.com/wp-content/uploads/2021/03/SPARK-data-terms-of-use.pdf","All SPARK data can be downloaded here:
https://www.collaborativedrug.com/SPARK-data-downloads","","","","","","","","","","","","","","","","","","","",001,SPK-0256451-001,1.0 Hydrochloride,325.596,"","","",PMID:30034604 - Cmpd : 9k,"","","",CHEMBL4208568,"","","",30034604,https://dx.doi.org/10.1021/acsmedchemlett.8b00161,Published Article - data from ChEMBL26,Huggins 2018 ACS Med Chem Lett 9:702,9k,"","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",2021-02-16,Huggins 2018 ACS Med. Chem. Lett. 9:702,"","Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

DOI: https://dx.doi.org/10.1021/acsmedchemlett.8b00161","",Curated Data,> 65.1,MIC,> 65.1,Test article,> 200,Visual,< 3.7,"","",Acinetobacter baumannii,AB5075,5075,Yes,Not characterized,"","Model strain for pathogenesis studies, MDR. Mutant library available (Gallagher 2015 J Bacteriol 197:2027)",MDR,"","","","37C, 16 hours, microtiter plate",CAMHB,"",Broth microdilution,Huggins 2018 ACS Med. Chem. Lett. 9:702,https://app.collaborativedrug.com/vaults/4724/runs/4